<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 3.2a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: vsta_10kxbrl.xfr; Date: 2012/07/02T18:03:44 -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2012-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2012-01-31" xmlns:us-roles="http://fasb.org/us-roles/2012-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2012-01-31" xmlns:vsta="http://vistagen.com/20120331">
    <link:schemaRef xlink:href="vsta-20120331.xsd" xlink:type="simple" />
    <xbrli:context id="From2011-04-01to2012-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-04-01</xbrli:startDate>
        <xbrli:endDate>2012-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-06-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-06-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2010-04-01to2011-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2010-04-01</xbrli:startDate>
        <xbrli:endDate>2011-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From1998-05-26to2012-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>1998-05-26</xbrli:startDate>
        <xbrli:endDate>2012-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf1998-05-25">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>1998-05-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2000-04-01to2001-03-31_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2000-04-01</xbrli:startDate>
        <xbrli:endDate>2001-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2001-04-01to2002-03-31_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2001-04-01</xbrli:startDate>
        <xbrli:endDate>2002-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2003-04-01to2004-03-31_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2003-04-01</xbrli:startDate>
        <xbrli:endDate>2004-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2004-04-01to2005-03-31_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2004-04-01</xbrli:startDate>
        <xbrli:endDate>2005-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2005-04-01to2006-03-31_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2005-04-01</xbrli:startDate>
        <xbrli:endDate>2006-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-04-01to2012-03-31_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-04-01</xbrli:startDate>
        <xbrli:endDate>2012-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf1998-05-25_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>1998-05-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2000-03-31_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2000-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2001-03-31_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2001-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2002-03-31_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2002-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2003-03-31_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2003-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2004-03-31_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2004-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2005-03-31_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2005-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2006-03-31_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2006-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2007-03-31_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2007-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2008-03-31_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2008-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2009-03-31_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2009-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-03-31_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-03-31_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-03-31_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From1998-05-26to1999-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>1998-05-26</xbrli:startDate>
        <xbrli:endDate>1999-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From1999-04-01to2000-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>1999-04-01</xbrli:startDate>
        <xbrli:endDate>2000-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2000-04-01to2001-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2000-04-01</xbrli:startDate>
        <xbrli:endDate>2001-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2001-04-01to2002-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2001-04-01</xbrli:startDate>
        <xbrli:endDate>2002-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2002-04-01to2003-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2002-04-01</xbrli:startDate>
        <xbrli:endDate>2003-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2003-04-01to2004-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2003-04-01</xbrli:startDate>
        <xbrli:endDate>2004-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2004-04-01to2005-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2004-04-01</xbrli:startDate>
        <xbrli:endDate>2005-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2005-04-01to2006-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2005-04-01</xbrli:startDate>
        <xbrli:endDate>2006-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2006-04-01to2007-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2006-04-01</xbrli:startDate>
        <xbrli:endDate>2007-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2007-04-01to2008-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2007-04-01</xbrli:startDate>
        <xbrli:endDate>2008-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2008-04-01to2009-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2008-04-01</xbrli:startDate>
        <xbrli:endDate>2009-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2009-04-01to2010-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2009-04-01</xbrli:startDate>
        <xbrli:endDate>2010-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-04-01to2012-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-04-01</xbrli:startDate>
        <xbrli:endDate>2012-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf1998-05-25_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>1998-05-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf1999-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>1999-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2000-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2000-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2001-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2001-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2002-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2002-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2003-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2003-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2004-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2004-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2005-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2005-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2006-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2006-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2007-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2007-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2008-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2008-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2009-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2009-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-03-31_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From1998-05-26to1999-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>1998-05-26</xbrli:startDate>
        <xbrli:endDate>1999-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From1999-04-01to2000-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>1999-04-01</xbrli:startDate>
        <xbrli:endDate>2000-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2000-04-01to2001-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2000-04-01</xbrli:startDate>
        <xbrli:endDate>2001-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2001-04-01to2002-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2001-04-01</xbrli:startDate>
        <xbrli:endDate>2002-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2002-04-01to2003-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2002-04-01</xbrli:startDate>
        <xbrli:endDate>2003-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2003-04-01to2004-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2003-04-01</xbrli:startDate>
        <xbrli:endDate>2004-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2004-04-01to2005-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2004-04-01</xbrli:startDate>
        <xbrli:endDate>2005-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2005-04-01to2006-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2005-04-01</xbrli:startDate>
        <xbrli:endDate>2006-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2006-04-01to2007-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2006-04-01</xbrli:startDate>
        <xbrli:endDate>2007-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2007-04-01to2008-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2007-04-01</xbrli:startDate>
        <xbrli:endDate>2008-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2008-04-01to2009-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2008-04-01</xbrli:startDate>
        <xbrli:endDate>2009-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2009-04-01to2010-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2009-04-01</xbrli:startDate>
        <xbrli:endDate>2010-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2010-04-01to2011-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2010-04-01</xbrli:startDate>
        <xbrli:endDate>2011-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-04-01to2012-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-04-01</xbrli:startDate>
        <xbrli:endDate>2012-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf1998-05-25_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>1998-05-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf1999-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>1999-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2000-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2000-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2001-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2001-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2002-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2002-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2003-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2003-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2004-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2004-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2005-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2005-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2006-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2006-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2007-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2007-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2008-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2008-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2009-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2009-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-03-31_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From1998-05-26to1999-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>1998-05-26</xbrli:startDate>
        <xbrli:endDate>1999-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From1999-04-01to2000-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>1999-04-01</xbrli:startDate>
        <xbrli:endDate>2000-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2000-04-01to2001-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2000-04-01</xbrli:startDate>
        <xbrli:endDate>2001-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2001-04-01to2002-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2001-04-01</xbrli:startDate>
        <xbrli:endDate>2002-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2002-04-01to2003-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2002-04-01</xbrli:startDate>
        <xbrli:endDate>2003-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2003-04-01to2004-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2003-04-01</xbrli:startDate>
        <xbrli:endDate>2004-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2004-04-01to2005-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2004-04-01</xbrli:startDate>
        <xbrli:endDate>2005-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2005-04-01to2006-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2005-04-01</xbrli:startDate>
        <xbrli:endDate>2006-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2006-04-01to2007-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2006-04-01</xbrli:startDate>
        <xbrli:endDate>2007-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2007-04-01to2008-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2007-04-01</xbrli:startDate>
        <xbrli:endDate>2008-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2008-04-01to2009-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2008-04-01</xbrli:startDate>
        <xbrli:endDate>2009-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2009-04-01to2010-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2009-04-01</xbrli:startDate>
        <xbrli:endDate>2010-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2010-04-01to2011-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2010-04-01</xbrli:startDate>
        <xbrli:endDate>2011-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-04-01to2012-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-04-01</xbrli:startDate>
        <xbrli:endDate>2012-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf1998-05-25_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>1998-05-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf1999-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>1999-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2000-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2000-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2001-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2001-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2002-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2002-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2003-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2003-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2004-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2004-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2005-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2005-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2006-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2006-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2007-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2007-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2008-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2008-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2009-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2009-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-03-31_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From1998-05-26to1999-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>1998-05-26</xbrli:startDate>
        <xbrli:endDate>1999-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From1999-04-01to2000-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>1999-04-01</xbrli:startDate>
        <xbrli:endDate>2000-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2000-04-01to2001-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2000-04-01</xbrli:startDate>
        <xbrli:endDate>2001-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2001-04-01to2002-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2001-04-01</xbrli:startDate>
        <xbrli:endDate>2002-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2002-04-01to2003-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2002-04-01</xbrli:startDate>
        <xbrli:endDate>2003-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2003-04-01to2004-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2003-04-01</xbrli:startDate>
        <xbrli:endDate>2004-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2004-04-01to2005-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2004-04-01</xbrli:startDate>
        <xbrli:endDate>2005-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2005-04-01to2006-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2005-04-01</xbrli:startDate>
        <xbrli:endDate>2006-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2006-04-01to2007-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2006-04-01</xbrli:startDate>
        <xbrli:endDate>2007-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2007-04-01to2008-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2007-04-01</xbrli:startDate>
        <xbrli:endDate>2008-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2008-04-01to2009-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2008-04-01</xbrli:startDate>
        <xbrli:endDate>2009-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2009-04-01to2010-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2009-04-01</xbrli:startDate>
        <xbrli:endDate>2010-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2010-04-01to2011-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2010-04-01</xbrli:startDate>
        <xbrli:endDate>2011-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-04-01to2012-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-04-01</xbrli:startDate>
        <xbrli:endDate>2012-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf1998-05-25_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>1998-05-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf1999-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>1999-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2000-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2000-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2001-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2001-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2002-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2002-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2003-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2003-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2004-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2004-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2005-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2005-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2006-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2006-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2007-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2007-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2008-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2008-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2009-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2009-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-03-31_NotesReceivableFromSaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:NotesReceivableFromSaleOfStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From1998-05-26to1999-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>1998-05-26</xbrli:startDate>
        <xbrli:endDate>1999-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From1999-04-01to2000-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>1999-04-01</xbrli:startDate>
        <xbrli:endDate>2000-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2000-04-01to2001-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2000-04-01</xbrli:startDate>
        <xbrli:endDate>2001-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2001-04-01to2002-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2001-04-01</xbrli:startDate>
        <xbrli:endDate>2002-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2002-04-01to2003-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2002-04-01</xbrli:startDate>
        <xbrli:endDate>2003-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2003-04-01to2004-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2003-04-01</xbrli:startDate>
        <xbrli:endDate>2004-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2004-04-01to2005-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2004-04-01</xbrli:startDate>
        <xbrli:endDate>2005-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2005-04-01to2006-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2005-04-01</xbrli:startDate>
        <xbrli:endDate>2006-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2006-04-01to2007-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2006-04-01</xbrli:startDate>
        <xbrli:endDate>2007-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2007-04-01to2008-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2007-04-01</xbrli:startDate>
        <xbrli:endDate>2008-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2008-04-01to2009-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2008-04-01</xbrli:startDate>
        <xbrli:endDate>2009-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2009-04-01to2010-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2009-04-01</xbrli:startDate>
        <xbrli:endDate>2010-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2010-04-01to2011-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2010-04-01</xbrli:startDate>
        <xbrli:endDate>2011-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-04-01to2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-04-01</xbrli:startDate>
        <xbrli:endDate>2012-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf1998-05-25_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>1998-05-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf1999-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>1999-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2000-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2000-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2001-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2001-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2002-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2002-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2003-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2003-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2004-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2004-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2005-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2005-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2006-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2006-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2007-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2007-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2008-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2008-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2009-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2009-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From1998-05-26to1999-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>1998-05-26</xbrli:startDate>
        <xbrli:endDate>1999-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From1999-04-01to2000-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>1999-04-01</xbrli:startDate>
        <xbrli:endDate>2000-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2000-04-01to2001-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2000-04-01</xbrli:startDate>
        <xbrli:endDate>2001-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2001-04-01to2002-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2001-04-01</xbrli:startDate>
        <xbrli:endDate>2002-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2002-04-01to2003-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2002-04-01</xbrli:startDate>
        <xbrli:endDate>2003-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2003-04-01to2004-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2003-04-01</xbrli:startDate>
        <xbrli:endDate>2004-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2004-04-01to2005-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2004-04-01</xbrli:startDate>
        <xbrli:endDate>2005-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2005-04-01to2006-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2005-04-01</xbrli:startDate>
        <xbrli:endDate>2006-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2006-04-01to2007-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2006-04-01</xbrli:startDate>
        <xbrli:endDate>2007-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2007-04-01to2008-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2007-04-01</xbrli:startDate>
        <xbrli:endDate>2008-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2008-04-01to2009-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2008-04-01</xbrli:startDate>
        <xbrli:endDate>2009-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2009-04-01to2010-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2009-04-01</xbrli:startDate>
        <xbrli:endDate>2010-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf1999-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>1999-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2000-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2000-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2001-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2001-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2002-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2002-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2003-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2003-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2004-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2004-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2005-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2005-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2006-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2006-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2007-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2007-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2008-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2008-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2009-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2009-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From1998-05-26to2000-03-31_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>1998-05-26</xbrli:startDate>
        <xbrli:endDate>2000-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2000-04-01to2001-03-31_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2000-04-01</xbrli:startDate>
        <xbrli:endDate>2001-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2001-04-01to2002-03-31_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2001-04-01</xbrli:startDate>
        <xbrli:endDate>2002-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2003-04-01to2004-03-31_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2003-04-01</xbrli:startDate>
        <xbrli:endDate>2004-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2004-04-01to2005-03-31_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2004-04-01</xbrli:startDate>
        <xbrli:endDate>2005-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2005-04-01to2006-03-31_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2005-04-01</xbrli:startDate>
        <xbrli:endDate>2006-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-04-01to2012-03-31_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-04-01</xbrli:startDate>
        <xbrli:endDate>2012-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf1998-05-25_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>1998-05-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2000-03-31_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2000-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2001-03-31_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2001-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2002-03-31_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2002-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2003-03-31_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2003-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2004-03-31_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2004-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2005-03-31_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2005-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2006-03-31_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2006-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2007-03-31_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2007-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2008-03-31_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2008-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2009-03-31_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2009-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-03-31_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-03-31_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-03-31_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From1998-05-26to2000-03-31_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>1998-05-26</xbrli:startDate>
        <xbrli:endDate>2000-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From1998-05-26to2000-03-31_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>1998-05-26</xbrli:startDate>
        <xbrli:endDate>2000-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2000-04-01to2001-03-31_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2000-04-01</xbrli:startDate>
        <xbrli:endDate>2001-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2001-04-01to2002-03-31_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2001-04-01</xbrli:startDate>
        <xbrli:endDate>2002-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2003-04-01to2004-03-31_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2003-04-01</xbrli:startDate>
        <xbrli:endDate>2004-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2004-04-01to2005-03-31_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2004-04-01</xbrli:startDate>
        <xbrli:endDate>2005-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2005-04-01to2006-03-31_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2005-04-01</xbrli:startDate>
        <xbrli:endDate>2006-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-04-01to2012-03-31_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-04-01</xbrli:startDate>
        <xbrli:endDate>2012-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf1998-05-25_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>1998-05-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2000-03-31_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2000-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2001-03-31_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2001-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2002-03-31_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2002-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2003-03-31_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2003-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2004-03-31_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2004-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2005-03-31_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2005-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2006-03-31_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2006-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2007-03-31_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2007-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2008-03-31_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2008-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2009-03-31_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2009-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-03-31_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-03-31_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-03-31_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From1998-05-26to2000-03-31_SeriesB1PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:SeriesB1PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>1998-05-26</xbrli:startDate>
        <xbrli:endDate>2000-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2000-04-01to2001-03-31_SeriesB1PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:SeriesB1PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2000-04-01</xbrli:startDate>
        <xbrli:endDate>2001-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2001-04-01to2002-03-31_SeriesB1PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:SeriesB1PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2001-04-01</xbrli:startDate>
        <xbrli:endDate>2002-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2003-04-01to2004-03-31_SeriesB1PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:SeriesB1PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2003-04-01</xbrli:startDate>
        <xbrli:endDate>2004-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2004-04-01to2005-03-31_SeriesB1PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:SeriesB1PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2004-04-01</xbrli:startDate>
        <xbrli:endDate>2005-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2005-04-01to2006-03-31_SeriesB1PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:SeriesB1PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2005-04-01</xbrli:startDate>
        <xbrli:endDate>2006-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-04-01to2012-03-31_SeriesB1PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:SeriesB1PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-04-01</xbrli:startDate>
        <xbrli:endDate>2012-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf1998-05-25_SeriesB1PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:SeriesB1PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>1998-05-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2000-03-31_SeriesB1PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:SeriesB1PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2000-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2001-03-31_SeriesB1PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:SeriesB1PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2001-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2002-03-31_SeriesB1PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:SeriesB1PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2002-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2003-03-31_SeriesB1PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:SeriesB1PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2003-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2004-03-31_SeriesB1PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:SeriesB1PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2004-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2005-03-31_SeriesB1PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:SeriesB1PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2005-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2006-03-31_SeriesB1PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:SeriesB1PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2006-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2007-03-31_SeriesB1PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:SeriesB1PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2007-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2008-03-31_SeriesB1PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:SeriesB1PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2008-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2009-03-31_SeriesB1PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:SeriesB1PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2009-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-03-31_SeriesB1PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:SeriesB1PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-03-31_SeriesB1PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:SeriesB1PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-03-31_SeriesB1PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">vsta:SeriesB1PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From1998-05-26to2000-03-31_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>1998-05-26</xbrli:startDate>
        <xbrli:endDate>2000-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2000-04-01to2001-03-31_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2000-04-01</xbrli:startDate>
        <xbrli:endDate>2001-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2001-04-01to2002-03-31_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2001-04-01</xbrli:startDate>
        <xbrli:endDate>2002-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2003-04-01to2004-03-31_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2003-04-01</xbrli:startDate>
        <xbrli:endDate>2004-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2004-04-01to2005-03-31_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2004-04-01</xbrli:startDate>
        <xbrli:endDate>2005-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2005-04-01to2006-03-31_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2005-04-01</xbrli:startDate>
        <xbrli:endDate>2006-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-04-01to2012-03-31_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-04-01</xbrli:startDate>
        <xbrli:endDate>2012-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf1998-05-25_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>1998-05-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2000-03-31_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2000-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2001-03-31_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2001-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2002-03-31_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2002-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2003-03-31_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2003-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2004-03-31_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2004-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2005-03-31_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2005-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2006-03-31_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2006-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2007-03-31_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2007-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2008-03-31_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2008-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2009-03-31_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2009-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-03-31_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-03-31_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-03-31_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From1998-05-26to2000-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001411685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>1998-05-26</xbrli:startDate>
        <xbrli:endDate>2000-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <dei:EntityRegistrantName contextRef="From2011-04-01to2012-03-31">VistaGen Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2011-04-01to2012-03-31">0001411685</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2011-04-01to2012-03-31">10-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2011-04-01to2012-03-31">2012-03-31</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2011-04-01to2012-03-31">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2011-04-01to2012-03-31">--03-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2011-04-01to2012-03-31">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2011-04-01to2012-03-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2011-04-01to2012-03-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityFilerCategory contextRef="From2011-04-01to2012-03-31">Smaller Reporting Company</dei:EntityFilerCategory>
    <dei:DocumentFiscalPeriodFocus contextRef="From2011-04-01to2012-03-31">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2011-04-01to2012-03-31">2012</dei:DocumentFiscalYearFocus>
    <dei:EntityPublicFloat contextRef="AsOf2012-06-28" unitRef="USD" decimals="0">22210726</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2012-06-28" unitRef="Shares" decimals="INF">17559963</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">29000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">31100</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">74500</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">87700</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:AssetsCurrent contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">238100</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">204800</us-gaap:AssetsCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">50900</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">23300</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:ReceivablesNetCurrent contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">106200</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">42200</us-gaap:ReceivablesNetCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">81000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">139300</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2010-03-31" unitRef="USD" decimals="0">201000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf1998-05-25" unitRef="USD" xsi:nil="true" />
    <us-gaap:Assets contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">341600</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">323600</us-gaap:Assets>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">3181900</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">10825700</us-gaap:LiabilitiesCurrent>
    <vsta:AccruedInterestOnPromissoryNotes contextRef="AsOf2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:AccruedInterestOnPromissoryNotes contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">1310800</vsta:AccruedInterestOnPromissoryNotes>
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2012-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">4809200</us-gaap:ConvertibleNotesPayable>
    <vsta:DeferredRevenues contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">13200</vsta:DeferredRevenues>
    <vsta:DeferredRevenues contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">78800</vsta:DeferredRevenues>
    <vsta:NoninterestBearingPromissoryNotes contextRef="AsOf2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:NoninterestBearingPromissoryNotes contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">1105700</vsta:NoninterestBearingPromissoryNotes>
    <us-gaap:CapitalLeaseObligationsCurrent contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">10500</us-gaap:CapitalLeaseObligationsCurrent>
    <us-gaap:CapitalLeaseObligationsCurrent contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">30100</us-gaap:CapitalLeaseObligationsCurrent>
    <vsta:PutOptionAndNoteTermExtensionOptionLiabilities contextRef="AsOf2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:PutOptionAndNoteTermExtensionOptionLiabilities contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">90800</vsta:PutOptionAndNoteTermExtensionOptionLiabilities>
    <vsta:NotesPayableAndAccruedInterestToRelatedParties contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">150800</vsta:NotesPayableAndAccruedInterestToRelatedParties>
    <vsta:NotesPayableAndAccruedInterestToRelatedParties contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">50400</vsta:NotesPayableAndAccruedInterestToRelatedParties>
    <us-gaap:NotesAndLoansPayableCurrent contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">599300</us-gaap:NotesAndLoansPayableCurrent>
    <us-gaap:NotesAndLoansPayableCurrent contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">160900</us-gaap:NotesAndLoansPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">657300</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">1421900</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">1750800</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">1767100</us-gaap:AccountsPayableCurrent>
    <us-gaap:Liabilities contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">6047200</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">18673300</us-gaap:Liabilities>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">2865300</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">7847600</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="AsOf2012-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">417100</us-gaap:OtherLiabilitiesNoncurrent>
    <vsta:AccountsPayableNonCurrent contextRef="AsOf2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:AccountsPayableNonCurrent contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">1140600</vsta:AccountsPayableNonCurrent>
    <us-gaap:CapitalLeaseObligationsNoncurrent contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">9700</us-gaap:CapitalLeaseObligationsNoncurrent>
    <us-gaap:CapitalLeaseObligationsNoncurrent contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">4500</us-gaap:CapitalLeaseObligationsNoncurrent>
    <vsta:AccruedOfficersCompensation contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">57000</vsta:AccruedOfficersCompensation>
    <vsta:AccruedOfficersCompensation contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">57000</vsta:AccruedOfficersCompensation>
    <vsta:AccruedInterestOnPromissoryNotesNonCurrent contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">5300</vsta:AccruedInterestOnPromissoryNotesNonCurrent>
    <vsta:AccruedInterestOnPromissoryNotesNonCurrent contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">585400</vsta:AccruedInterestOnPromissoryNotesNonCurrent>
    <vsta:ConvertiblePromissoryNotesNetOfCurrentPortion contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">700</vsta:ConvertiblePromissoryNotesNetOfCurrentPortion>
    <vsta:ConvertiblePromissoryNotesNetOfCurrentPortion contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">3326000</vsta:ConvertiblePromissoryNotesNetOfCurrentPortion>
    <vsta:NotesPayableAndAccruedInterestToRelatedPartiesNonCurrent contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">125100</vsta:NotesPayableAndAccruedInterestToRelatedPartiesNonCurrent>
    <vsta:NotesPayableAndAccruedInterestToRelatedPartiesNonCurrent contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">210800</vsta:NotesPayableAndAccruedInterestToRelatedPartiesNonCurrent>
    <vsta:NotesPayableAndAccruedInterest contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">2667500</vsta:NotesPayableAndAccruedInterest>
    <vsta:NotesPayableAndAccruedInterest contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">2106200</vsta:NotesPayableAndAccruedInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">341600</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">323600</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">-5705600</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">-32884500</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2010-03-31" unitRef="USD" decimals="0">-26337100</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf1998-05-25" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf1998-05-25_SeriesAPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2012-03-31_SeriesAPreferredStockMember" unitRef="USD" decimals="0">400</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf1998-05-25_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf1999-03-31_CommonStockMember" unitRef="USD" decimals="0">2600</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2000-03-31_CommonStockMember" unitRef="USD" decimals="0">2900</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2001-03-31_CommonStockMember" unitRef="USD" decimals="0">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2002-03-31_CommonStockMember" unitRef="USD" decimals="0">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2003-03-31_CommonStockMember" unitRef="USD" decimals="0">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2004-03-31_CommonStockMember" unitRef="USD" decimals="0">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2005-03-31_CommonStockMember" unitRef="USD" decimals="0">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2006-03-31_CommonStockMember" unitRef="USD" decimals="0">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2007-03-31_CommonStockMember" unitRef="USD" decimals="0">3400</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2008-03-31_CommonStockMember" unitRef="USD" decimals="0">3400</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2009-03-31_CommonStockMember" unitRef="USD" decimals="0">3400</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2010-03-31_CommonStockMember" unitRef="USD" decimals="0">5200</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2011-03-31_CommonStockMember" unitRef="USD" decimals="0">5200</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2012-03-31_CommonStockMember" unitRef="USD" decimals="0">18700</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf1998-05-25_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf1999-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">2800</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2000-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">83900</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2001-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">225700</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2002-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">266600</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2003-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">404900</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2004-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">419100</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2005-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">450900</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2006-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">460800</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2007-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1664500</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2008-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">2401000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2009-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">2588200</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2010-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">6923800</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2011-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">9867400</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2012-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">52539500</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf1998-05-25_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf1999-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2000-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2001-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2002-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2003-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2004-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2005-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2006-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2007-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2008-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2009-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2010-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2011-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2012-03-31_TreasuryStockMember" unitRef="USD" decimals="0">-3231700</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf1998-05-25_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf1999-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2000-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2001-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2002-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2003-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2004-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2005-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2006-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2007-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" decimals="0">-149800</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2008-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" decimals="0">-159000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2009-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" decimals="0">-166900</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2010-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" decimals="0">-175300</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2011-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" decimals="0">-184100</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2012-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" decimals="0">-250000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf1998-05-25_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf1999-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-230900</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2000-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-930900</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2001-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-2739900</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2002-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-4852900</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2003-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-5355500</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2004-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-14111000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2005-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-15193800</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2006-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-16965900</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2007-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-18965700</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2008-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-24412400</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2009-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-29108600</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2010-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-33090800</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2011-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-42573000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-54782500</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf1999-03-31" unitRef="USD" decimals="0">-225500</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2000-03-31" unitRef="USD" decimals="0">-844100</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2001-03-31" unitRef="USD" decimals="0">-2511200</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2002-03-31" unitRef="USD" decimals="0">-4583300</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2003-03-31" unitRef="USD" decimals="0">-4947600</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2004-03-31" unitRef="USD" decimals="0">-13688900</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2005-03-31" unitRef="USD" decimals="0">-14739900</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2006-03-31" unitRef="USD" decimals="0">-16502100</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2007-03-31" unitRef="USD" decimals="0">-17447600</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2008-03-31" unitRef="USD" decimals="0">-22167000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2009-03-31" unitRef="USD" decimals="0">-26683900</us-gaap:StockholdersEquity>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">-54782500</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">-42573000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <vsta:NotesReceivableFromSaleOfCommonStockToOthers contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">-250000</vsta:NotesReceivableFromSaleOfCommonStockToOthers>
    <vsta:NotesReceivableFromSaleOfCommonStockToOthers contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">-184100</vsta:NotesReceivableFromSaleOfCommonStockToOthers>
    <us-gaap:TreasuryStockValue contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">3231700</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="AsOf2011-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">52539500</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">9867400</us-gaap:AdditionalPaidInCapital>
    <us-gaap:CommonStockValue contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">18700</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">5200</us-gaap:CommonStockValue>
    <vsta:PreferredStockSeriesA contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">400</vsta:PreferredStockSeriesA>
    <vsta:PreferredStockSeriesA contextRef="AsOf2011-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PreferredStockValue contextRef="AsOf2012-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PreferredStockValue contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">14534800</us-gaap:PreferredStockValue>
    <us-gaap:Revenues contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">1342200</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">2071000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">16169800</us-gaap:Revenues>
    <us-gaap:OtherSalesRevenueNet contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherSalesRevenueNet contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherSalesRevenueNet contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">1123500</us-gaap:OtherSalesRevenueNet>
    <vsta:RevenueFromExternalCustomers contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:RevenueFromExternalCustomers contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:RevenueFromExternalCustomers contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">2283600</vsta:RevenueFromExternalCustomers>
    <us-gaap:RevenueFromGrants contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">1342200</us-gaap:RevenueFromGrants>
    <us-gaap:RevenueFromGrants contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">2071000</us-gaap:RevenueFromGrants>
    <us-gaap:RevenueFromGrants contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">12762700</us-gaap:RevenueFromGrants>
    <us-gaap:OperatingExpenses contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">10385600</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">8635900</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">60766500</us-gaap:OperatingExpenses>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">4997000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">4957700</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">27118400</us-gaap:GeneralAndAdministrativeExpense>
    <vsta:AcquiredInProcessResearchAndDevelopment contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:AcquiredInProcessResearchAndDevelopment contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:AcquiredInProcessResearchAndDevelopment contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">7523200</vsta:AcquiredInProcessResearchAndDevelopment>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">5388600</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">3678200</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">26124900</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingIncomeLoss contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">-9043400</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">-6564900</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">-44596700</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">1893200</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">3119400</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">9441500</us-gaap:InterestExpense>
    <vsta:ChangeInPutAndNoteExtensionOptionAndWarrantLiabilities contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">78000</vsta:ChangeInPutAndNoteExtensionOptionAndWarrantLiabilities>
    <vsta:ChangeInPutAndNoteExtensionOptionAndWarrantLiabilities contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">-203900</vsta:ChangeInPutAndNoteExtensionOptionAndWarrantLiabilities>
    <vsta:ChangeInPutAndNoteExtensionOptionAndWarrantLiabilities contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">-418500</vsta:ChangeInPutAndNoteExtensionOptionAndWarrantLiabilities>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">-1193500</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">-1193500</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">-12207900</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">-9480600</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">-54765700</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:OtherIncome contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">200</us-gaap:OtherIncome>
    <us-gaap:OtherIncome contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">-200</us-gaap:OtherIncome>
    <us-gaap:OtherIncome contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">47500</us-gaap:OtherIncome>
    <us-gaap:NetIncomeLoss contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">-12209500</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">-9482200</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">-54782500</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From1998-05-26to1999-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-230900</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From1999-04-01to2000-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2000-04-01to2001-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-1809000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2001-04-01to2002-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-2113000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2002-04-01to2003-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-502600</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2003-04-01to2004-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-8755500</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2004-04-01to2005-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-1082800</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2005-04-01to2006-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-1772100</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2006-04-01to2007-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-1999800</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2007-04-01to2008-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-5446700</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2008-04-01to2009-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-4696200</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2009-04-01to2010-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-4124500</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2010-04-01to2011-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-9482200</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2011-04-01to2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-12209500</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From1998-05-26to1999-03-31" unitRef="USD" decimals="0">-230900</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From1999-04-01to2000-03-31" unitRef="USD" decimals="0">-700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2000-04-01to2001-03-31" unitRef="USD" decimals="0">-1809000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2001-04-01to2002-03-31" unitRef="USD" decimals="0">-2113000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2002-04-01to2003-03-31" unitRef="USD" decimals="0">-502600</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2003-04-01to2004-03-31" unitRef="USD" decimals="0">-8755500</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2004-04-01to2005-03-31" unitRef="USD" decimals="0">-1082800</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2005-04-01to2006-03-31" unitRef="USD" decimals="0">-1772100</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2006-04-01to2007-03-31" unitRef="USD" decimals="0">-1999800</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2007-04-01to2008-03-31" unitRef="USD" decimals="0">-5446700</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2008-04-01to2009-03-31" unitRef="USD" decimals="0">-4696200</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2009-04-01to2010-03-31" unitRef="USD" decimals="0">-4124500</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">1600</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">1600</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">16800</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EarningsPerShareDiluted contextRef="From2011-04-01to2012-03-31" unitRef="USDPShares" decimals="INF">-0.83</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2010-04-01to2011-03-31" unitRef="USDPShares" decimals="INF">-1.81</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2011-04-01to2012-03-31" unitRef="Shares" decimals="INF">14736651</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2010-04-01to2011-03-31" unitRef="Shares" decimals="INF">5241110</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <vsta:AmortizationOfDiscountsOn77.5And10Notes contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">57200</vsta:AmortizationOfDiscountsOn77.5And10Notes>
    <vsta:AmortizationOfDiscountsOn77.5And10Notes contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">71000</vsta:AmortizationOfDiscountsOn77.5And10Notes>
    <vsta:AmortizationOfDiscountsOn77.5And10Notes contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">259200</vsta:AmortizationOfDiscountsOn77.5And10Notes>
    <vsta:AmortizationOfDiscountsOnPlatinumNotes contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">909000</vsta:AmortizationOfDiscountsOnPlatinumNotes>
    <vsta:AmortizationOfDiscountsOnPlatinumNotes contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">1376600</vsta:AmortizationOfDiscountsOnPlatinumNotes>
    <vsta:AmortizationOfDiscountsOnPlatinumNotes contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">3548700</vsta:AmortizationOfDiscountsOnPlatinumNotes>
    <vsta:AmortizationOfDiscountsOnAugust2010ShortTermNotes contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">14300</vsta:AmortizationOfDiscountsOnAugust2010ShortTermNotes>
    <vsta:AmortizationOfDiscountsOnAugust2010ShortTermNotes contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">557700</vsta:AmortizationOfDiscountsOnAugust2010ShortTermNotes>
    <vsta:AmortizationOfDiscountsOnAugust2010ShortTermNotes contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">572000</vsta:AmortizationOfDiscountsOnAugust2010ShortTermNotes>
    <vsta:AmortizationOfDiscountsOnFebruary201212ConvertibleNotes contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">-4200</vsta:AmortizationOfDiscountsOnFebruary201212ConvertibleNotes>
    <vsta:AmortizationOfDiscountsOnFebruary201212ConvertibleNotes contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:AmortizationOfDiscountsOnFebruary201212ConvertibleNotes contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">-4200</vsta:AmortizationOfDiscountsOnFebruary201212ConvertibleNotes>
    <vsta:ChangeInPutAndNoteTermExtensionOptionAndWarrantLiabilities contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">77900</vsta:ChangeInPutAndNoteTermExtensionOptionAndWarrantLiabilities>
    <vsta:ChangeInPutAndNoteTermExtensionOptionAndWarrantLiabilities contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">-203900</vsta:ChangeInPutAndNoteTermExtensionOptionAndWarrantLiabilities>
    <vsta:ChangeInPutAndNoteTermExtensionOptionAndWarrantLiabilities contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">-418600</vsta:ChangeInPutAndNoteTermExtensionOptionAndWarrantLiabilities>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">131200</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">1056600</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:ShareBasedCompensation contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">1591300</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">1628800</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">4354300</us-gaap:ShareBasedCompensation>
    <vsta:LossOnEarlyExtinguishmentOfDebt contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">1193500</vsta:LossOnEarlyExtinguishmentOfDebt>
    <vsta:LossOnEarlyExtinguishmentOfDebt contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:LossOnEarlyExtinguishmentOfDebt contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">1193500</vsta:LossOnEarlyExtinguishmentOfDebt>
    <vsta:ExpenseRelatedToModificationOfWarrants contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">741700</vsta:ExpenseRelatedToModificationOfWarrants>
    <vsta:ExpenseRelatedToModificationOfWarrants contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:ExpenseRelatedToModificationOfWarrants contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">741700</vsta:ExpenseRelatedToModificationOfWarrants>
    <vsta:FairValueOfCommonStockGrantedForServicesFollowingMerger contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">452000</vsta:FairValueOfCommonStockGrantedForServicesFollowingMerger>
    <vsta:FairValueOfCommonStockGrantedForServicesFollowingMerger contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">452000</vsta:FairValueOfCommonStockGrantedForServicesFollowingMerger>
    <vsta:ConsultingServicesByRelatedPartiesSettledByIssuingPromissoryNotes contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:ConsultingServicesByRelatedPartiesSettledByIssuingPromissoryNotes contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:ConsultingServicesByRelatedPartiesSettledByIssuingPromissoryNotes contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">44600</vsta:ConsultingServicesByRelatedPartiesSettledByIssuingPromissoryNotes>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">-16800</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">2838600</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">4385500</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">16580600</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDepositOtherAssets contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">2100</us-gaap:IncreaseDecreaseInDepositOtherAssets>
    <us-gaap:IncreaseDecreaseInDepositOtherAssets contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">4500</us-gaap:IncreaseDecreaseInDepositOtherAssets>
    <us-gaap:IncreaseDecreaseInDepositOtherAssets contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">-29000</us-gaap:IncreaseDecreaseInDepositOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">-1900</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">630900</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">-4500</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">-64000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">205000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">-106200</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">-3565800</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">-841300</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">-17508500</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">-65600</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">-60500</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">13200</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">-32400</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">-57800</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">-680800</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsToAcquireMachineryAndEquipment contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">32400</us-gaap:PaymentsToAcquireMachineryAndEquipment>
    <us-gaap:PaymentsToAcquireMachineryAndEquipment contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">57800</us-gaap:PaymentsToAcquireMachineryAndEquipment>
    <us-gaap:PaymentsToAcquireMachineryAndEquipment contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">680800</us-gaap:PaymentsToAcquireMachineryAndEquipment>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">2679200</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">2800000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">4198600</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:ProceedsFromUnsecuredLinesOfCredit contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromUnsecuredLinesOfCredit contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromUnsecuredLinesOfCredit contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">200000</us-gaap:ProceedsFromUnsecuredLinesOfCredit>
    <vsta:ProceedsFromIssuanceOf7NotePayableToFoundingStockholder contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsFromIssuanceOf7NotePayableToFoundingStockholder contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsFromIssuanceOf7NotePayableToFoundingStockholder contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">90000</vsta:ProceedsFromIssuanceOf7NotePayableToFoundingStockholder>
    <vsta:NetProceedsFromIssuanceOf7ConvertibleNotes contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:NetProceedsFromIssuanceOf7ConvertibleNotes contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:NetProceedsFromIssuanceOf7ConvertibleNotes contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">575000</vsta:NetProceedsFromIssuanceOf7ConvertibleNotes>
    <vsta:NetProceedsFromIssuanceOf10ConvertibleNotesAndWarrants contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:NetProceedsFromIssuanceOf10ConvertibleNotesAndWarrants contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:NetProceedsFromIssuanceOf10ConvertibleNotesAndWarrants contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">1655000</vsta:NetProceedsFromIssuanceOf10ConvertibleNotesAndWarrants>
    <vsta:NetProceedsFromIssuanceOf20062007NotesAndWarrants contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:NetProceedsFromIssuanceOf20062007NotesAndWarrants contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:NetProceedsFromIssuanceOf20062007NotesAndWarrants contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">1025000</vsta:NetProceedsFromIssuanceOf20062007NotesAndWarrants>
    <vsta:NetProceedsFromIssuanceOf20082010NotesAndWarrants contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:NetProceedsFromIssuanceOf20082010NotesAndWarrants contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">270000</vsta:NetProceedsFromIssuanceOf20082010NotesAndWarrants>
    <vsta:NetProceedsFromIssuanceOf20082010NotesAndWarrants contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">2971800</vsta:NetProceedsFromIssuanceOf20082010NotesAndWarrants>
    <vsta:NetProceedsFromIssuanceOfPlatinumNotesAndWarrants contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:NetProceedsFromIssuanceOfPlatinumNotesAndWarrants contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:NetProceedsFromIssuanceOfPlatinumNotesAndWarrants contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">3700000</vsta:NetProceedsFromIssuanceOfPlatinumNotesAndWarrants>
    <vsta:ProceedsFromIssuanceOf7NotesPayable contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsFromIssuanceOf7NotesPayable contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsFromIssuanceOf7NotesPayable contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">55000</vsta:ProceedsFromIssuanceOf7NotesPayable>
    <vsta:NetProceedsFromIssuanceOfAugust2010ShortTermNotesAndWarrants contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:NetProceedsFromIssuanceOfAugust2010ShortTermNotesAndWarrants contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">800000</vsta:NetProceedsFromIssuanceOfAugust2010ShortTermNotesAndWarrants>
    <vsta:NetProceedsFromIssuanceOfAugust2010ShortTermNotesAndWarrants contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">800000</vsta:NetProceedsFromIssuanceOfAugust2010ShortTermNotesAndWarrants>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">757600</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">205600</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">1332400</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">14500</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
    <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">27000</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
    <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">100500</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">-58300</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">-61700</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">81000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">3539900</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">837400</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">18270300</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <vsta:ResearchAndDevelopmentExpensesTextBlock contextRef="From2011-04-01to2012-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company recorded research and development&#13;expenses of approximately $5.4&amp;#160;million and $3.7&amp;#160;million in the fiscal years ended March&amp;#160;31, 2012 and 2011, respectively.&#13;Research and development expense is composed primarily of employee compensation expenses, including stock &amp;#150;based compensation,&amp;#160;&amp;#160;and&#13;direct project expenses, including costs incurred by third-party research collaborators, some of which may be reimbursed under&#13;the terms of grant or collaboration agreements.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</vsta:ResearchAndDevelopmentExpensesTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2011-04-01to2012-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The provision for income taxes for&#13;the periods presented in the consolidated statements of operations represents minimum California franchise taxes. Income tax expense&#13;differed from the amounts computed by applying the U.S.&amp;#160;federal income tax rate of 34% to pretax losses as a result of the&#13;following:&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="line-height: 115%; text-align: center; border-bottom: Black 1pt solid"&gt;Fiscal Years Ended March 31,&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;2011&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 70%; line-height: 115%"&gt;Computed expected tax benefit&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; line-height: 115%; text-align: right"&gt;(34.0)&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;%&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; line-height: 115%; text-align: right"&gt;(34.0)&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Losses not benefitted&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;34.0&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;34.0&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Other&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;0.1&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;0.1&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Income tax expense&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;0.1&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;0.1&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Deferred income taxes reflect the net&#13;tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and&#13;the amounts used for income tax purposes. Significant components of the Company&amp;#146;s deferred tax assets are as follows (thousands):&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="line-height: 115%; text-align: center; border-bottom: Black 1pt solid"&gt;March 31,&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;2011&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Deferred tax assets:&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 70%; line-height: 115%"&gt;Net operating loss carryovers&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 12%; line-height: 115%; text-align: right"&gt;16,191&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 12%; line-height: 115%; text-align: right"&gt;13,197&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Basis differences in fixed assets&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;13&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;19&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Accruals and reserves&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;9&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;6&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Total deferred tax assets&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;16,213&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;13,222&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Valuation allowance&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(16,213&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(13,222&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Net deferred tax assets&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Realization of deferred tax assets is&#13;dependent upon future earnings, if any, the timing and amount of which are uncertain. Accordingly, the deferred tax assets have&#13;been fully offset by a valuation allowance. The valuation allowance increased by $2,991,000 and $2,675,000 during the fiscal years&#13;ended March&amp;#160;31, 2012 and 2011, respectively. When realized, deferred tax assets related to employee stock options will be&#13;credited to additional paid-in capital.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of March&amp;#160;31, 2012, the Company&#13;had U.S.&amp;#160;federal net operating loss carryforwards of $41.2 million, which will expire in fiscal years&amp;#160;2019 through 2032.&amp;#160;&#13;As of March&amp;#160;31, 2012, the Company had state net operating loss carryforwards of $37.3 million, which will expire in fiscal&#13;years&amp;#160;2013 through 2032.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;U.S.&amp;#160;federal and state tax&#13;laws include substantial restrictions on the utilization of net operating loss carryforwards in the event of an ownership&#13;change of a corporation. The Company has not performed a change in ownership analysis since its inception in 1998 and&#13;accordingly some or all of its net operating loss carryforwards may not be available to offset future taxable income, if any.&#13;Even if the loss carryforwards are available they may be subject to substantial annual limitations resulting from past&#13;ownership changes, and ownership changes occurring after March&amp;#160;31, 2012, that could result in the expiration of the loss&#13;carryforwards before they are utilized.&amp;#160;&amp;#160; &lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company files income tax returns&#13;in the U.S.&amp;#160;federal and Canadian jurisdictions and California and Maryland state jurisdictions. The Company is subject to&#13;U.S.&amp;#160;federal and state income tax examinations by tax authorities for tax years 1999 through 2012 due to net operating losses&#13;that are being carried forward for tax purposes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company does not have any uncertain&#13;tax positions or unrecognized tax benefits at March&amp;#160;31, 2012 and 2011. The Company&amp;#146;s policy is to recognize interest&#13;and penalties related to income taxes as components of interest expense and other expense, respectively.&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <vsta:LicensingAndCollaborativeAgreementsTextBlock contextRef="From2011-04-01to2012-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;University Health Network&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On September 17, 2007, the Company and&#13;University Health Network (&amp;#34;UHN&amp;#34;) entered a Sponsored Research Collaboration Agreement (&amp;#147;SRCA&amp;#148;) to develop&#13;certain stem cell technologies for drug discovery and drug rescue technologies. Under the SRCA the Company is sponsoring stem cell&#13;research by its co-founder, Dr.&amp;#160;Gordon Keller, Director of the UHN&amp;#146;s McEwen Centre, focused on developing improved methods&#13;for differentiation of cardiomyocytes (heart cells) from pluripotent stem cells, and their uses as biological systems for drug&#13;discovery and drug rescue, as well as cell therapy. Pursuant to our SRCA with UHN, we have the right to acquire exclusive worldwide&#13;rights to any inventions arising from these studies under pre-negotiated terms. The SRCA was amended on April 19, 2010 to extend&#13;the term to five years and give the Company various options to extend the term for an additional three years. On December 15, 2010,&#13;the Company and UHN entered into a second amendment to expand the scope of work to include induced pluripotent stem cell technology&#13;and to further expand the scope of research and term extension options. On April 25, 2011, the Company and UHN amended the SRCA&#13;a third time to expand the scope to include therapeutic and stem cell therapy applications of induced pluripotent cells and to&#13;extend the date during which the Company may elect to fund additional projects to April 30, 2012.&amp;#160;&amp;#160;On October 24, 2011,&#13;the Company and UHN amended the SRCA a fourth time to identify five key programs that will further support the Company&amp;#146;s&#13;core drug rescue initiatives and potential cell therapy applications.&amp;#160;&amp;#160;Under the terms of the fourth amendment, the Company&#13;is obligated to make monthly payments of $50,000 per month from October 2011 through September 2012 to fund these programs.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Concurrent with the execution of the&#13;fourth amendment to the SRCA, the Company and UHN entered into a License Agreement under the terms of which UHN granted the Company&#13;exclusive rights to the use of a novel molecule that can be employed in the identification and isolation of mature and immature&#13;human cardiomyocytes from pluripotent stem cells, as well as methods for the production of cardiomyocytes from pluripotent stem&#13;cells that express this marker. In consideration for the grant of the license, the Company has agreed to make payments to UHN totaling&#13;$3.9 million, if, and when, it achieves certain milestones set forth in the License Agreement, and to pay UHN royalties based on&#13;the receipt of revenue by the Company attributable to the licensed patents.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In March 2012, the Company and UHN entered&#13;into License Agreement No. 2 under the terms of which UHN granted the Company exclusive rights to the use of technology included&#13;in a new U.S. patent application to develop hematopoietic precursor stem cells from human pluripotent stem cells.&amp;#160;&amp;#160;Hematopoietic&#13;precursor stem cells give rise to all red and white blood cells and platelets in the body. The Company plans to use the UHN invention&#13;to improve the cell culture methods utilized to efficiently produce hematopoietic stem cell populations. In consideration for the&#13;grant of the license, the Company issued to UHN 55,555 shares of its common stock, valued at $155,000 in March 2012 and is obligated&#13;to make a cash payment of $25,000 in July 2012.&amp;#160;&amp;#160;Under the terms of License Agreement No. 2, the Company has also agreed&#13;to make payments to UHN totaling $3.9 million, if, and when, it achieves certain milestones designated in License Agreement No.&#13;2, and to pay UHN royalties based on the receipt of revenue by the Company attributable to the licensed patents.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;U.S. National Institutes of Health&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Since the Company&amp;#146;s inception&#13;in 1998, the U.S. National Institutes of Health (&amp;#34;NIH&amp;#34;) has awarded it a total of $11.3 million in non-dilutive research&#13;and development grants, including $2.3 million to support research and development of its &lt;i&gt;Human Clinical Trials in a Test Tube&amp;#153;&lt;/i&gt;&#13;platform and, as described below, a total of $8.8 million for nonclinical and Phase 1 clinical development of AV-101 (also referred&#13;to in scientific literature as &amp;#147;4-Cl-KYN&amp;#148;).&amp;#160;&amp;#160;AV-101, the Company&amp;#146;s lead small molecule drug candidate,&#13;is currently in Phase 1b clinical development in the U.S.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During fiscal years 2006 through 2008,&#13;the U.S. National Institutes of Health (&amp;#34;NIH&amp;#34;) awarded the Company a $4.2&amp;#160;million grant to support preclinical development&#13;of AV-101 for treatment of neuropathic pain and other neurodegenerative diseases such as Huntington&amp;#146;s and Parkinson&amp;#146;s&#13;diseases. In April 2009, the NIH awarded the Company a $4.2&amp;#160;million grant to support the Phase I clinical development of AV-101,&#13;which amount was subsequently increased to a total of $4.6 million in July 2010. The Company recognized $1.2&amp;#160;million and $1.4&#13;million of grant revenue related to AV-101 in the fiscal years ended March 31, 2012 and 2011, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;Cato Research Ltd.&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has built a strategic development&#13;relationship with Cato Research Ltd. (&amp;#147;CRL&amp;#148;), a global contract research and development organization, or CRO, and&#13;an affiliate of the Company&amp;#146;s largest stockholder.&amp;#160;&amp;#160;See Note 14, &lt;i&gt;Related Party Transactions&lt;/i&gt;.&amp;#160;&amp;#160;CRL&#13;has provided the Company with access to essential CRO services supporting its preclinical and planned clinical development programs.&#13;The Company recorded research and development expenses of $1,461,300 and $429,200 in the fiscal years ended March 31, 2012 and&#13;2011, respectively, for services provided by CRL.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</vsta:LicensingAndCollaborativeAgreementsTextBlock>
    <vsta:StockOptionPlansAnd401KPlanTextBlock contextRef="From2011-04-01to2012-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has the following share-based&#13;compensation plans.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;2008 Stock Incentive Plan&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On December&amp;#160;19, 2008, the Company&#13;adopted the 2008 Stock Incentive Plan (the &amp;#147;2008 Plan&amp;#148;). The maximum number of shares of the Company&amp;#146;s common&#13;stock that may be granted pursuant to the 2008 Plan is 5,000,000&amp;#160;shares. The maximum number of shares that may be granted&#13;under the 2008 Plan is subject to adjustments for stock splits, stock dividends or other similar changes in the common stock or&#13;capital structure.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;1999 Stock Incentive Plan&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On December&amp;#160;6, 1999, the Company&#13;adopted the 1999 Stock Incentive Plan (the &amp;#147;1999 Plan&amp;#148;). The Company initially reserved 900,000&amp;#160;shares for the&#13;issuance of awards under the 1999 Plan. The 1999 Plan has terminated under its own terms and, as a result, no awards may currently&#13;be granted under the 1999 Plan. However, the options and awards that have already been granted pursuant to the 1999 Plan remain&#13;operative.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Scientific Advisory Board 1998&#13;Stock Incentive Plan&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&amp;#146;s Board of Directors&#13;adopted the Scientific Advisory Board 1998 Stock Incentive Plan (the &amp;#147;SAB&amp;#160;Plan&amp;#148;) in July 1998. The Board of Directors&#13;authorized 25,000&amp;#160;shares of common stock for awards from the SAB&amp;#160;Plan.&amp;#160;&amp;#160;No awards have been granted from the&#13;SAB&amp;#160;Plan since August 2001.&amp;#160;&amp;#160;The SAB&amp;#160;Plan expired in July 2008 and all of the options granted from the SAB&#13;Plan have either been exercised or expired during fiscal 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Description of the 2008 Plan&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Under the terms of the 2008 Plan, the&#13;Compensation Committee of the Company&amp;#146;s Board of Directors may grant shares, options or similar rights having either a fixed&#13;or variable price related to the fair market value of the shares and with an exercise or conversion privilege related to the passage&#13;of time, the occurrence of one or more events, or the satisfaction of performance criteria or other conditions, or any other security&#13;with the value derived from the value of the shares. Such awards include stock options, restricted stock, restricted stock units,&#13;stock appreciation rights and dividend equivalent rights.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Compensation Committee may grant&#13;nonstatutory stock options under the 2008 Plan at a price of not less than 100% of the fair market value of the Company&amp;#146;s&#13;common stock on the date the option is granted. Incentive stock options under the 2008 Plan may be granted at a price of not less&#13;than 100% of the fair market value of the Company&amp;#146;s common stock on the date the option is granted. Incentive stock options&#13;granted to employees who, on the date of grant, own stock representing more than 10% of the voting power of all of the Company&amp;#146;s&#13;classes of stock are granted at an exercise price of not less than 110% of the fair market value of the Company&amp;#146;s common&#13;stock. The maximum term of these incentive stock options granted to employees who own stock possessing more than 10% of the voting&#13;power of all classes of the Company&amp;#146;s stock may not exceed five years. The maximum term of an incentive stock option granted&#13;to any other participant may not exceed ten years. The Compensation Committee determines the term and exercise or purchase price&#13;of all other awards granted under the 2008 Plan. The Compensation Committee also determines the terms and conditions of awards,&#13;including the vesting schedule and any forfeiture provisions. Awards under the 2008 Plan may vest upon the passage of time or upon&#13;the attainment of certain performance criteria established by the Compensation Committee.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Unless terminated sooner, the 2008 Plan&#13;will automatically terminate in 2017. The Board of Directors may at any time amend, suspend or terminate the Company&amp;#146;s 2008&#13;Plan.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company recorded $1,113,900 and&#13;$1,154,000 of share-based compensation, net of estimated forfeitures, in general and administrative expenses in the consolidated&#13;statements of operations for fiscal years ended March&amp;#160;31, 2012 and 2011, respectively. The Company recorded $477,400 and $474,800&#13;of share-based compensation, net of estimated forfeitures, in research and development expenses, in the consolidated statements&#13;of operations for the fiscal years ended March&amp;#160;31, 2012 and 2011, respectively. No tax benefit has been recognized related&#13;to share-based compensation expense for fiscal years ended March&amp;#160;31, 2012 or 2011, since the Company has incurred cumulative&#13;net losses for which a valuation allowance has been established. No stock options were granted during the fiscal year ended March&#13;31,&amp;#160;2011.&amp;#160; The Company used the Black-Scholes option valuation model with the following assumptions to determine share-based&#13;compensation expense for the fiscal year ended March 31, 2012:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 82%; line-height: 115%"&gt;Expected dividend yield&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; line-height: 115%; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Exercise price (market price on grant date)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.58 to $2.99&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Risk-free interest rate&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; text-align: right"&gt;1.19% to 3.39%&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Expected term (years)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; text-align: right"&gt;6.25 to 10.0&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Volatility&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; text-align: right"&gt;78.9% to 91.3%&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Fair value per share at grant date&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.08 to $2.48&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The expected dividend yield is zero, as the Company has not&#13;paid any dividends and does not anticipate paying dividends in the near future. The risk-free interest rate for periods related&#13;to the expected life of the options is based on the U.S.&amp;#160;Treasury yield curve in effect at the time of grant. The expected&#13;volatility is based on historical volatilities of peer group public companies&amp;#146; stock over the expected term of the option.&#13;The expected term of options represents the period that the Company&amp;#146;s share-based compensation awards are expected to be&#13;outstanding. The Company used the simplified method provided in SEC Staff Accounting Bulletin&amp;#160;107 to estimate the expected&#13;term. The Company calculated the forfeiture rate based on an analysis of historical data as it reasonably approximates the currently&#13;anticipated rate of forfeitures for granted and outstanding options that have not vested.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;The following table summarizes stock option activity under&#13;the Company&amp;#146;s stock option plans:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="14" style="line-height: 115%; text-align: center; border-bottom: Black 1pt solid"&gt;Fiscal Years Ended March 31,&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;2011&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; text-align: center"&gt;Weighted&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; text-align: center"&gt;Weighted&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; text-align: center"&gt;Average&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; text-align: center"&gt;Average&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; text-align: center"&gt;Number of&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; text-align: center"&gt;Exercise&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; text-align: center"&gt;Number of&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; text-align: center"&gt;Exercise&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;Shares&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;Price&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;Shares&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;Price&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 40%; line-height: 115%"&gt;&amp;#160;Options outstanding at beginning of period&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; line-height: 115%; text-align: right"&gt;3,949,153&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 12%; line-height: 115%; text-align: right"&gt;1.42&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; line-height: 115%; text-align: right"&gt;3,949,153&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 12%; line-height: 115%; text-align: right"&gt;1.42&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Options granted&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1,020,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.88&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Options exercised&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(113,939&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;0.88&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Options forfeited&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(30,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.75&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Options expired&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(19,443&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;0.80&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Options outstanding at end of period&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;4,805,771&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.53&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;3,949,153&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.42&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Options exercisable at end of period&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;3,740,135&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.45&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;2,686,561&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.38&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Weighted average grant-date fair value of&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;options granted during the period&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;1.36&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;At March&amp;#160;31, 2012 there were 433,700&#13;shares of the Company&amp;#146;s common stock remaining available for grant under the 2008 Plan.&amp;#160;&amp;#160;The Company received cash&#13;proceeds of $102,200 as a result of options exercised during the year ended March 31, 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Aggregate intrinsic value is the sum&#13;of the amounts by which the fair value of the stock exceeded the exercise price (&amp;#147;in-the-money-options&amp;#148;). Based on&#13;the quoted market price of the Company&amp;#146;s common stock of $2.74 per share on March 31, 2012, the aggregate intrinsic value&#13;of outstanding options at that date was $5,807,700, of which $4,838,700 related to exercisable options.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table summarizes information&#13;on stock options outstanding and exercisable under the 2008 Plan and the 1999 Plan as of March 31, 2012:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="10" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;Options Outstanding&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;Options Exercisable&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; text-align: center"&gt;Weighted&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; text-align: center"&gt;Average&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; text-align: center"&gt;Weighted&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; text-align: center"&gt;Weighted&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; text-align: center"&gt;Remaining&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; text-align: center"&gt;Average&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; text-align: center"&gt;Average&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; text-align: center"&gt;Exercise&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; text-align: center"&gt;Number&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; text-align: center"&gt;Years until&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; text-align: center"&gt;Exercise&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; text-align: center"&gt;Number&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; text-align: center"&gt;Exercise&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;Price&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;Outstanding&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;Expiration&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;Price&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;Exercisable&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;Price&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 2%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 16%; line-height: 115%; text-align: right"&gt;0.72 - $0.95&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; line-height: 115%; text-align: right"&gt;364,816&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; line-height: 115%; text-align: right"&gt;3.89&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 10%; line-height: 115%; text-align: right"&gt;0.80&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; line-height: 115%; text-align: right"&gt;364,816&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 10%; line-height: 115%; text-align: right"&gt;0.80&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.13&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;287,500&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;5.74&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.13&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;241,242&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.13&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.50&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;2,838,800&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;7.68&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.50&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;2,791,924&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.50&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.65 - $1.925&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1,000,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;7.63&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.76&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;158,749&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.66&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;2.10 - $2.99&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;314,655&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;7.04&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;2.33&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;183,404&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;2.16&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;4,805,771&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;7.22&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.530&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;3,740,135&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.450&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of March 31, 2012, there was approximately&#13;$1,051,100 of unrecognized compensation cost related to non-vested share-based compensation awards, which is expected to be recognized&#13;through September 2015.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Stock Grants from 2008 Plan&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As discussed in Note 8, &lt;i&gt;Convertible&#13;Promissory Notes and Other Notes Payable, &lt;/i&gt;in April and May 2011, the Company issued an aggregate of 139,600 shares of its common&#13;stock from the 2008 Plan to Desjardins and McCarthy as partial compensation for services performed by the two entities.&amp;#160;&amp;#160;At&#13;the date of issuance, the shares were valued at $1.75 per share and the Company recorded $244,300 in general and administrative&#13;expense in connection with the issuances.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;401(k) Plan&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company maintains a retirement and&#13;deferred savings plan for its employees. This plan is intended to qualify as a tax-qualified plan under Section&amp;#160;401(k) of&#13;the Internal Revenue Code. The retirement and deferred savings plan provides that each participant may contribute a portion of&#13;his or her pre-tax compensation, subject to statutory limits. Under the plan, each employee is fully vested in his or her deferred&#13;salary contributions. Employee contributions are held and invested by the plan&amp;#146;s trustee. The retirement and deferred savings&#13;plan also permits the Company to make discretionary contributions, subject to established limits and a vesting schedule. To date,&#13;the Company has not made any discretionary contributions to the retirement and deferred savings plan on behalf of participating&#13;employees.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</vsta:StockOptionPlansAnd401KPlanTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2011-04-01to2012-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;Cato Holding Company, doing business as Cato BioVentures&#13;(&amp;#34;CBV&amp;#34;), the parent of CRL, is currently one of the Company&amp;#146;s largest institutional stockholders, holding common&#13;stock and warrants to purchase common stock. Prior to the May 11, 2011 conversion of the 2006/2007 Notes and the August 2010 Short-Term&#13;Notes, and the conversion of&amp;#160;&amp;#160;preferred stock into shares of common stock, CBV held 2006/2007 Notes, August 2010 Short-Terms&#13;Notes, and a majority of the Company's Series B-1 Preferred Stock.&amp;#160;&amp;#160;Shawn Singh, the Company&amp;#146;s Chief Executive&#13;Officer and member of its Board of Directors, served as Managing Principal of CBV and as an officer of CRL until August 2009.&#13;As described in Note&amp;#160;8, &lt;i&gt;Convertible Promissory Notes and Other Notes Payable&lt;/i&gt;, in April 2011, CBV loaned the Company&#13;$352,273 under a promissory note.&amp;#160;&amp;#160;During fiscal year 2007, the Company entered into a contract research organization&#13;arrangement with CRL related to the development of its lead drug candidate, AV-101, under which the Company incurred expenses&#13;of $1,461,300 and $429,200 for the fiscal years ended March&amp;#160;31, 2012 and 2011, respectively, a substantial portion of which&#13;were reimbursed under the NIH grant.&amp;#160;&amp;#160;Total interest expense on notes payable and the line of credit to CBV was $93,100&#13;and $92,600 for the fiscal years ended March 31, 2012 and 2011, respectively, with the majority of amounts reported for periods&#13;prior to May 2011 having been converted to equity. On April 29, 2011, the Company issued 157,143 shares of common stock, valued&#13;at $1.75 per share, as prepayment for research and development services to be performed by CRL during 2011.&amp;#160;&amp;#160;As described&#13;in Note 9, &lt;i&gt;Capital Stock, &lt;/i&gt;in December 2011, the Company entered into an Agreement Regarding Payment of Invoices and Warrant&#13;Exercises with CHC, CRL and the CHC affiliates under which CHC and the CHC Affiliates exercised warrants at discounted exercise&#13;prices to purchase an aggregate of 492,541 shares of the Company&amp;#146;s common stock and the Company received $60,200 cash, and,&#13;in lieu of cash payment for certain of the warrant exercises, settled outstanding liabilities of $245,300 for past services received&#13;from CRL and prepaid $226,400 for future services to be received from CRL, which services had been fully received by March 31,&#13;2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Prior to his April 2003 appointment&#13;as one of the Company&amp;#146;s officers (on a part-time basis) and as a director, the Company retained Mr. Singh as a consultant&#13;to provide legal and other consulting services. During the course of the consultancy, as payment for his services, the Company&#13;issued him warrants to purchase 55,898&amp;#160;shares of common stock at $0.80 per share and a 7% promissory note in the principal&#13;amount of $26,400. On May 11, 2011, and concurrent with the Merger, the Company paid the outstanding balance of principal and accrued&#13;interest totaling $36,000 (see Note&amp;#160;8, &lt;i&gt;Convertible Promissory Notes and Other Notes&lt;/i&gt; &lt;i&gt;Payable&lt;/i&gt;). Upon the approval&#13;by the Board of Directors, in December 2006, the Company accepted a full-recourse promissory note in the amount of $103,400 from&#13;Mr. Singh in payment of the exercise price for options and warrants to purchase an aggregate of 126,389&amp;#160;shares of the Company&amp;#146;s&#13;common stock. The note accrued interest at a rate of 4.90% per annum and was due and payable no later than the earlier of (i)&amp;#160;December&amp;#160;1,&#13;2016 or (ii)&amp;#160;ten days prior to the Company becoming subject to the requirements of the Securities Exchange Act of 1934, as&#13;amended (&amp;#147;Exchange Act&amp;#148;).&amp;#160;&amp;#160;On May 11, 2011, in connection with the Merger, the $128,200 outstanding balance&#13;of the principal and accrued interest on this note was cancelled in accordance with Mr. Singh's employment agreement and recorded&#13;as additional compensation. In accordance with his employment agreement, Mr. Singh is also entitled to an income tax gross-up on&#13;the compensation related to the note cancellation.&amp;#160;&amp;#160;At March 31, 2012, the Company had accrued $101,900 as an estimate&#13;of the gross-up amount, but had not paid it to Mr. Singh.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In March 2007, the Company accepted&#13;a full recourse promissory note in the amount of $46,400 from Franklin Rice, its former Chief Financial Officer and a former director&#13;of the Company in exchange for his exercise of options to purchase 52,681 shares of the Company&amp;#146;s common stock.&amp;#160;&amp;#160;The&#13;note accrued interest at a rate of 4.90% per annum and was due and payable no later than the earlier of (i)&amp;#160;March&amp;#160;1,&#13;2017 or (ii)&amp;#160;ten days prior to the Company becoming subject to the requirements of the Exchange Act.&amp;#160;&amp;#160;On May 11,&#13;2011, in connection with the Merger, the $57,000 outstanding balance of principal and accrued interest on this note was cancelled&#13;in accordance with Mr. Rice's employment agreement and recorded as additional compensation.&amp;#160;&amp;#160;In accordance with his employment&#13;agreement, Mr. Rice is entitled to an income tax gross-up on the compensation related to the note cancellation.&amp;#160;&amp;#160;At March&#13;31, 2012, the Company had accrued $33,900 as an estimate of the gross-up amount, but had not paid it to Mr. Rice.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company previously engaged Jon A.&#13;Saxe, a current director, separately from his duties as a director, as a management consultant from July&amp;#160;1, 2000 through June&amp;#160;30,&#13;2010 to provide strategic and other business advisory services. As payment for consulting services rendered through June&amp;#160;30,&#13;2010, Mr. Saxe has been issued warrants and non-qualified options to purchase an aggregate of 250,815 shares of the Company&amp;#146;s&#13;common stock, of which he has exercised warrants to purchase 18,568 shares.&amp;#160;&amp;#160;Additionally, Mr. Saxe was issued a 7% promissory&#13;note in the amount of $8,000.&amp;#160;&amp;#160;On May 11, 2011, the $14,400 balance of the note and related accrued interest plus a note&#13;cancellation premium of $5,100 was converted to 11,142 shares of the Company&amp;#146;s common stock and a three-year warrant to purchase&#13;2,784 shares of common stock at an exercise price of $2.50 per share.&amp;#160;&amp;#160;In lieu of payment from the Company, in December&#13;2011, Mr. Saxe exercised the warrant as a part of the Discounted Warrant Exercise Program at an exercise price of $1.25 per share&#13;in satisfaction of amounts owed to him in conjunction with his service as a member of the Board of Directors.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2011-04-01to2012-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;From time to time, the Company may become&#13;involved in claims and other legal matters arising in the ordinary course of business. Management is not currently aware of any&#13;matters that will have a material adverse effect on the Company&amp;#146;s consolidated financial position, results of operations&#13;or its cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company indemnifies its officers&#13;and directors for certain events or occurrences while the officer or director is or was serving at the Company&amp;#146;s request&#13;in such capacity. The term of the indemnification period is for the officer&amp;#146;s or director&amp;#146;s lifetime. The Company will&#13;indemnify the officers or directors against any and all expenses incurred by the officers or directors because of their status&#13;as one of the Company&amp;#146;s directors or executive officers to the fullest extent permitted by California law. The Company has&#13;never incurred costs to defend lawsuits or settle claims related to these indemnification agreements.&amp;#160; The Company has a director&#13;and officer insurance policy which limits the Company's exposure and may enable it to recover a portion of any future amounts paid.&amp;#160;&#13;The Company believes the fair value of these indemnification agreements is minimal. Accordingly, there are no liabilities recorded&#13;for these agreements at March&amp;#160;31, 2012 or 2011.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In the normal course of business, the&#13;Company provides indemnifications of varying scopes under agreements with other companies, typically clinical research organizations,&#13;investigators, clinical sites, suppliers and others.&amp;#160; Pursuant to these agreements, the Company generally indemnifies, holds&#13;harmless, and agrees to reimburse the indemnified parties for losses suffered or incurred by the indemnified parties in connection&#13;with the use or testing of the Company's product candidates or with any U.S. patents or any copyright or other intellectual property&#13;infringement claims by any third party with respect to the Company's product candidates.&amp;#160; The terms of these indemnification&#13;agreements are generally perpetual.&amp;#160; The potential future payments the Company could be required to make under these indemnification&#13;agreements is unlimited.&amp;#160; The Company maintains liability insurance coverage that limits its exposure.&amp;#160; The Company believes&#13;the fair value of these indemnification agreements is minimal.&amp;#160; Accordingly, the Company has not recorded any liabilities&#13;for these agreements as of March 31, 2012 or 2011.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Leases&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of March&amp;#160;31, 2012 and 2011,&#13;the following assets are under capital lease obligations and included in property and equipment:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="line-height: 115%; text-align: center; border-bottom: Black 1pt solid"&gt;March 31,&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;2011&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 70%; line-height: 115%"&gt;&amp;#160;Leased laboratory and computer equipment&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 12%; line-height: 115%; text-align: right"&gt;139,700&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 12%; line-height: 115%; text-align: right"&gt;120,700&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Accumulated amortization&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(119,200&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(92,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;20,500&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;28,700&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Amortization expense for assets recorded&#13;under capital leases is included in depreciation expense.&amp;#160; Future minimum payments, by year and in the aggregate, required&#13;under capital leases are as follows:&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;Fiscal Years Ending March 31,&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;Equipment Capital Leases&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 77%; line-height: 115%"&gt;2013&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 20%; line-height: 115%; text-align: right"&gt;12,100&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;2014&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;7,500&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;2015&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;3,100&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;2016&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;2017&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Future minimum lease payments&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;22,700&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Less imputed interest included in minimum lease payments&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(2,500&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Present value of minimum lease payments&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;20,200&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Less current portion&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(10,500&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Non-current capital lease obligation&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;9,700&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Future minimum payments under operating&#13;leases relate to the Company&amp;#146;s facility lease in South San Francisco, California through June 30, 2013 and total $175,500&#13;and $44,200 for the fiscal years ended March 31, 2013 and 2014, respectively.&amp;#160;&amp;#160;Total facility rent expense incurred by&#13;the Company for the fiscal years ended March&amp;#160;31, 2012 and 2011 was $166,000 and $151,600, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Long-term Debt Repayment&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;At March 31, 2012, future minimum principal&#13;payments related to long-term debt were as follows:&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;Fiscal Years Ending March 31,&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;Amount&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 78%; line-height: 115%"&gt;2013&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 19%; line-height: 115%; text-align: right"&gt;750,300&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;2014&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1,319,100&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;2015&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;688,900&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;2016&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1,396,900&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;2017&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;7,100&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Thereafter through October 2023&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;119,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;4,281,300&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2011-04-01to2012-03-31">&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has evaluated&#13;subsequent events through July 2, 2012 and has identified the following material events and transactions that occurred after&#13;March 31, 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In April and June 2012, the Company entered into various contracts for investor relations&#13;and public company services pursuant to which it granted three-year warrants to purchase 50,000 shares of the Company&amp;#146;s&#13;common stock at an exercise price of $2.80 per share; three-year warrants to purchase 100,000 shares of the Company's common&#13;stock at an exercise price of $3.00 per share; an aggregate of 400,000 shares of the Company's restricted common stock; and&#13;is obligated to make cash payments totaling $112,500 through December 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During May and June 2012, warrant holders&#13;exercised warrants to purchase an aggregate of 539,554 shares of the Company&amp;#146;s common stock and the Company received cash&#13;proceeds of $257,300. In addition, certain warrant holders exercised warrants to purchase an aggregate of 25,000 shares of the&#13;Company&amp;#146;s common stock in lieu of payment by the Company in satisfaction of amounts due for services in the aggregate amount&#13;of $12,500. In connection with the foregoing exercises, the Company issued three-year warrants to purchase 179,857 shares of the&#13;Company&amp;#146;s common stock at an exercise price of $3.00 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #494949; text-align: justify"&gt;&lt;font style="color: Black"&gt;On&#13;June 29, 2012, the Company and Platinum Long Term Growth Fund VII, LLC (&amp;#147;Platinum&amp;#148;) entered into an Exchange Agreement&#13;(the &amp;#147;Exchange Agreement&amp;#148;) pursuant to which the Company has agreed to issue Platinum 62,945 shares of the Company&amp;#146;s&#13;Series A Preferred in exchange for 629,450 shares of common stock owned by Platinum, in consideration for Platinum&amp;#146;s agreement&#13;to purchase from the Company secured convertible promissory notes in the aggregate principal amount of $500,000 (each a &amp;#147;Platinum&#13;Note&amp;#148; and together, the &amp;#147;Platinum Notes&amp;#148;).&amp;#160;&amp;#160;The Platinum Notes were issued on July 2, 2012 in the&#13;aggregate principal amount of $500,000.&amp;#160;&amp;#160;In the event the Company consummates an equity or equity-based financing, or&#13;series of financing transactions resulting in gross proceeds to the Company of at least $3.0 million (&amp;#147;Qualified Financing&amp;#148;),&#13;the principal and accrued interest due under the terms of the Platinum Notes shall automatically convert into such securities&#13;issued in connection with the Qualified Financing.&amp;#160;Repayment of&amp;#160;all amounts due under the terms of the Platinum Notes&#13;are secured by the Company&amp;#146;s assets, including its tangible and intangible personal property, licenses, patent licenses,&#13;trademarks and trademark licenses, pursuant to the terms of a Security Agreement.&amp;#160;&amp;#160;In connection with the Exchange Agreement,&#13;Platinum has also agreed to invest at least $500,000 in the Qualified Financing, provided that the Company secures binding commitments&#13;from other investors in the Qualified Financing aggregating at least $3.0 million within 90 days following the date of the Exchange&#13;Agreement.&amp;#160;&amp;#160;In addition, Platinum, at its option, may exchange all or a portion of its Series A Preferred for the securities&#13;issued in connection with the Qualified Financing based on the stated value of $15.00 per share of Series A Preferred.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <vsta:SupplementalFinancialInformationTextBlock contextRef="From2011-04-01to2012-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Quarterly Results of Operations (Unaudited)&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table presents the unaudited&#13;statements of operations data for each of the eight quarters in the period ended March 31, 2012.&amp;#160;&amp;#160;This information represents&#13;the activity of VistaGen (the California corporation) for the fiscal year ended March 31, 2011 and for the pre-Merger portion of&#13;the first quarter of fiscal 2012 and the consolidated activity of VistaGen (the California corporation) and Excaliber from May&#13;11, 2011 (the date of the Merger) through March 31, 2012. A total of 1,569,000 shares of common stock, representing the 784,500&#13;shares held by stockholders of Excaliber immediately prior to the Merger and effected for the post-Merger two-for-one forward stock&#13;split described in Note 1, &lt;i&gt;Description of Business&lt;/i&gt;, have been retroactively reflected as outstanding for the entire fiscal&#13;year ended March 31, 2011 and for the period prior to the Merger in the fiscal year ended March 31, 2012 for purposes of determining&#13;basic and diluted loss per common share below.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The information has been presented&#13;on the same basis as the audited financial statements and all necessary adjustments, consisting only of normal recurring adjustments,&#13;have been included in the amounts below to present fairly the unaudited quarterly results when read in conjunction with the audited&#13;financial statements and related notes. The operating results for any quarter should not be relied upon as necessarily indicative&#13;of results for any future period.&lt;br /&gt;&#13;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Unaudited Quarterly Results of Operations&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;(in thousands, except share and per&#13;share amounts)&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="14" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;Three Months Ended&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;June 30, 2011&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;September 30, 2011&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;December 31, 2011&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;March 31, 2012&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;Fiscal Year 2012&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Revenues:&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 40%; padding-left: 9pt; line-height: 115%; text-indent: 9pt"&gt;&amp;#160;Grant revenue&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 9%; border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;555&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 9%; border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;316&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 9%; border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;2&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 9%; border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;469&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 9%; border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;1,342&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: 0.25in"&gt;&amp;#160;&amp;#160;Total revenues&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;555&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;316&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;2&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;469&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;1,342&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Operating expenses:&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 9pt; line-height: 115%; text-indent: 9pt"&gt;&amp;#160;Research and development&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1,028&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1,227&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1,306&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1,828&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;5,389&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 9pt; line-height: 115%; text-indent: 9pt"&gt;&amp;#160;General and administrative&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;1,127&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;894&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;1,548&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;1,428&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;4,997&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: 0.25in"&gt;&amp;#160;&amp;#160;Total operating expenses&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;2,155&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;2,121&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;2,854&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;3,256&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;10,386&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Loss from operations&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(1,600&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(1,805&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(2,852&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(2,787&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(9,044&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Other expenses, net:&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 9pt; line-height: 115%; text-indent: 9pt"&gt;&amp;#160;Interest expense, net&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(731&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(451&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(455&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(256&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(1,893&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td colspan="4" style="padding-left: 9pt; line-height: 115%; text-indent: 9pt"&gt;&amp;#160;Change in put and note extension option and&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 9pt; line-height: 115%; text-indent: 9pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;warrant liabilities&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(78&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(78&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 9pt; line-height: 115%; text-indent: 9pt"&gt;&amp;#160;Loss on early extinguishment of debt&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(1,193&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(1,193&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Loss before income taxes&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(2,409&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(2,256&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(4,500&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(3,043&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(12,208&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Income taxes&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(2&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(2&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Net loss&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(2,411&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(2,256&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(4,500&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(3,043&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(12,210&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Basic and diluted net loss per common share&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(0.22&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(0.15&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(0.28&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(0.18&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(0.83&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Weighted average shares used in computing&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 9pt; line-height: 115%; text-indent: 9pt"&gt;&amp;#160;basic and diluted net loss per common share&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;11,105,854&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;15,241,904&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;16,035,861&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;16,542,717&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;14,736,651&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="14" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;Three Months Ended&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;June 30, 2010&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;September 30, 2010&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;December 31, 2010&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;March 31, 2011&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;Fiscal Year 2011&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Revenues:&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 40%; padding-left: 9pt; line-height: 115%; text-indent: 9pt"&gt;&amp;#160;Grant revenue&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 9%; border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;734&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 9%; border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;399&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 9%; border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;585&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 9%; border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;353&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 9%; border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;2,071&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: 0.25in"&gt;&amp;#160;&amp;#160;Total revenues&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;734&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;399&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;585&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;353&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;2,071&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Operating expenses:&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 9pt; line-height: 115%; text-indent: 9pt"&gt;&amp;#160;Research and development&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;675&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;692&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;447&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1,864&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;3,678&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 9pt; line-height: 115%; text-indent: 9pt"&gt;&amp;#160;General and administrative&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;520&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;570&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;2,665&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;1,203&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;4,958&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: 0.25in"&gt;&amp;#160;&amp;#160;Total operating expenses&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;1,195&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;1,262&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;3,112&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;3,067&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;8,636&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Loss from operations&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(461&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(863&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(2,527&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(2,714&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(6,565&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Other expenses, net:&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 9pt; line-height: 115%; text-indent: 9pt"&gt;&amp;#160;Interest expense, net&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(531&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(711&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(1,009&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(868&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(3,119&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td colspan="4" style="padding-left: 9pt; line-height: 115%; text-indent: 9pt"&gt;&amp;#160;Change in put and note extension option and&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 9pt; line-height: 115%; text-indent: 9pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;warrant liabilities&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;10&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;3&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;144&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;47&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;204&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Loss before income taxes&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(982&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(1,571&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(3,392&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(3,535&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(9,480&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Income taxes&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(2&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(2&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Net loss&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(982&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(1,573&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(3,392&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(3,535&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(9,482&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Basic and diluted net loss per common share&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(0.19&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(0.30&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(0.65&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(0.67&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(1.81&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Weighted average shares used in computing&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 9pt; line-height: 115%; text-indent: 9pt"&gt;basic and diluted net loss per common share&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;5,241,110&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;5,241,110&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;5,241,110&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;5,241,110&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;5,241,110&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;br /&gt;&#13;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</vsta:SupplementalFinancialInformationTextBlock>
    <us-gaap:InterestPaid contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">265400</us-gaap:InterestPaid>
    <us-gaap:InterestPaid contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">147400</us-gaap:InterestPaid>
    <us-gaap:InterestPaid contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">439700</us-gaap:InterestPaid>
    <us-gaap:IncomeTaxesPaid contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">1600</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">1600</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">16800</us-gaap:IncomeTaxesPaid>
    <vsta:ProceedsFromExerciseOfWarrantsUnderDiscountedWarrantExerciseProgram contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">1166300</vsta:ProceedsFromExerciseOfWarrantsUnderDiscountedWarrantExerciseProgram>
    <vsta:ProceedsFromExerciseOfWarrantsUnderDiscountedWarrantExerciseProgram contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">1166300</vsta:ProceedsFromExerciseOfWarrantsUnderDiscountedWarrantExerciseProgram>
    <vsta:NetProceedsFromIssuanceOfFebruary201212ConvertibleNotesAndWarrants contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">466500</vsta:NetProceedsFromIssuanceOfFebruary201212ConvertibleNotesAndWarrants>
    <vsta:NetProceedsFromIssuanceOfFebruary201212ConvertibleNotesAndWarrants contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:NetProceedsFromIssuanceOfFebruary201212ConvertibleNotesAndWarrants contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">466500</vsta:NetProceedsFromIssuanceOfFebruary201212ConvertibleNotesAndWarrants>
    <vsta:FairValueOfWarrantsGrantedForServicesFollowingMerger contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">564500</vsta:FairValueOfWarrantsGrantedForServicesFollowingMerger>
    <vsta:FairValueOfWarrantsGrantedForServicesFollowingMerger contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsGrantedForServicesFollowingMerger contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">564500</vsta:FairValueOfWarrantsGrantedForServicesFollowingMerger>
    <vsta:FairValueOfAdditionalWarrantsGrantedUnderDiscountedWarrantExerciseProgram contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">138100</vsta:FairValueOfAdditionalWarrantsGrantedUnderDiscountedWarrantExerciseProgram>
    <vsta:FairValueOfAdditionalWarrantsGrantedUnderDiscountedWarrantExerciseProgram contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfAdditionalWarrantsGrantedUnderDiscountedWarrantExerciseProgram contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">138100</vsta:FairValueOfAdditionalWarrantsGrantedUnderDiscountedWarrantExerciseProgram>
    <vsta:FairValueOfCommonStockIssuedForNoteTermModification contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">22400</vsta:FairValueOfCommonStockIssuedForNoteTermModification>
    <vsta:FairValueOfCommonStockIssuedForNoteTermModification contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfCommonStockIssuedForNoteTermModification contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">22400</vsta:FairValueOfCommonStockIssuedForNoteTermModification>
    <vsta:AmortizationOfImputedDiscountOnNonInterestBearingNotes contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:AmortizationOfImputedDiscountOnNonInterestBearingNotes contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:AmortizationOfImputedDiscountOnNonInterestBearingNotes contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">45000</vsta:AmortizationOfImputedDiscountOnNonInterestBearingNotes>
    <vsta:ForgivenessOfAccruedCompensationAndAccruedInterestPayableToOfficersTransferredToEquity contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:ForgivenessOfAccruedCompensationAndAccruedInterestPayableToOfficersTransferredToEquity contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:ForgivenessOfAccruedCompensationAndAccruedInterestPayableToOfficersTransferredToEquity contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">800000</vsta:ForgivenessOfAccruedCompensationAndAccruedInterestPayableToOfficersTransferredToEquity>
    <vsta:ExerciseOfWarrantsAndOptionsInExchangeForDebtCancellation contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:ExerciseOfWarrantsAndOptionsInExchangeForDebtCancellation contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:ExerciseOfWarrantsAndOptionsInExchangeForDebtCancellation contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">112800</vsta:ExerciseOfWarrantsAndOptionsInExchangeForDebtCancellation>
    <vsta:SettlementOfAccruedAndPrepaidInterestByIssuanceOfSeriesCPreferredStock contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:SettlementOfAccruedAndPrepaidInterestByIssuanceOfSeriesCPreferredStock contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:SettlementOfAccruedAndPrepaidInterestByIssuanceOfSeriesCPreferredStock contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">35300</vsta:SettlementOfAccruedAndPrepaidInterestByIssuanceOfSeriesCPreferredStock>
    <vsta:ConversionOf10NotesPayableNetOfDiscountAndRelatedAccruedInterestIntoSeriesCPreferredStock contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:ConversionOf10NotesPayableNetOfDiscountAndRelatedAccruedInterestIntoSeriesCPreferredStock contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:ConversionOf10NotesPayableNetOfDiscountAndRelatedAccruedInterestIntoSeriesCPreferredStock contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">2050300</vsta:ConversionOf10NotesPayableNetOfDiscountAndRelatedAccruedInterestIntoSeriesCPreferredStock>
    <vsta:IssuanceOfSeriesB1PreferredStockForAcquiredInprocessResearchAndDevelopment contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriesB1PreferredStockForAcquiredInprocessResearchAndDevelopment contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriesB1PreferredStockForAcquiredInprocessResearchAndDevelopment contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">7523200</vsta:IssuanceOfSeriesB1PreferredStockForAcquiredInprocessResearchAndDevelopment>
    <vsta:ConversionOf7NotesPayableNetOfDiscountAndRelatedAccruedInterestIntoSeriesBPreferredStock contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:ConversionOf7NotesPayableNetOfDiscountAndRelatedAccruedInterestIntoSeriesBPreferredStock contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:ConversionOf7NotesPayableNetOfDiscountAndRelatedAccruedInterestIntoSeriesBPreferredStock contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">508000</vsta:ConversionOf7NotesPayableNetOfDiscountAndRelatedAccruedInterestIntoSeriesBPreferredStock>
    <vsta:ConversionOfAccountsPayableIntoConvertiblePromissoryNotes contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:ConversionOfAccountsPayableIntoConvertiblePromissoryNotes contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:ConversionOfAccountsPayableIntoConvertiblePromissoryNotes contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">893700</vsta:ConversionOfAccountsPayableIntoConvertiblePromissoryNotes>
    <vsta:ConversionOfAccountsPayableIntoNotePayable contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:ConversionOfAccountsPayableIntoNotePayable contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">1126200</vsta:ConversionOfAccountsPayableIntoNotePayable>
    <vsta:ConversionOfAccountsPayableIntoNotePayable contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">2810300</vsta:ConversionOfAccountsPayableIntoNotePayable>
    <vsta:ConversionOfAccountsPayableIntoCommonStock contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">275400</vsta:ConversionOfAccountsPayableIntoCommonStock>
    <vsta:ConversionOfAccountsPayableIntoCommonStock contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:ConversionOfAccountsPayableIntoCommonStock contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">1824100</vsta:ConversionOfAccountsPayableIntoCommonStock>
    <vsta:ConversionOfAccruedInterestOnConvertiblePromissoryNotesIntoCommonStock contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:ConversionOfAccruedInterestOnConvertiblePromissoryNotesIntoCommonStock contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:ConversionOfAccruedInterestOnConvertiblePromissoryNotesIntoCommonStock contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">921400</vsta:ConversionOfAccruedInterestOnConvertiblePromissoryNotesIntoCommonStock>
    <vsta:NotesReceivableFromSaleOfCommonStockToRelatedPartiesUponExerciseOfOptionsAndWarrants contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:NotesReceivableFromSaleOfCommonStockToRelatedPartiesUponExerciseOfOptionsAndWarrants contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:NotesReceivableFromSaleOfCommonStockToRelatedPartiesUponExerciseOfOptionsAndWarrants contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">149800</vsta:NotesReceivableFromSaleOfCommonStockToRelatedPartiesUponExerciseOfOptionsAndWarrants>
    <us-gaap:CapitalLeaseObligationsIncurred contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">19000</us-gaap:CapitalLeaseObligationsIncurred>
    <us-gaap:CapitalLeaseObligationsIncurred contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CapitalLeaseObligationsIncurred contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">139700</us-gaap:CapitalLeaseObligationsIncurred>
    <vsta:RecognitionOfPutOptionAndNoteTermExtensionOptionLiabilitiesUponIssuanceOfPlatinumNotes contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:RecognitionOfPutOptionAndNoteTermExtensionOptionLiabilitiesUponIssuanceOfPlatinumNotes contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:RecognitionOfPutOptionAndNoteTermExtensionOptionLiabilitiesUponIssuanceOfPlatinumNotes contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">141200</vsta:RecognitionOfPutOptionAndNoteTermExtensionOptionLiabilitiesUponIssuanceOfPlatinumNotes>
    <vsta:IncrementalFairValueOfPutOptionAndNoteTermExtensionOptionLiabilitiesFromDebtModifications contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:IncrementalFairValueOfPutOptionAndNoteTermExtensionOptionLiabilitiesFromDebtModifications contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">158000</vsta:IncrementalFairValueOfPutOptionAndNoteTermExtensionOptionLiabilitiesFromDebtModifications>
    <vsta:IncrementalFairValueOfPutOptionAndNoteTermExtensionOptionLiabilitiesFromDebtModifications contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">479400</vsta:IncrementalFairValueOfPutOptionAndNoteTermExtensionOptionLiabilitiesFromDebtModifications>
    <vsta:IncrementalFairValueOfNoteConversionOptionFromDebtModification contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:IncrementalFairValueOfNoteConversionOptionFromDebtModification contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">1062800</vsta:IncrementalFairValueOfNoteConversionOptionFromDebtModification>
    <vsta:IncrementalFairValueOfNoteConversionOptionFromDebtModification contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">1891200</vsta:IncrementalFairValueOfNoteConversionOptionFromDebtModification>
    <vsta:IncrementalFairValueOfWarrantFromDebtModifications contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:IncrementalFairValueOfWarrantFromDebtModifications contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">121100</vsta:IncrementalFairValueOfWarrantFromDebtModifications>
    <vsta:IncrementalFairValueOfWarrantFromDebtModifications contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">276700</vsta:IncrementalFairValueOfWarrantFromDebtModifications>
    <vsta:RecognitionOfWarrantLiabilityUponAdoptionOfNewAccountingStandard contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:RecognitionOfWarrantLiabilityUponAdoptionOfNewAccountingStandard contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:RecognitionOfWarrantLiabilityUponAdoptionOfNewAccountingStandard contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">151300</vsta:RecognitionOfWarrantLiabilityUponAdoptionOfNewAccountingStandard>
    <vsta:FairValueOfWarrantsIssuedWithAugust2010ShortTermNotes contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedWithAugust2010ShortTermNotes contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">130900</vsta:FairValueOfWarrantsIssuedWithAugust2010ShortTermNotes>
    <vsta:FairValueOfWarrantsIssuedWithAugust2010ShortTermNotes contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">130900</vsta:FairValueOfWarrantsIssuedWithAugust2010ShortTermNotes>
    <vsta:NoteDiscountUponIssuanceOfAugust2010ShorttermNotes contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:NoteDiscountUponIssuanceOfAugust2010ShorttermNotes contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">320000</vsta:NoteDiscountUponIssuanceOfAugust2010ShorttermNotes>
    <vsta:NoteDiscountUponIssuanceOfAugust2010ShorttermNotes contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">320000</vsta:NoteDiscountUponIssuanceOfAugust2010ShorttermNotes>
    <vsta:FairValueOfWarrantsIssuedWithFebruary201212ConvertibleNotes contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">542000</vsta:FairValueOfWarrantsIssuedWithFebruary201212ConvertibleNotes>
    <vsta:FairValueOfWarrantsIssuedWithFebruary201212ConvertibleNotes contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedWithFebruary201212ConvertibleNotes contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">542000</vsta:FairValueOfWarrantsIssuedWithFebruary201212ConvertibleNotes>
    <vsta:NoteDiscountUponIssuanceOfFebruary201212ConvertibleNotes contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">495200</vsta:NoteDiscountUponIssuanceOfFebruary201212ConvertibleNotes>
    <vsta:NoteDiscountUponIssuanceOfFebruary201212ConvertibleNotes contextRef="From2010-04-01to2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:NoteDiscountUponIssuanceOfFebruary201212ConvertibleNotes contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">495200</vsta:NoteDiscountUponIssuanceOfFebruary201212ConvertibleNotes>
    <us-gaap:DepreciationAndAmortization contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">45600</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">45300</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From1998-05-26to2012-03-31" unitRef="USD" decimals="0">743700</us-gaap:DepreciationAndAmortization>
    <us-gaap:SharesIssued contextRef="AsOf1998-05-25_SeriesAPreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:SharesIssued contextRef="AsOf2012-03-31_SeriesAPreferredStockMember" unitRef="Shares" decimals="INF">437055</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf1998-05-25_CommonStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:SharesIssued contextRef="AsOf1999-03-31_CommonStockMember" unitRef="Shares" decimals="INF">2573000</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2000-03-31_CommonStockMember" unitRef="Shares" decimals="INF">2877375</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2001-03-31_CommonStockMember" unitRef="Shares" decimals="INF">2991375</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2002-03-31_CommonStockMember" unitRef="Shares" decimals="INF">2992886</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2003-03-31_CommonStockMember" unitRef="Shares" decimals="INF">3007886</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2004-03-31_CommonStockMember" unitRef="Shares" decimals="INF">3010811</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2005-03-31_CommonStockMember" unitRef="Shares" decimals="INF">3021519</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2006-03-31_CommonStockMember" unitRef="Shares" decimals="INF">3036123</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2007-03-31_CommonStockMember" unitRef="Shares" decimals="INF">3392504</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2008-03-31_CommonStockMember" unitRef="Shares" decimals="INF">3414738</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2009-03-31_CommonStockMember" unitRef="Shares" decimals="INF">3418232</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2010-03-31_CommonStockMember" unitRef="Shares" decimals="INF">5241110</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2011-03-31_CommonStockMember" unitRef="Shares" decimals="INF">5241110</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2012-03-31_CommonStockMember" unitRef="Shares" decimals="INF">18704267</us-gaap:SharesIssued>
    <vsta:CommonStockIssuedForServicesAmount contextRef="From2009-04-01to2010-03-31_CommonStockMember" unitRef="USD" decimals="0">200</vsta:CommonStockIssuedForServicesAmount>
    <vsta:CommonStockIssuedForServicesAmount contextRef="From2009-04-01to2010-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">262300</vsta:CommonStockIssuedForServicesAmount>
    <vsta:CommonStockIssuedForServicesAmount contextRef="From2009-04-01to2010-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedForServicesAmount contextRef="From2009-04-01to2010-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedForServicesAmount contextRef="From2009-04-01to2010-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedForServicesAmount contextRef="From2009-04-01to2010-03-31" unitRef="USD" decimals="0">262500</vsta:CommonStockIssuedForServicesAmount>
    <vsta:CommonStockIssuedForServicesShares contextRef="From2009-04-01to2010-03-31_CommonStockMember" unitRef="Shares" decimals="INF">175000</vsta:CommonStockIssuedForServicesShares>
    <vsta:InitialSaleOfCommonStockForCashToFounderAmount contextRef="From1998-05-26to1999-03-31_CommonStockMember" unitRef="USD" decimals="0">1000</vsta:InitialSaleOfCommonStockForCashToFounderAmount>
    <vsta:InitialSaleOfCommonStockForCashToFounderAmount contextRef="From1998-05-26to1999-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">4000</vsta:InitialSaleOfCommonStockForCashToFounderAmount>
    <vsta:InitialSaleOfCommonStockForCashToFounderAmount contextRef="From1998-05-26to1999-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:InitialSaleOfCommonStockForCashToFounderAmount contextRef="From1998-05-26to1999-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:InitialSaleOfCommonStockForCashToFounderAmount contextRef="From1998-05-26to1999-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:InitialSaleOfCommonStockForCashToFounderAmount contextRef="From1998-05-26to1999-03-31" unitRef="USD" decimals="0">5000</vsta:InitialSaleOfCommonStockForCashToFounderAmount>
    <vsta:InitialSaleOfCommonStockForCashToFounderShares contextRef="From1998-05-26to1999-03-31_CommonStockMember" unitRef="Shares" decimals="INF">1000000</vsta:InitialSaleOfCommonStockForCashToFounderShares>
    <vsta:FairValueOfCommonStockIssuedForServicesAmount contextRef="From1998-05-26to1999-03-31_CommonStockMember" unitRef="USD" decimals="0">400</vsta:FairValueOfCommonStockIssuedForServicesAmount>
    <vsta:FairValueOfCommonStockIssuedForServicesAmount contextRef="From1999-04-01to2000-03-31_CommonStockMember" unitRef="USD" decimals="0">100</vsta:FairValueOfCommonStockIssuedForServicesAmount>
    <vsta:FairValueOfCommonStockIssuedForServicesAmount contextRef="From2000-04-01to2001-03-31_CommonStockMember" unitRef="USD" decimals="0">100</vsta:FairValueOfCommonStockIssuedForServicesAmount>
    <vsta:FairValueOfCommonStockIssuedForServicesAmount contextRef="From1998-05-26to1999-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">400</vsta:FairValueOfCommonStockIssuedForServicesAmount>
    <vsta:FairValueOfCommonStockIssuedForServicesAmount contextRef="From1999-04-01to2000-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">21800</vsta:FairValueOfCommonStockIssuedForServicesAmount>
    <vsta:FairValueOfCommonStockIssuedForServicesAmount contextRef="From2000-04-01to2001-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">32900</vsta:FairValueOfCommonStockIssuedForServicesAmount>
    <vsta:FairValueOfCommonStockIssuedForServicesAmount contextRef="From1998-05-26to1999-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfCommonStockIssuedForServicesAmount contextRef="From1999-04-01to2000-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfCommonStockIssuedForServicesAmount contextRef="From2000-04-01to2001-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfCommonStockIssuedForServicesAmount contextRef="From1998-05-26to1999-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfCommonStockIssuedForServicesAmount contextRef="From1999-04-01to2000-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfCommonStockIssuedForServicesAmount contextRef="From2000-04-01to2001-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfCommonStockIssuedForServicesAmount contextRef="From1998-05-26to1999-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfCommonStockIssuedForServicesAmount contextRef="From1999-04-01to2000-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfCommonStockIssuedForServicesAmount contextRef="From2000-04-01to2001-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfCommonStockIssuedForServicesAmount contextRef="From1998-05-26to1999-03-31" unitRef="USD" decimals="0">400</vsta:FairValueOfCommonStockIssuedForServicesAmount>
    <vsta:FairValueOfCommonStockIssuedForServicesAmount contextRef="From1999-04-01to2000-03-31" unitRef="USD" decimals="0">21900</vsta:FairValueOfCommonStockIssuedForServicesAmount>
    <vsta:FairValueOfCommonStockIssuedForServicesAmount contextRef="From2000-04-01to2001-03-31" unitRef="USD" decimals="0">33000</vsta:FairValueOfCommonStockIssuedForServicesAmount>
    <vsta:FairValueOfCommonStockIssuedForServicesShares contextRef="From1998-05-26to1999-03-31_CommonStockMember" unitRef="Shares" decimals="INF">4000</vsta:FairValueOfCommonStockIssuedForServicesShares>
    <vsta:FairValueOfCommonStockIssuedForServicesShares contextRef="From1999-04-01to2000-03-31_CommonStockMember" unitRef="Shares" decimals="INF">104375</vsta:FairValueOfCommonStockIssuedForServicesShares>
    <vsta:FairValueOfCommonStockIssuedForServicesShares contextRef="From2000-04-01to2001-03-31_CommonStockMember" unitRef="Shares" decimals="INF">100000</vsta:FairValueOfCommonStockIssuedForServicesShares>
    <vsta:SaleOfCommonStockForCashAmount contextRef="From1999-04-01to2000-03-31_CommonStockMember" unitRef="USD" decimals="0">200</vsta:SaleOfCommonStockForCashAmount>
    <vsta:SaleOfCommonStockForCashAmount contextRef="From2006-04-01to2007-03-31_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:SaleOfCommonStockForCashAmount contextRef="From1999-04-01to2000-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">19800</vsta:SaleOfCommonStockForCashAmount>
    <vsta:SaleOfCommonStockForCashAmount contextRef="From2006-04-01to2007-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1000</vsta:SaleOfCommonStockForCashAmount>
    <vsta:SaleOfCommonStockForCashAmount contextRef="From1999-04-01to2000-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:SaleOfCommonStockForCashAmount contextRef="From2006-04-01to2007-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:SaleOfCommonStockForCashAmount contextRef="From1999-04-01to2000-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:SaleOfCommonStockForCashAmount contextRef="From2006-04-01to2007-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:SaleOfCommonStockForCashAmount contextRef="From1999-04-01to2000-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:SaleOfCommonStockForCashAmount contextRef="From2006-04-01to2007-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:SaleOfCommonStockForCashAmount contextRef="From1999-04-01to2000-03-31" unitRef="USD" decimals="0">20000</vsta:SaleOfCommonStockForCashAmount>
    <vsta:SaleOfCommonStockForCashAmount contextRef="From2006-04-01to2007-03-31" unitRef="USD" decimals="0">1000</vsta:SaleOfCommonStockForCashAmount>
    <vsta:SaleOfCommonStockForCashShares contextRef="From1999-04-01to2000-03-31_CommonStockMember" unitRef="Shares" decimals="INF">200000</vsta:SaleOfCommonStockForCashShares>
    <vsta:SaleOfCommonStockForCashShares contextRef="From2006-04-01to2007-03-31_CommonStockMember" unitRef="Shares" decimals="INF">10000</vsta:SaleOfCommonStockForCashShares>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2000-04-01to2001-03-31_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2001-04-01to2002-03-31_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2002-04-01to2003-03-31_CommonStockMember" unitRef="USD" decimals="0">0</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2003-04-01to2004-03-31_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2004-04-01to2005-03-31_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2005-04-01to2006-03-31_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2007-04-01to2008-03-31_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2000-04-01to2001-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">4600</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2001-04-01to2002-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">500</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2002-04-01to2003-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">5000</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2003-04-01to2004-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">600</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2004-04-01to2005-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">4800</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2005-04-01to2006-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">6600</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2007-04-01to2008-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1900</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2000-04-01to2001-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2001-04-01to2002-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2002-04-01to2003-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2003-04-01to2004-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2004-04-01to2005-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2005-04-01to2006-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2007-04-01to2008-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2000-04-01to2001-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2001-04-01to2002-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2002-04-01to2003-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2003-04-01to2004-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2004-04-01to2005-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2005-04-01to2006-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2007-04-01to2008-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2000-04-01to2001-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2001-04-01to2002-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2002-04-01to2003-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2003-04-01to2004-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2004-04-01to2005-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2005-04-01to2006-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2007-04-01to2008-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2000-04-01to2001-03-31" unitRef="USD" decimals="0">4600</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2001-04-01to2002-03-31" unitRef="USD" decimals="0">500</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2002-04-01to2003-03-31" unitRef="USD" decimals="0">5000</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2003-04-01to2004-03-31" unitRef="USD" decimals="0">600</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2004-04-01to2005-03-31" unitRef="USD" decimals="0">4800</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2005-04-01to2006-03-31" unitRef="USD" decimals="0">6600</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2007-04-01to2008-03-31" unitRef="USD" decimals="0">1900</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount>
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">564500</vsta:FairValueOfWarrantsIssuedForServices>
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From1999-04-01to2000-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">39500</vsta:FairValueOfWarrantsIssuedForServices>
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2000-04-01to2001-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">13100</vsta:FairValueOfWarrantsIssuedForServices>
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2001-04-01to2002-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">33100</vsta:FairValueOfWarrantsIssuedForServices>
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2002-04-01to2003-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">46500</vsta:FairValueOfWarrantsIssuedForServices>
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2003-04-01to2004-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">2200</vsta:FairValueOfWarrantsIssuedForServices>
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2004-04-01to2005-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1500</vsta:FairValueOfWarrantsIssuedForServices>
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2005-04-01to2006-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">3300</vsta:FairValueOfWarrantsIssuedForServices>
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2006-04-01to2007-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">3100</vsta:FairValueOfWarrantsIssuedForServices>
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2007-04-01to2008-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">224000</vsta:FairValueOfWarrantsIssuedForServices>
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2008-04-01to2009-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">5300</vsta:FairValueOfWarrantsIssuedForServices>
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2011-04-01to2012-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">564500</vsta:FairValueOfWarrantsIssuedForServices>
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From1999-04-01to2000-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2000-04-01to2001-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2001-04-01to2002-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2002-04-01to2003-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2003-04-01to2004-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2004-04-01to2005-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2005-04-01to2006-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2006-04-01to2007-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2007-04-01to2008-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2008-04-01to2009-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2011-04-01to2012-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From1999-04-01to2000-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2000-04-01to2001-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2001-04-01to2002-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2002-04-01to2003-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2003-04-01to2004-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2004-04-01to2005-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2005-04-01to2006-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2006-04-01to2007-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2007-04-01to2008-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2008-04-01to2009-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2011-04-01to2012-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From1999-04-01to2000-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2000-04-01to2001-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2001-04-01to2002-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2002-04-01to2003-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2003-04-01to2004-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2004-04-01to2005-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2005-04-01to2006-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2006-04-01to2007-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2007-04-01to2008-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2008-04-01to2009-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2011-04-01to2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From1999-04-01to2000-03-31" unitRef="USD" decimals="0">39500</vsta:FairValueOfWarrantsIssuedForServices>
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2000-04-01to2001-03-31" unitRef="USD" decimals="0">13100</vsta:FairValueOfWarrantsIssuedForServices>
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2001-04-01to2002-03-31" unitRef="USD" decimals="0">33100</vsta:FairValueOfWarrantsIssuedForServices>
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2002-04-01to2003-03-31" unitRef="USD" decimals="0">46500</vsta:FairValueOfWarrantsIssuedForServices>
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2003-04-01to2004-03-31" unitRef="USD" decimals="0">2200</vsta:FairValueOfWarrantsIssuedForServices>
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2004-04-01to2005-03-31" unitRef="USD" decimals="0">1500</vsta:FairValueOfWarrantsIssuedForServices>
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2005-04-01to2006-03-31" unitRef="USD" decimals="0">3300</vsta:FairValueOfWarrantsIssuedForServices>
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2006-04-01to2007-03-31" unitRef="USD" decimals="0">3100</vsta:FairValueOfWarrantsIssuedForServices>
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2007-04-01to2008-03-31" unitRef="USD" decimals="0">224000</vsta:FairValueOfWarrantsIssuedForServices>
    <vsta:FairValueOfWarrantsIssuedForServices contextRef="From2008-04-01to2009-03-31" unitRef="USD" decimals="0">5300</vsta:FairValueOfWarrantsIssuedForServices>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanShares contextRef="From2000-04-01to2001-03-31_CommonStockMember" unitRef="Shares" decimals="INF">14000</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanShares>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanShares contextRef="From2001-04-01to2002-03-31_CommonStockMember" unitRef="Shares" decimals="INF">1511</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanShares>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanShares contextRef="From2002-04-01to2003-03-31_CommonStockMember" unitRef="Shares" decimals="INF">15000</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanShares>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanShares contextRef="From2003-04-01to2004-03-31_CommonStockMember" unitRef="Shares" decimals="INF">2925</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanShares>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanShares contextRef="From2004-04-01to2005-03-31_CommonStockMember" unitRef="Shares" decimals="INF">10708</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanShares>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanShares contextRef="From2005-04-01to2006-03-31_CommonStockMember" unitRef="Shares" decimals="INF">14604</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanShares>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanShares contextRef="From2007-04-01to2008-03-31_CommonStockMember" unitRef="Shares" decimals="INF">2234</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanShares>
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith7ConvertibleNotes contextRef="From2000-04-01to2001-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">91200</vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith7ConvertibleNotes>
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith7ConvertibleNotes contextRef="From2000-04-01to2001-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith7ConvertibleNotes contextRef="From2000-04-01to2001-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith7ConvertibleNotes contextRef="From2000-04-01to2001-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith7ConvertibleNotes contextRef="From2000-04-01to2001-03-31" unitRef="USD" decimals="0">91200</vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith7ConvertibleNotes>
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith10ConvertibleNotes contextRef="From2001-04-01to2002-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">7300</vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith10ConvertibleNotes>
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith10ConvertibleNotes contextRef="From2002-04-01to2003-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">86800</vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith10ConvertibleNotes>
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith10ConvertibleNotes contextRef="From2003-04-01to2004-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">11400</vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith10ConvertibleNotes>
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith10ConvertibleNotes contextRef="From2001-04-01to2002-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith10ConvertibleNotes contextRef="From2002-04-01to2003-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith10ConvertibleNotes contextRef="From2003-04-01to2004-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith10ConvertibleNotes contextRef="From2001-04-01to2002-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith10ConvertibleNotes contextRef="From2002-04-01to2003-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith10ConvertibleNotes contextRef="From2003-04-01to2004-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith10ConvertibleNotes contextRef="From2001-04-01to2002-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith10ConvertibleNotes contextRef="From2002-04-01to2003-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith10ConvertibleNotes contextRef="From2003-04-01to2004-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith10ConvertibleNotes contextRef="From2001-04-01to2002-03-31" unitRef="USD" decimals="0">7300</vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith10ConvertibleNotes>
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith10ConvertibleNotes contextRef="From2002-04-01to2003-03-31" unitRef="USD" decimals="0">86800</vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith10ConvertibleNotes>
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith10ConvertibleNotes contextRef="From2003-04-01to2004-03-31" unitRef="USD" decimals="0">11400</vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWith10ConvertibleNotes>
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithSeriescPreferredStock contextRef="From2004-04-01to2005-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">25500</vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithSeriescPreferredStock>
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithSeriescPreferredStock contextRef="From2004-04-01to2005-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithSeriescPreferredStock contextRef="From2004-04-01to2005-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithSeriescPreferredStock contextRef="From2004-04-01to2005-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithSeriescPreferredStock contextRef="From2004-04-01to2005-03-31" unitRef="USD" decimals="0">25500</vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithSeriescPreferredStock>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForCashAmount contextRef="From2006-04-01to2007-03-31_CommonStockMember" unitRef="USD" decimals="0">100</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForCashAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForCashAmount contextRef="From2006-04-01to2007-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">27600</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForCashAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForCashAmount contextRef="From2006-04-01to2007-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForCashAmount contextRef="From2006-04-01to2007-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForCashAmount contextRef="From2006-04-01to2007-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForCashAmount contextRef="From2006-04-01to2007-03-31" unitRef="USD" decimals="0">27700</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForCashAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForCashShares contextRef="From2006-04-01to2007-03-31_CommonStockMember" unitRef="Shares" decimals="INF">33465</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForCashShares>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForDebtCancellationAmount contextRef="From2006-04-01to2007-03-31_CommonStockMember" unitRef="USD" decimals="0">100</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForDebtCancellationAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForDebtCancellationAmount contextRef="From2006-04-01to2007-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">112700</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForDebtCancellationAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForDebtCancellationAmount contextRef="From2006-04-01to2007-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForDebtCancellationAmount contextRef="From2006-04-01to2007-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForDebtCancellationAmount contextRef="From2006-04-01to2007-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForDebtCancellationAmount contextRef="From2006-04-01to2007-03-31" unitRef="USD" decimals="0">112800</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForDebtCancellationAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForDebtCancellationShares contextRef="From2006-04-01to2007-03-31_CommonStockMember" unitRef="Shares" decimals="INF">108418</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForDebtCancellationShares>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForNotesReceivableAmount contextRef="From2006-04-01to2007-03-31_CommonStockMember" unitRef="USD" decimals="0">200</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForNotesReceivableAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForNotesReceivableAmount contextRef="From2006-04-01to2007-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">149600</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForNotesReceivableAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForNotesReceivableAmount contextRef="From2006-04-01to2007-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForNotesReceivableAmount contextRef="From2006-04-01to2007-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" decimals="0">-149800</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForNotesReceivableAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForNotesReceivableAmount contextRef="From2006-04-01to2007-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForNotesReceivableAmount contextRef="From2006-04-01to2007-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForNotesReceivableShares contextRef="From2006-04-01to2007-03-31_CommonStockMember" unitRef="Shares" decimals="INF">204498</vsta:CommonStockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAndWarrantsForNotesReceivableShares>
    <vsta:SharebasedCompensationExpense contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">1591300</vsta:SharebasedCompensationExpense>
    <vsta:SharebasedCompensationExpense contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">1628800</vsta:SharebasedCompensationExpense>
    <vsta:SharebasedCompensationExpense contextRef="From2006-04-01to2007-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">109800</vsta:SharebasedCompensationExpense>
    <vsta:SharebasedCompensationExpense contextRef="From2007-04-01to2008-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">247600</vsta:SharebasedCompensationExpense>
    <vsta:SharebasedCompensationExpense contextRef="From2008-04-01to2009-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">108200</vsta:SharebasedCompensationExpense>
    <vsta:SharebasedCompensationExpense contextRef="From2009-04-01to2010-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">668500</vsta:SharebasedCompensationExpense>
    <vsta:SharebasedCompensationExpense contextRef="From2010-04-01to2011-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1628800</vsta:SharebasedCompensationExpense>
    <vsta:SharebasedCompensationExpense contextRef="From2011-04-01to2012-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1591300</vsta:SharebasedCompensationExpense>
    <vsta:SharebasedCompensationExpense contextRef="From2006-04-01to2007-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:SharebasedCompensationExpense contextRef="From2007-04-01to2008-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:SharebasedCompensationExpense contextRef="From2008-04-01to2009-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:SharebasedCompensationExpense contextRef="From2009-04-01to2010-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:SharebasedCompensationExpense contextRef="From2010-04-01to2011-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:SharebasedCompensationExpense contextRef="From2011-04-01to2012-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:SharebasedCompensationExpense contextRef="From2006-04-01to2007-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:SharebasedCompensationExpense contextRef="From2007-04-01to2008-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:SharebasedCompensationExpense contextRef="From2008-04-01to2009-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:SharebasedCompensationExpense contextRef="From2009-04-01to2010-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:SharebasedCompensationExpense contextRef="From2010-04-01to2011-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:SharebasedCompensationExpense contextRef="From2011-04-01to2012-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:SharebasedCompensationExpense contextRef="From2006-04-01to2007-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:SharebasedCompensationExpense contextRef="From2007-04-01to2008-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:SharebasedCompensationExpense contextRef="From2008-04-01to2009-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:SharebasedCompensationExpense contextRef="From2009-04-01to2010-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:SharebasedCompensationExpense contextRef="From2010-04-01to2011-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:SharebasedCompensationExpense contextRef="From2011-04-01to2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:SharebasedCompensationExpense contextRef="From2006-04-01to2007-03-31" unitRef="USD" decimals="0">109800</vsta:SharebasedCompensationExpense>
    <vsta:SharebasedCompensationExpense contextRef="From2007-04-01to2008-03-31" unitRef="USD" decimals="0">247600</vsta:SharebasedCompensationExpense>
    <vsta:SharebasedCompensationExpense contextRef="From2008-04-01to2009-03-31" unitRef="USD" decimals="0">108200</vsta:SharebasedCompensationExpense>
    <vsta:SharebasedCompensationExpense contextRef="From2009-04-01to2010-03-31" unitRef="USD" decimals="0">668500</vsta:SharebasedCompensationExpense>
    <vsta:ForgivenessOfAccruedCompensationAndAccruedInterestPayableToOfficers contextRef="From2006-04-01to2007-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">799900</vsta:ForgivenessOfAccruedCompensationAndAccruedInterestPayableToOfficers>
    <vsta:ForgivenessOfAccruedCompensationAndAccruedInterestPayableToOfficers contextRef="From2006-04-01to2007-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:ForgivenessOfAccruedCompensationAndAccruedInterestPayableToOfficers contextRef="From2006-04-01to2007-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:ForgivenessOfAccruedCompensationAndAccruedInterestPayableToOfficers contextRef="From2006-04-01to2007-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:ForgivenessOfAccruedCompensationAndAccruedInterestPayableToOfficers contextRef="From2006-04-01to2007-03-31" unitRef="USD" decimals="0">799900</vsta:ForgivenessOfAccruedCompensationAndAccruedInterestPayableToOfficers>
    <vsta:CommonStockIssuedUponSettlementOfEmploymentContractAmount contextRef="From2007-04-01to2008-03-31_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponSettlementOfEmploymentContractAmount contextRef="From2007-04-01to2008-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">42000</vsta:CommonStockIssuedUponSettlementOfEmploymentContractAmount>
    <vsta:CommonStockIssuedUponSettlementOfEmploymentContractAmount contextRef="From2007-04-01to2008-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponSettlementOfEmploymentContractAmount contextRef="From2007-04-01to2008-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponSettlementOfEmploymentContractAmount contextRef="From2007-04-01to2008-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponSettlementOfEmploymentContractAmount contextRef="From2007-04-01to2008-03-31" unitRef="USD" decimals="0">42000</vsta:CommonStockIssuedUponSettlementOfEmploymentContractAmount>
    <vsta:CommonStockIssuedUponSettlementOfEmploymentContractShares contextRef="From2007-04-01to2008-03-31_CommonStockMember" unitRef="Shares" decimals="INF">20000</vsta:CommonStockIssuedUponSettlementOfEmploymentContractShares>
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithPlatinumNotes contextRef="From2007-04-01to2008-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">221000</vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithPlatinumNotes>
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithPlatinumNotes contextRef="From2007-04-01to2008-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithPlatinumNotes contextRef="From2007-04-01to2008-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithPlatinumNotes contextRef="From2007-04-01to2008-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithPlatinumNotes contextRef="From2007-04-01to2008-03-31" unitRef="USD" decimals="0">221000</vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithPlatinumNotes>
    <vsta:AccruedInterestOnNotesReceivable contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">-1000</vsta:AccruedInterestOnNotesReceivable>
    <vsta:AccruedInterestOnNotesReceivable contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">-8800</vsta:AccruedInterestOnNotesReceivable>
    <vsta:AccruedInterestOnNotesReceivable contextRef="From2007-04-01to2008-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" decimals="0">-9200</vsta:AccruedInterestOnNotesReceivable>
    <vsta:AccruedInterestOnNotesReceivable contextRef="From2008-04-01to2009-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" decimals="0">-7900</vsta:AccruedInterestOnNotesReceivable>
    <vsta:AccruedInterestOnNotesReceivable contextRef="From2009-04-01to2010-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" decimals="0">-8400</vsta:AccruedInterestOnNotesReceivable>
    <vsta:AccruedInterestOnNotesReceivable contextRef="From2010-04-01to2011-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" decimals="0">-8800</vsta:AccruedInterestOnNotesReceivable>
    <vsta:AccruedInterestOnNotesReceivable contextRef="From2011-04-01to2012-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:AccruedInterestOnNotesReceivable contextRef="From2007-04-01to2008-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:AccruedInterestOnNotesReceivable contextRef="From2008-04-01to2009-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:AccruedInterestOnNotesReceivable contextRef="From2009-04-01to2010-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:AccruedInterestOnNotesReceivable contextRef="From2010-04-01to2011-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:AccruedInterestOnNotesReceivable contextRef="From2011-04-01to2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">-1000</vsta:AccruedInterestOnNotesReceivable>
    <vsta:AccruedInterestOnNotesReceivable contextRef="From2007-04-01to2008-03-31" unitRef="USD" decimals="0">-9200</vsta:AccruedInterestOnNotesReceivable>
    <vsta:AccruedInterestOnNotesReceivable contextRef="From2008-04-01to2009-03-31" unitRef="USD" decimals="0">-7900</vsta:AccruedInterestOnNotesReceivable>
    <vsta:AccruedInterestOnNotesReceivable contextRef="From2009-04-01to2010-03-31" unitRef="USD" decimals="0">-8400</vsta:AccruedInterestOnNotesReceivable>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom2008StockIncentivePlanAndScientificAdvisoryPlanAmount contextRef="From2008-04-01to2009-03-31_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom2008StockIncentivePlanAndScientificAdvisoryPlanAmount contextRef="From2008-04-01to2009-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1000</vsta:CommonStockIssuedUponExerciseOfOptionsFrom2008StockIncentivePlanAndScientificAdvisoryPlanAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom2008StockIncentivePlanAndScientificAdvisoryPlanAmount contextRef="From2008-04-01to2009-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom2008StockIncentivePlanAndScientificAdvisoryPlanAmount contextRef="From2008-04-01to2009-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom2008StockIncentivePlanAndScientificAdvisoryPlanAmount contextRef="From2008-04-01to2009-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom2008StockIncentivePlanAndScientificAdvisoryPlanAmount contextRef="From2008-04-01to2009-03-31" unitRef="USD" decimals="0">1000</vsta:CommonStockIssuedUponExerciseOfOptionsFrom2008StockIncentivePlanAndScientificAdvisoryPlanAmount>
    <vsta:CommonStockIssuedUponExerciseOfOptionsFrom2008StockIncentivePlanAndScientificAdvisoryPlanShares contextRef="From2008-04-01to2009-03-31_CommonStockMember" unitRef="Shares" decimals="INF">3500</vsta:CommonStockIssuedUponExerciseOfOptionsFrom2008StockIncentivePlanAndScientificAdvisoryPlanShares>
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithPlatinumNotesAndIncrementalFairValueOfWarrantModification contextRef="From2008-04-01to2009-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">72700</vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithPlatinumNotesAndIncrementalFairValueOfWarrantModification>
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithPlatinumNotesAndIncrementalFairValueOfWarrantModification contextRef="From2008-04-01to2009-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithPlatinumNotesAndIncrementalFairValueOfWarrantModification contextRef="From2008-04-01to2009-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithPlatinumNotesAndIncrementalFairValueOfWarrantModification contextRef="From2008-04-01to2009-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithPlatinumNotesAndIncrementalFairValueOfWarrantModification contextRef="From2008-04-01to2009-03-31" unitRef="USD" decimals="0">72700</vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithPlatinumNotesAndIncrementalFairValueOfWarrantModification>
    <vsta:EffectOfReverseStockSplit contextRef="From2008-04-01to2009-03-31_CommonStockMember" unitRef="USD" decimals="0">-6</vsta:EffectOfReverseStockSplit>
    <vsta:CumulativeEffectOfAdoptingNewAccountingStandard contextRef="From2009-04-01to2010-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-293700</vsta:CumulativeEffectOfAdoptingNewAccountingStandard>
    <vsta:CumulativeEffectOfAdoptingNewAccountingStandard contextRef="From2009-04-01to2010-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CumulativeEffectOfAdoptingNewAccountingStandard contextRef="From2009-04-01to2010-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CumulativeEffectOfAdoptingNewAccountingStandard contextRef="From2009-04-01to2010-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="0">142300</vsta:CumulativeEffectOfAdoptingNewAccountingStandard>
    <vsta:CumulativeEffectOfAdoptingNewAccountingStandard contextRef="From2009-04-01to2010-03-31" unitRef="USD" decimals="0">-151400</vsta:CumulativeEffectOfAdoptingNewAccountingStandard>
    <vsta:CommonStockIssuedUponExerciseOfWarrantAmount contextRef="From2009-04-01to2010-03-31_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfWarrantAmount contextRef="From2009-04-01to2010-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">100</vsta:CommonStockIssuedUponExerciseOfWarrantAmount>
    <vsta:CommonStockIssuedUponExerciseOfWarrantAmount contextRef="From2009-04-01to2010-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfWarrantAmount contextRef="From2009-04-01to2010-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfWarrantAmount contextRef="From2009-04-01to2010-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedUponExerciseOfWarrantAmount contextRef="From2009-04-01to2010-03-31" unitRef="USD" decimals="0">100</vsta:CommonStockIssuedUponExerciseOfWarrantAmount>
    <vsta:CommonStockIssuedUponExerciseOfWarrantShares contextRef="From2009-04-01to2010-03-31_CommonStockMember" unitRef="Shares" decimals="INF">1086</vsta:CommonStockIssuedUponExerciseOfWarrantShares>
    <vsta:CommonStockIssuedForCancellationOfAccountsPayableAndAccruedInterestAmount contextRef="From2009-04-01to2010-03-31_CommonStockMember" unitRef="USD" decimals="0">1600</vsta:CommonStockIssuedForCancellationOfAccountsPayableAndAccruedInterestAmount>
    <vsta:CommonStockIssuedForCancellationOfAccountsPayableAndAccruedInterestAmount contextRef="From2009-04-01to2010-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">2468600</vsta:CommonStockIssuedForCancellationOfAccountsPayableAndAccruedInterestAmount>
    <vsta:CommonStockIssuedForCancellationOfAccountsPayableAndAccruedInterestAmount contextRef="From2009-04-01to2010-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedForCancellationOfAccountsPayableAndAccruedInterestAmount contextRef="From2009-04-01to2010-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedForCancellationOfAccountsPayableAndAccruedInterestAmount contextRef="From2009-04-01to2010-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockIssuedForCancellationOfAccountsPayableAndAccruedInterestAmount contextRef="From2009-04-01to2010-03-31" unitRef="USD" decimals="0">2470200</vsta:CommonStockIssuedForCancellationOfAccountsPayableAndAccruedInterestAmount>
    <vsta:CommonStockIssuedForCancellationOfAccountsPayableAndAccruedInterestShares contextRef="From2009-04-01to2010-03-31_CommonStockMember" unitRef="Shares" decimals="INF">1646792</vsta:CommonStockIssuedForCancellationOfAccountsPayableAndAccruedInterestShares>
    <vsta:IncrementalFairValueOfNoteConversionOptionsFromDebtModification contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">1062800</vsta:IncrementalFairValueOfNoteConversionOptionsFromDebtModification>
    <vsta:IncrementalFairValueOfNoteConversionOptionsFromDebtModification contextRef="From2009-04-01to2010-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">828500</vsta:IncrementalFairValueOfNoteConversionOptionsFromDebtModification>
    <vsta:IncrementalFairValueOfNoteConversionOptionsFromDebtModification contextRef="From2010-04-01to2011-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1062800</vsta:IncrementalFairValueOfNoteConversionOptionsFromDebtModification>
    <vsta:IncrementalFairValueOfNoteConversionOptionsFromDebtModification contextRef="From2009-04-01to2010-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IncrementalFairValueOfNoteConversionOptionsFromDebtModification contextRef="From2010-04-01to2011-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IncrementalFairValueOfNoteConversionOptionsFromDebtModification contextRef="From2009-04-01to2010-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IncrementalFairValueOfNoteConversionOptionsFromDebtModification contextRef="From2009-04-01to2010-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:IncrementalFairValueOfNoteConversionOptionsFromDebtModification contextRef="From2009-04-01to2010-03-31" unitRef="USD" decimals="0">828500</vsta:IncrementalFairValueOfNoteConversionOptionsFromDebtModification>
    <vsta:FairValueOfWarrantsIssuedForServicesAndIncrementalFairValueOfWarrantModification contextRef="From2009-04-01to2010-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">110100</vsta:FairValueOfWarrantsIssuedForServicesAndIncrementalFairValueOfWarrantModification>
    <vsta:FairValueOfWarrantsIssuedForServicesAndIncrementalFairValueOfWarrantModification contextRef="From2009-04-01to2010-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServicesAndIncrementalFairValueOfWarrantModification contextRef="From2009-04-01to2010-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServicesAndIncrementalFairValueOfWarrantModification contextRef="From2009-04-01to2010-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedForServicesAndIncrementalFairValueOfWarrantModification contextRef="From2009-04-01to2010-03-31" unitRef="USD" decimals="0">110100</vsta:FairValueOfWarrantsIssuedForServicesAndIncrementalFairValueOfWarrantModification>
    <vsta:FairValueOfWarrantsIssuedInConnectionWith7.5Notes contextRef="From2009-04-01to2010-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">291200</vsta:FairValueOfWarrantsIssuedInConnectionWith7.5Notes>
    <vsta:FairValueOfWarrantsIssuedInConnectionWith7.5Notes contextRef="From2009-04-01to2010-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedInConnectionWith7.5Notes contextRef="From2009-04-01to2010-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedInConnectionWith7.5Notes contextRef="From2009-04-01to2010-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfWarrantsIssuedInConnectionWith7.5Notes contextRef="From2009-04-01to2010-03-31" unitRef="USD" decimals="0">291200</vsta:FairValueOfWarrantsIssuedInConnectionWith7.5Notes>
    <vsta:FairValueOfWarrantsIssuedInConnectionWithAugust2010ShorttermNotes contextRef="From2010-04-01to2011-03-31" unitRef="USD" decimals="0">252000</vsta:FairValueOfWarrantsIssuedInConnectionWithAugust2010ShorttermNotes>
    <vsta:FairValueOfWarrantsIssuedInConnectionWithAugust2010ShorttermNotes contextRef="From2010-04-01to2011-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">252000</vsta:FairValueOfWarrantsIssuedInConnectionWithAugust2010ShorttermNotes>
    <vsta:FairValueOfWarrantsIssuedInConnectionWithAugust2010ShorttermNotes contextRef="From2010-04-01to2011-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:ReclassificationOfWarrantLiabilityToEquity contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">424100</vsta:ReclassificationOfWarrantLiabilityToEquity>
    <vsta:ReclassificationOfWarrantLiabilityToEquity contextRef="From2011-04-01to2012-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">424100</vsta:ReclassificationOfWarrantLiabilityToEquity>
    <vsta:ReclassificationOfWarrantLiabilityToEquity contextRef="From2011-04-01to2012-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:ReclassificationOfWarrantLiabilityToEquity contextRef="From2011-04-01to2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:IncrementalValueOfPlatinumNoteModification contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">1070600</vsta:IncrementalValueOfPlatinumNoteModification>
    <vsta:IncrementalValueOfPlatinumNoteModification contextRef="From2011-04-01to2012-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1070600</vsta:IncrementalValueOfPlatinumNoteModification>
    <vsta:IncrementalValueOfPlatinumNoteModification contextRef="From2011-04-01to2012-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IncrementalValueOfPlatinumNoteModification contextRef="From2011-04-01to2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:IncrementalValueOfMorrisonFoersterWarrantModification contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">58700</vsta:IncrementalValueOfMorrisonFoersterWarrantModification>
    <vsta:IncrementalValueOfMorrisonFoersterWarrantModification contextRef="From2011-04-01to2012-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">58700</vsta:IncrementalValueOfMorrisonFoersterWarrantModification>
    <vsta:IncrementalValueOfMorrisonFoersterWarrantModification contextRef="From2011-04-01to2012-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IncrementalValueOfMorrisonFoersterWarrantModification contextRef="From2011-04-01to2012-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IncrementalValueOfMorrisonFoersterWarrantModification contextRef="From2011-04-01to2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedInMay2011PrivatePlacementNetOf202000PlacementFeesAmount contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">3176200</vsta:StockIssuedInMay2011PrivatePlacementNetOf202000PlacementFeesAmount>
    <vsta:StockIssuedInMay2011PrivatePlacementNetOf202000PlacementFeesAmount contextRef="From2011-04-01to2012-03-31_CommonStockMember" unitRef="USD" decimals="0">2200</vsta:StockIssuedInMay2011PrivatePlacementNetOf202000PlacementFeesAmount>
    <vsta:StockIssuedInMay2011PrivatePlacementNetOf202000PlacementFeesAmount contextRef="From2011-04-01to2012-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">3674000</vsta:StockIssuedInMay2011PrivatePlacementNetOf202000PlacementFeesAmount>
    <vsta:StockIssuedInMay2011PrivatePlacementNetOf202000PlacementFeesAmount contextRef="From2011-04-01to2012-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedInMay2011PrivatePlacementNetOf202000PlacementFeesAmount contextRef="From2011-04-01to2012-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" decimals="0">-500000</vsta:StockIssuedInMay2011PrivatePlacementNetOf202000PlacementFeesAmount>
    <vsta:StockIssuedInMay2011PrivatePlacementNetOf202000PlacementFeesAmount contextRef="From2011-04-01to2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedInMay2011PrivatePlacementNetOf202000PlacementFeesShares contextRef="From2011-04-01to2012-03-31_CommonStockMember" unitRef="Shares" decimals="INF">2216106</vsta:StockIssuedInMay2011PrivatePlacementNetOf202000PlacementFeesShares>
    <vsta:PaymentsOnNoteReceivableForSaleOfStock contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">250000</vsta:PaymentsOnNoteReceivableForSaleOfStock>
    <vsta:PaymentsOnNoteReceivableForSaleOfStock contextRef="From2011-04-01to2012-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" decimals="0">250000</vsta:PaymentsOnNoteReceivableForSaleOfStock>
    <vsta:StockIssuedUponConversionOfConvertiblePromissoryNotesAmount contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">6174800</vsta:StockIssuedUponConversionOfConvertiblePromissoryNotesAmount>
    <vsta:StockIssuedUponConversionOfConvertiblePromissoryNotesAmount contextRef="From2011-04-01to2012-03-31_CommonStockMember" unitRef="USD" decimals="0">3500</vsta:StockIssuedUponConversionOfConvertiblePromissoryNotesAmount>
    <vsta:StockIssuedUponConversionOfConvertiblePromissoryNotesAmount contextRef="From2011-04-01to2012-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">6171300</vsta:StockIssuedUponConversionOfConvertiblePromissoryNotesAmount>
    <vsta:StockIssuedUponConversionOfConvertiblePromissoryNotesAmount contextRef="From2011-04-01to2012-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedUponConversionOfConvertiblePromissoryNotesAmount contextRef="From2011-04-01to2012-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedUponConversionOfConvertiblePromissoryNotesAmount contextRef="From2011-04-01to2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedUponConversionOfConvertiblePromissoryNotesShares contextRef="From2011-04-01to2012-03-31_CommonStockMember" unitRef="Shares" decimals="INF">3528290</vsta:StockIssuedUponConversionOfConvertiblePromissoryNotesShares>
    <vsta:StockIssuedUponConversionOfAllSeriesOfPreferredStockAmount contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">14534800</vsta:StockIssuedUponConversionOfAllSeriesOfPreferredStockAmount>
    <vsta:StockIssuedUponConversionOfAllSeriesOfPreferredStockAmount contextRef="From2011-04-01to2012-03-31_CommonStockMember" unitRef="USD" decimals="0">2900</vsta:StockIssuedUponConversionOfAllSeriesOfPreferredStockAmount>
    <vsta:StockIssuedUponConversionOfAllSeriesOfPreferredStockAmount contextRef="From2011-04-01to2012-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">14531900</vsta:StockIssuedUponConversionOfAllSeriesOfPreferredStockAmount>
    <vsta:StockIssuedUponConversionOfAllSeriesOfPreferredStockAmount contextRef="From2011-04-01to2012-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedUponConversionOfAllSeriesOfPreferredStockAmount contextRef="From2011-04-01to2012-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedUponConversionOfAllSeriesOfPreferredStockAmount contextRef="From2011-04-01to2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedUponConversionOfAllSeriesOfPreferredStockShares contextRef="From2011-04-01to2012-03-31_CommonStockMember" unitRef="Shares" decimals="INF">2884655</vsta:StockIssuedUponConversionOfAllSeriesOfPreferredStockShares>
    <vsta:FairValueOfStockIssuedForServicesPriorToMergerAmount contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">2225500</vsta:FairValueOfStockIssuedForServicesPriorToMergerAmount>
    <vsta:FairValueOfStockIssuedForServicesPriorToMergerAmount contextRef="From2011-04-01to2012-03-31_CommonStockMember" unitRef="USD" decimals="0">1400</vsta:FairValueOfStockIssuedForServicesPriorToMergerAmount>
    <vsta:FairValueOfStockIssuedForServicesPriorToMergerAmount contextRef="From2011-04-01to2012-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">2224100</vsta:FairValueOfStockIssuedForServicesPriorToMergerAmount>
    <vsta:FairValueOfStockIssuedForServicesPriorToMergerAmount contextRef="From2011-04-01to2012-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfStockIssuedForServicesPriorToMergerAmount contextRef="From2011-04-01to2012-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfStockIssuedForServicesPriorToMergerAmount contextRef="From2011-04-01to2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfStockIssuedForServicesPriorToMergerShares contextRef="From2011-04-01to2012-03-31_CommonStockMember" unitRef="Shares" decimals="INF">1371743</vsta:FairValueOfStockIssuedForServicesPriorToMergerShares>
    <vsta:StockIssuedUponExerciseOfModifiedWarrantsIncludesPlatinumExercisesAmount contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">3429300</vsta:StockIssuedUponExerciseOfModifiedWarrantsIncludesPlatinumExercisesAmount>
    <vsta:StockIssuedUponExerciseOfModifiedWarrantsIncludesPlatinumExercisesAmount contextRef="From2011-04-01to2012-03-31_CommonStockMember" unitRef="USD" decimals="0">3100</vsta:StockIssuedUponExerciseOfModifiedWarrantsIncludesPlatinumExercisesAmount>
    <vsta:StockIssuedUponExerciseOfModifiedWarrantsIncludesPlatinumExercisesAmount contextRef="From2011-04-01to2012-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">3426200</vsta:StockIssuedUponExerciseOfModifiedWarrantsIncludesPlatinumExercisesAmount>
    <vsta:StockIssuedUponExerciseOfModifiedWarrantsIncludesPlatinumExercisesAmount contextRef="From2011-04-01to2012-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedUponExerciseOfModifiedWarrantsIncludesPlatinumExercisesAmount contextRef="From2011-04-01to2012-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedUponExerciseOfModifiedWarrantsIncludesPlatinumExercisesAmount contextRef="From2011-04-01to2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedUponExerciseOfModifiedWarrantsIncludesPlatinumExercisesShares contextRef="From2011-04-01to2012-03-31_CommonStockMember" unitRef="Shares" decimals="INF">3121259</vsta:StockIssuedUponExerciseOfModifiedWarrantsIncludesPlatinumExercisesShares>
    <vsta:IncrementalValueOfWarrantModificationsIncludingModificationOfPlatinumWarrants contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">1028900</vsta:IncrementalValueOfWarrantModificationsIncludingModificationOfPlatinumWarrants>
    <vsta:IncrementalValueOfWarrantModificationsIncludingModificationOfPlatinumWarrants contextRef="From2011-04-01to2012-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1028900</vsta:IncrementalValueOfWarrantModificationsIncludingModificationOfPlatinumWarrants>
    <vsta:IncrementalValueOfWarrantModificationsIncludingModificationOfPlatinumWarrants contextRef="From2011-04-01to2012-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IncrementalValueOfWarrantModificationsIncludingModificationOfPlatinumWarrants contextRef="From2011-04-01to2012-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IncrementalValueOfWarrantModificationsIncludingModificationOfPlatinumWarrants contextRef="From2011-04-01to2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfBonusWarrantsUnderDiscountedWarrantExerciseProgram contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">138100</vsta:FairValueOfBonusWarrantsUnderDiscountedWarrantExerciseProgram>
    <vsta:FairValueOfBonusWarrantsUnderDiscountedWarrantExerciseProgram contextRef="From2011-04-01to2012-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">138100</vsta:FairValueOfBonusWarrantsUnderDiscountedWarrantExerciseProgram>
    <vsta:FairValueOfBonusWarrantsUnderDiscountedWarrantExerciseProgram contextRef="From2011-04-01to2012-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfBonusWarrantsUnderDiscountedWarrantExerciseProgram contextRef="From2011-04-01to2012-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfBonusWarrantsUnderDiscountedWarrantExerciseProgram contextRef="From2011-04-01to2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedInFall2011FollowonOfferingAmount contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">111300</vsta:StockIssuedInFall2011FollowonOfferingAmount>
    <vsta:StockIssuedInFall2011FollowonOfferingAmount contextRef="From2011-04-01to2012-03-31_CommonStockMember" unitRef="USD" decimals="0">100</vsta:StockIssuedInFall2011FollowonOfferingAmount>
    <vsta:StockIssuedInFall2011FollowonOfferingAmount contextRef="From2011-04-01to2012-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">111200</vsta:StockIssuedInFall2011FollowonOfferingAmount>
    <vsta:StockIssuedInFall2011FollowonOfferingAmount contextRef="From2011-04-01to2012-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedInFall2011FollowonOfferingAmount contextRef="From2011-04-01to2012-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedInFall2011FollowonOfferingAmount contextRef="From2011-04-01to2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedInFall2011FollowonOfferingShares contextRef="From2011-04-01to2012-03-31_CommonStockMember" unitRef="Shares" decimals="INF">63570</vsta:StockIssuedInFall2011FollowonOfferingShares>
    <vsta:StockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">102200</vsta:StockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount>
    <vsta:StockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2011-04-01to2012-03-31_CommonStockMember" unitRef="USD" decimals="0">100</vsta:StockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount>
    <vsta:StockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2011-04-01to2012-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">102100</vsta:StockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount>
    <vsta:StockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2011-04-01to2012-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2011-04-01to2012-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanAmount contextRef="From2011-04-01to2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanShares contextRef="From2011-04-01to2012-03-31_CommonStockMember" unitRef="Shares" decimals="INF">113979</vsta:StockIssuedUponExerciseOfOptionsFrom1999StockIncentivePlanShares>
    <vsta:FairValueOfStockIssuedForServicesFollowingMergerAmount contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">452000</vsta:FairValueOfStockIssuedForServicesFollowingMergerAmount>
    <vsta:FairValueOfStockIssuedForServicesFollowingMergerAmount contextRef="From2011-04-01to2012-03-31_CommonStockMember" unitRef="USD" decimals="0">200</vsta:FairValueOfStockIssuedForServicesFollowingMergerAmount>
    <vsta:FairValueOfStockIssuedForServicesFollowingMergerAmount contextRef="From2011-04-01to2012-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">451800</vsta:FairValueOfStockIssuedForServicesFollowingMergerAmount>
    <vsta:FairValueOfStockIssuedForServicesFollowingMergerAmount contextRef="From2011-04-01to2012-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfStockIssuedForServicesFollowingMergerAmount contextRef="From2011-04-01to2012-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfStockIssuedForServicesFollowingMergerAmount contextRef="From2011-04-01to2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:FairValueOfStockIssuedForServicesFollowingMergerShares contextRef="From2011-04-01to2012-03-31_CommonStockMember" unitRef="Shares" decimals="INF">155555</vsta:FairValueOfStockIssuedForServicesFollowingMergerShares>
    <vsta:ProceedsAllocatedToWarrantsIssuedAndBeneficialConversionFeatureInConnectionWith12ConvertibleNotes contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">461700</vsta:ProceedsAllocatedToWarrantsIssuedAndBeneficialConversionFeatureInConnectionWith12ConvertibleNotes>
    <vsta:ProceedsAllocatedToWarrantsIssuedAndBeneficialConversionFeatureInConnectionWith12ConvertibleNotes contextRef="From2011-04-01to2012-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">461700</vsta:ProceedsAllocatedToWarrantsIssuedAndBeneficialConversionFeatureInConnectionWith12ConvertibleNotes>
    <vsta:ProceedsAllocatedToWarrantsIssuedAndBeneficialConversionFeatureInConnectionWith12ConvertibleNotes contextRef="From2011-04-01to2012-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedAndBeneficialConversionFeatureInConnectionWith12ConvertibleNotes contextRef="From2011-04-01to2012-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedAndBeneficialConversionFeatureInConnectionWith12ConvertibleNotes contextRef="From2011-04-01to2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedInConnectionWithNoteTermExtensionAmount contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">22400</vsta:StockIssuedInConnectionWithNoteTermExtensionAmount>
    <vsta:StockIssuedInConnectionWithNoteTermExtensionAmount contextRef="From2011-04-01to2012-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">22400</vsta:StockIssuedInConnectionWithNoteTermExtensionAmount>
    <vsta:StockIssuedInConnectionWithNoteTermExtensionAmount contextRef="From2011-04-01to2012-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedInConnectionWithNoteTermExtensionAmount contextRef="From2011-04-01to2012-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedInConnectionWithNoteTermExtensionAmount contextRef="From2011-04-01to2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedInConnectionWithNoteTermExtensionShares contextRef="From2011-04-01to2012-03-31_CommonStockMember" unitRef="Shares" decimals="INF">8000</vsta:StockIssuedInConnectionWithNoteTermExtensionShares>
    <vsta:StockIssuedUponConversionOfPlatinumNoteToEquityNetOfPlatinumWarrantExerciseReflectedAboveAmount contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">3387900</vsta:StockIssuedUponConversionOfPlatinumNoteToEquityNetOfPlatinumWarrantExerciseReflectedAboveAmount>
    <vsta:StockIssuedUponConversionOfPlatinumNoteToEquityNetOfPlatinumWarrantExerciseReflectedAboveAmount contextRef="From2011-04-01to2012-03-31_SeriesAPreferredStockMember" unitRef="USD" decimals="0">200</vsta:StockIssuedUponConversionOfPlatinumNoteToEquityNetOfPlatinumWarrantExerciseReflectedAboveAmount>
    <vsta:StockIssuedUponConversionOfPlatinumNoteToEquityNetOfPlatinumWarrantExerciseReflectedAboveAmount contextRef="From2011-04-01to2012-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">3387700</vsta:StockIssuedUponConversionOfPlatinumNoteToEquityNetOfPlatinumWarrantExerciseReflectedAboveAmount>
    <vsta:StockIssuedUponConversionOfPlatinumNoteToEquityNetOfPlatinumWarrantExerciseReflectedAboveAmount contextRef="From2011-04-01to2012-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedUponConversionOfPlatinumNoteToEquityNetOfPlatinumWarrantExerciseReflectedAboveAmount contextRef="From2011-04-01to2012-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedUponConversionOfPlatinumNoteToEquityNetOfPlatinumWarrantExerciseReflectedAboveAmount contextRef="From2011-04-01to2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockIssuedUponConversionOfPlatinumNoteToEquityNetOfPlatinumWarrantExerciseReflectedAboveShares contextRef="From2011-04-01to2012-03-31_SeriesAPreferredStockMember" unitRef="Shares" decimals="INF">231090</vsta:StockIssuedUponConversionOfPlatinumNoteToEquityNetOfPlatinumWarrantExerciseReflectedAboveShares>
    <vsta:CommonStockExchangedForSeriesPreferredUnderAgreementsWithPlatinumCommonStockExchangeAgreementAmount contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockExchangedForSeriesPreferredUnderAgreementsWithPlatinumCommonStockExchangeAgreementAmount contextRef="From2011-04-01to2012-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">750600</vsta:CommonStockExchangedForSeriesPreferredUnderAgreementsWithPlatinumCommonStockExchangeAgreementAmount>
    <vsta:CommonStockExchangedForSeriesPreferredUnderAgreementsWithPlatinumCommonStockExchangeAgreementAmount contextRef="From2011-04-01to2012-03-31_TreasuryStockMember" unitRef="USD" decimals="0">-750600</vsta:CommonStockExchangedForSeriesPreferredUnderAgreementsWithPlatinumCommonStockExchangeAgreementAmount>
    <vsta:CommonStockExchangedForSeriesPreferredUnderAgreementsWithPlatinumCommonStockExchangeAgreementAmount contextRef="From2011-04-01to2012-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockExchangedForSeriesPreferredUnderAgreementsWithPlatinumCommonStockExchangeAgreementAmount contextRef="From2011-04-01to2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockExchangedForSeriesPreferredUnderAgreementsWithPlatinumCommonStockExchangeAgreementShares contextRef="From2011-04-01to2012-03-31_SeriesAPreferredStockMember" unitRef="Shares" decimals="INF">45980</vsta:CommonStockExchangedForSeriesPreferredUnderAgreementsWithPlatinumCommonStockExchangeAgreementShares>
    <vsta:CommonStockExchangedForSeriesPreferredUnderAgreementsWithPlatinumNoteAndWarrantExchangeAgreementAmount contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:CommonStockExchangedForSeriesPreferredUnderAgreementsWithPlatinumNoteAndWarrantExchangeAgreementAmount contextRef="From2011-04-01to2012-03-31_SeriesAPreferredStockMember" unitRef="USD" decimals="0">200</vsta:CommonStockExchangedForSeriesPreferredUnderAgreementsWithPlatinumNoteAndWarrantExchangeAgreementAmount>
    <vsta:CommonStockExchangedForSeriesPreferredUnderAgreementsWithPlatinumNoteAndWarrantExchangeAgreementAmount contextRef="From2011-04-01to2012-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">2480900</vsta:CommonStockExchangedForSeriesPreferredUnderAgreementsWithPlatinumNoteAndWarrantExchangeAgreementAmount>
    <vsta:CommonStockExchangedForSeriesPreferredUnderAgreementsWithPlatinumNoteAndWarrantExchangeAgreementAmount contextRef="From2011-04-01to2012-03-31_TreasuryStockMember" unitRef="USD" decimals="0">-2481100</vsta:CommonStockExchangedForSeriesPreferredUnderAgreementsWithPlatinumNoteAndWarrantExchangeAgreementAmount>
    <vsta:CommonStockExchangedForSeriesPreferredUnderAgreementsWithPlatinumNoteAndWarrantExchangeAgreementShares contextRef="From2011-04-01to2012-03-31_SeriesAPreferredStockMember" unitRef="Shares" decimals="INF">159985</vsta:CommonStockExchangedForSeriesPreferredUnderAgreementsWithPlatinumNoteAndWarrantExchangeAgreementShares>
    <vsta:ConvertiblePromissoryNotes contextRef="AsOf2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:ConvertiblePromissoryNotes contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">947400</vsta:ConvertiblePromissoryNotes>
    <us-gaap:PreferredStockNoParValue contextRef="AsOf2012-03-31" unitRef="USDPShares" xsi:nil="true" />
    <us-gaap:PreferredStockNoParValue contextRef="AsOf2011-03-31" unitRef="USDPShares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2012-03-31" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2011-03-31" unitRef="Shares" decimals="INF">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2012-03-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2011-03-31" unitRef="Shares" decimals="INF">2884655</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2012-03-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2011-03-31" unitRef="Shares" decimals="INF">2884655</us-gaap:PreferredStockSharesOutstanding>
    <vsta:NoninterestBearingPromissoryNotes1 contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">525000</vsta:NoninterestBearingPromissoryNotes1>
    <vsta:NoninterestBearingPromissoryNotes1 contextRef="AsOf2011-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:PreferredStockSeriesPerValue1 contextRef="AsOf2012-03-31" unitRef="USDPShares" decimals="INF">0.001</vsta:PreferredStockSeriesPerValue1>
    <vsta:PreferredStockSeriesPerValue1 contextRef="AsOf2011-03-31" unitRef="USDPShares" decimals="INF">0.001</vsta:PreferredStockSeriesPerValue1>
    <vsta:PreferredStockSeriesASharesAuthorized contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">10000000</vsta:PreferredStockSeriesASharesAuthorized>
    <vsta:PreferredStockSeriesASharesAuthorized contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">0</vsta:PreferredStockSeriesASharesAuthorized>
    <vsta:PreferredStockSeriesASharesIssued contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">437055</vsta:PreferredStockSeriesASharesIssued>
    <vsta:PreferredStockSeriesASharesIssued contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">0</vsta:PreferredStockSeriesASharesIssued>
    <vsta:PreferredStockSeriesASharesOutstanding contextRef="AsOf2012-03-31" unitRef="USD" decimals="0">437055</vsta:PreferredStockSeriesASharesOutstanding>
    <vsta:PreferredStockSeriesASharesOutstanding contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">0</vsta:PreferredStockSeriesASharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2012-03-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2011-03-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2012-03-31" unitRef="Shares" decimals="INF">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2011-03-31" unitRef="Shares" decimals="INF">400000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2012-03-31" unitRef="Shares" decimals="INF">18704267</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2011-03-31" unitRef="Shares" decimals="INF">5241110</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2012-03-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2011-03-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:TreasuryStockShares contextRef="AsOf2012-03-31" unitRef="Shares" decimals="INF">2083858</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares contextRef="AsOf2011-03-31" unitRef="Shares" decimals="INF">0</us-gaap:TreasuryStockShares>
    <us-gaap:NatureOfOperations contextRef="From2011-04-01to2012-03-31">&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;VistaGen Therapeutics, Inc. (&amp;#147;VistaGen&amp;#148;&#13;or the &amp;#147;Company&amp;#148;), a biotechnology company focused on using human proprietary pluripotent stem cell technology for&#13;drug rescue and cell therapy, was incorporated in California on May 26, 1998 (inception date).&amp;#160;&amp;#160;Excaliber Enterprises,&#13;Ltd. (&amp;#147;Excaliber&amp;#148;), a publicly-held company (formerly OTCBB: EXCA), was organized as a Nevada corporation on October&#13;6, 2005 to market specialty gift baskets to real estate and health care professionals and organizations through the Internet.&amp;#160;&amp;#160;Excaliber&#13;was not able to generate revenues from this concept and became inactive in 2007.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;After assessing both the prospects associated&#13;with its original business plan and the strategic opportunities associated with a merger with a business seeking the perceived&#13;advantages of being a publicly held corporation, Excaliber&amp;#146;s Board of Directors agreed to pursue a strategic merger with&#13;VistaGen, as described in more detail below.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 11, 2011, Excaliber acquired&#13;all outstanding shares of VistaGen common stock for 6,836,452 shares of Excaliber common stock (the &amp;#147;Merger&amp;#148;), and&#13;assumed VistaGen&amp;#146;s pre-Merger obligations to contingently issue shares of common stock  in accordance with stock option agreements,&#13;warrant agreements, and a convertible promissory note.&amp;#160;&amp;#160;As part of the Merger, Excaliber repurchased 5,064,207 shares&#13;of its common stock  from two stockholders for a nominal amount, leaving 784,500 shares of common stock outstanding at the date&#13;of the Merger.&amp;#160;&amp;#160;The 6,836,452 shares issued to VistaGen stockholders in connection with the Merger represented approximately&#13;90% of the outstanding shares of Excaliber&amp;#146;s common stock  after the Merger.&amp;#160;&amp;#160;As a result of the Merger, Excaliber&#13;adopted VistaGen&amp;#146;s business plan and&amp;#160;&amp;#160;the business of VistaGen became the business of Excaliber. Shortly after&#13;the Merger:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"&gt;&amp;#183;&amp;#160;&amp;#160;&amp;#9;Shawn&#13;K. Singh. J.D., Jon S. Saxe, J.D., H. Ralph Snodgrass, Ph.D., Gregory A. Bonfiglio, J.D., and Brian J. Underdown, Ph.D.,&#13;each a prior director of VistaGen, were appointed as directors of Excaliber;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"&gt;&amp;#183;&amp;#160;&amp;#160;&amp;#9;Stephanie&#13;Y. Jones and Matthew L. Jones resigned as officers and directors of Excaliber;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"&gt;&amp;#183;&amp;#160;&amp;#160;&amp;#9;The&#13;following persons were appointed as officers of Excaliber;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 22pt"&gt;o&amp;#160;&amp;#160;&amp;#9;Shawn K. Singh,&#13;J.D., Chief Executive Officer,&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 22pt"&gt;o&amp;#160;&amp;#160;&amp;#9;H. Ralph Snodgrass,&#13;Ph.D., President, Chief Scientific Officer, and&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 22pt"&gt;o&amp;#160;&amp;#160;&amp;#9;A. Franklin Rice,&#13;MBA, Chief Financial Officer and Secretary;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"&gt;&amp;#183;&amp;#160;&amp;#160;&amp;#9;Excaliber&amp;#146;s&#13;directors approved a two-for-one (2:1) forward stock split of Excaliber&amp;#146;s common stock;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"&gt;&amp;#183;&amp;#160;&amp;#160;&amp;#9;Excaliber&amp;#146;s&#13;directors approved an increase in the number of shares of common stock  Excaliber is authorized to issue from 200 million to 400&#13;million shares, (see Note 9, &lt;i&gt;Capital Stock&lt;/i&gt;);&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"&gt;&amp;#183;&amp;#160;&amp;#160;&amp;#9;Excaliber&#13;changed its name to &amp;#147;VistaGen Therapeutics, Inc.&amp;#148;; and&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"&gt;&amp;#183;&amp;#160;&amp;#160;&amp;#9;Excaliber&#13;adopted VistaGen's fiscal year-end of March 31, with VistaGen as the accounting acquirer.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;VistaGen, as the accounting acquirer&#13;in the Merger, recorded the Merger as the issuance of stock for the net monetary assets of Excaliber, accompanied by a recapitalization.&amp;#160;&amp;#160;This&#13;accounting for the transaction was identical to that resulting from a reverse acquisition, except that no goodwill or other intangible&#13;assets were recorded.&amp;#160;&amp;#160;A total of 1,569,000 shares of common stock, representing the 784,500 shares held by stockholders&#13;of Excaliber immediately prior to the Merger and effected for the post-Merger two-for-one forward stock split mentioned above,&#13;have been retroactively reflected as outstanding for all periods presented in the accompanying Consolidated Financial Statements.&amp;#160;&amp;#160;Additionally,&#13;the accompanying Consolidated Balance Sheets retroactively reflect the authorized capital stock and $0.001 par value of Excaliber&amp;#146;s&#13;common stock and the two-for one forward stock split after the Merger.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The consolidated financial statements&#13;in this report represent the activity of VistaGen (the California corporation) from May 26, 1998, and the consolidated activity&#13;of VistaGen (the California corporation) and Excaliber from May 11, 2011 (the date of the Merger) through March 31, 2012. The financial&#13;statements also include the accounts of VistaGen&amp;#146;s wholly-owned inactive subsidiaries, Artemis Neuroscience, Inc. (&amp;#147;Artemis&amp;#148;),&#13;a Maryland corporation, and VistaStem Canada, Inc., an Ontario corporation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Primary Merger-Related Transactions&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Immediately preceding and concurrent&#13;with the Merger:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-indent: -45pt"&gt;&amp;#183;&amp;#160;&amp;#160;&amp;#9;VistaGen&#13;sold 2,216,106 Units, consisting of one share of VistaGen's common stock and a three-year warrant to purchase one-fourth (1/4)&#13;of one share of VistaGen&amp;#146;s common stock at an exercise price of $2.50 per share, at a price of $1.75 per Unit in a private&#13;placement for aggregate gross offering proceeds of $3,878,197, including $2,369,194 in cash (&amp;#147;2011 Private Placement&amp;#148;).&amp;#160;&amp;#160;See&#13;Note 9, &lt;i&gt;Capital Stock&lt;/i&gt;, for a further description;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-indent: -45pt"&gt;&amp;#183;&amp;#160;&amp;#160;&amp;#9;Holders&#13;of certain promissory notes issued by VistaGen from 2006 through 2010 converted their notes totaling $6,174,793, including principal&#13;and accrued but unpaid interest, into 3,528,290 Units at $1.75 per Unit.&amp;#160;&amp;#160;These Units were the same Units issued in connection&#13;with the 2011 Private Placement.&amp;#160;&amp;#160;See Note 8, &lt;i&gt;Convertible Promissory Notes and Other Notes Payable&lt;/i&gt;; and&amp;#160;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-indent: -45pt"&gt;&amp;#183;&amp;#160;&amp;#160;&amp;#9;All&#13;holders of VistaGen's then-outstanding 2,884,655 shares of preferred stock converted all of their preferred shares into 2,884,655&#13;shares of VistaGen common stock.&amp;#160;&amp;#160;See Note 9, &lt;i&gt;Capital Stock&lt;/i&gt;.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;VistaGen is a biotechnology company&#13;focused on using stem cell technology as a drug rescue product engine to generate new, safer variants (drug rescue variants) of&#13;once-promising small molecule drug candidates discovered, developed and ultimately discontinued by large pharmaceutical companies&#13;due to heart or liver toxicity concerns, despite positive efficacy data demonstrating their potential therapeutic and commercial&#13;benefits. thereby &amp;#147;rescuing&amp;#148; their substantial prior investment in research and development.&amp;#160;&amp;#160;VistaGen plans&#13;to use its pluripotent stem cell technology to generate early indications, or predictions, of how humans will ultimately respond&#13;to new drug candidates before they are ever tested in humans.&amp;#160;&amp;#160;In parallel with its drug rescue activities, VistaGen&#13;is funding pilot nonclinical studies focused on potential iPS Cell-based cell therapy applications of its &lt;i&gt;Human Clinical Trials&#13;in a Test Tube&lt;/i&gt;&amp;#153; platform.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Early in the first quarter of calendar&#13;2012, VistaGen began a Phase 1b clinical study of AV-101, a small molecule drug candidate for treatment of neuropathic pain. This&#13;study includes testing AV-101 in healthy volunteers using the intradermal capsaicin model of neuropathic pain.&amp;#160;&amp;#160;This&#13;often-used induced neuropathic pain model will test whether AV-101 will reduce the increased pain sensitivity associated with a&#13;small injection under the skin of capsaicin, the material found in chili peppers. Neuropathic pain, a serious and chronic condition&#13;causing pain after an injury or disease of the peripheral or central nervous system, affects approximately 1.8 million people in&#13;the U.S. alone. To date, VistaGen has been awarded over $8.9 million from the U.S. National Institutes of Health (&amp;#147;NIH&amp;#148;)&#13;for development of AV-101. VistaGen plans to complete Phase 1 clinical development of AV-101 in the fourth quarter of calendar&#13;2012, at which time the Company will evaluate its strategic opportunities with respect to AV-101.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;VistaGen is in the development stage&#13;and, since inception, has devoted substantially all of its time and efforts to stem cell research, stem-cell based bioassay system&#13;development, small molecule drug development, creating, protecting and patenting intellectual property, recruiting personnel and&#13;raising working capital.&lt;/p&gt;</us-gaap:NatureOfOperations>
    <us-gaap:LiquidityDisclosureTextBlock contextRef="From2011-04-01to2012-03-31">&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The accompanying consolidated financial&#13;statements have been prepared assuming the Company will continue as a going concern. As a development stage company without sustainable&#13;revenues, VistaGen has experienced recurring losses and negative cash flows from operations. From inception through March 31, 2012,&#13;VistaGen has a deficit accumulated during its development stage of $54,782,500.&amp;#160;&amp;#160;The Company expects these conditions&#13;to continue for the foreseeable future as it expands its &lt;i&gt;Human Clinical Trials in a Test Tube&lt;/i&gt;&amp;#153; platform and executes&#13;its drug rescue and cell therapy business programs.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;At March 31, 2012 and 2011, the&#13;Company had approximately $81,000 and $139,300, respectively, in cash and cash equivalents. The Company does not believe such&#13;cash and cash equivalents will enable it to fund its operations through the next twelve months. The Company anticipates that&#13;its cash expenditures during the next twelve months will be between $4 million and $6 million and it expects to meet its cash&#13;needs and fund its working capital requirements through private placements of its securities, which may include both debt and&#13;equity securities and strategic collaborations. If the Company is unable to obtain sufficient financing, it may be required&#13;to reduce, defer, or discontinue certain of its research and development activities or may not be able to continue as a going&#13;concern entity. The consolidated financial statements do not include any adjustments that might result from the outcome of&#13;this uncertainty. Since March 31, 2012, the Company has received cash proceeds and satisfaction of amounts due for services&#13;in lieu of payments by the Company in the aggregate amount of $269,800 as a result of the exercise of previously-outstanding&#13;warrants by certain warrant holders.&amp;#160;&amp;#160;In June 2012, the Company entered into an agreement pursuant to which it will&#13;issue two secured convertible promissory notes in the aggregate principal amount of $500,000 to Platinum during July&#13;2012.&amp;#160;&amp;#160;See Note 16, &lt;i&gt;Subsequent Events, &lt;/i&gt;for a further description of these transactions.&lt;/p&gt;</us-gaap:LiquidityDisclosureTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2011-04-01to2012-03-31">&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The preparation of financial statements&#13;in conformity with U.S.&amp;#160;generally accepted accounting principles (&amp;#147;U.S. GAAP&amp;#148;) requires management to make estimates&#13;and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities&#13;at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual&#13;results could differ from those estimates.&amp;#160; Significant estimates include those relating to revenue recognition, share-based&#13;compensation, and the&amp;#160;assumptions used to value warrant modifications and the previous put option, note term extension, and&#13;warrant liabilities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;Principles of Consolidation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The accompanying consolidated financial&#13;statements include the Company&amp;#146;s accounts, and the accounts of its wholly-owned inactive subsidiaries, Artemis Neuroscience,&#13;Inc. (&amp;#147;Artemis&amp;#148;), a Maryland corporation, and VistaStem Canada, Inc., an Ontario corporation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Reverse Stock Split and Change&#13;in Authorized Number of Shares&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Upon the recommendation of VistaGen&amp;#146;s&#13;Board of Directors and the approval of its shareholders at its Annual Shareholders Meeting on December&amp;#160;19, 2008, VistaGen&#13;filed an Amendment to its Articles of Incorporation on January&amp;#160;20, 2009 pursuant to which each outstanding share of common&#13;stock was reverse-split and exchanged for one-tenth of a share of common stock, and each outstanding share of preferred stock was&#13;reverse-split and exchanged for one-tenth of a preferred share. Following that reverse stock split, VistaGen was authorized to&#13;issue up to 75,000,000 shares of its common stock and 20,000,000 shares of its preferred stock.&amp;#160;&amp;#160;All pre-Merger share&#13;and per share information in the accompanying consolidated financial statements and notes reflects the reverse stock split.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Effective with the Merger, the Company&#13;was authorized to issue up to 400,000,000 shares of common stock, $0.001 par value and no shares of preferred stock.&amp;#160;&amp;#160;On&#13;October 28, 2011, the Company held a special meeting of its stockholders at which the stockholders approved a proposal to amend&#13;the Company&amp;#146;s Articles of Incorporation to (1) reduce the number of authorized shares of the Company&amp;#146;s common stock&#13;from 400,000,000 shares&amp;#160;to 200,000,000 shares; (2) authorize the Company to issue up to 10,000,000 shares of preferred stock;&#13;and (3) authorize the Company&amp;#146;s Board of Directors to prescribe the classes, series and the number of each class or series&#13;of preferred stock and the voting powers, designations, preferences, limitations, restrictions and relative rights of each class&#13;or series of preferred stock.&amp;#160;&amp;#160;In December 2011, the Company&amp;#146;s Board of Directors authorized the creation of a&#13;series of up to 500,000 shares of Series A Preferred Stock, par value $0.001.&amp;#160;&amp;#160;See Note 9, &lt;i&gt;Capital Stock&lt;/i&gt;.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Cash and Cash Equivalents&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cash and cash equivalents are considered&#13;to be highly liquid investments with maturities of three months or less at the date of purchase.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Property and Equipment&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Property and equipment is stated at&#13;cost. Repairs and maintenance costs are expensed in the period incurred. Depreciation is calculated using the straight-line method&#13;over the estimated useful lives of the assets. The estimated useful lives of property and equipment range from five to seven years.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Impairment or Disposal of Long-Lived&#13;Assets&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company evaluates its long-lived&#13;assets for impairment, primarily property and equipment, whenever events or changes in circumstances indicate that their carrying&#13;value may not be recoverable from the estimated future cash flows expected to result from their use or eventual disposition. If&#13;the estimates of future undiscounted net cash flows are insufficient to recover the carrying value of the assets, the Company records&#13;an impairment loss in the amount by which the carrying value of the assets exceeds their fair value. If the assets are determined&#13;to be recoverable, but the useful lives are shorter than originally estimated, the Company depreciates or amortizes the net book&#13;value of the assets over the newly determined remaining useful lives. The Company has not recorded any impairment charges to date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;Revenue Recognition&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company generates revenue principally&#13;from collaborative research and development arrangements, technology access fees, and government grants. Revenue arrangements with&#13;multiple components are divided into separate units of accounting if certain criteria are met, including whether the delivered&#13;component has stand-alone value to the customer. Consideration received is allocated among the separate units of accounting based&#13;on their respective selling prices.&amp;#160;&amp;#160;The selling price for each unit is based on vendor-specific objective evidence,&#13;or VSOE, if available, third party evidence if VSOE is not available, or estimated selling price if neither VSOE nor third party&#13;evidence is available.&amp;#160;&amp;#160;The applicable revenue recognition criteria are then applied to each of the units.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company recognizes revenue when&#13;the four basic criteria of revenue recognition are met: (1)&amp;#160;a contractual agreement exists; (2)&amp;#160;the transfer of technology&#13;has been completed or services have been rendered; (3)&amp;#160;the fee is fixed or determinable; and (4)&amp;#160;collectability is reasonably&#13;assured. For each source of revenue, the Company complies with the above revenue recognition criteria in the following manner:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;ul style="list-style-type: disc; margin-top: 0in"&gt;&#13;&#13;&lt;li style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;Collaborative arrangements typically consist of non-refundable&#13;and/or exclusive technology access fees, cost reimbursements for specific research and development spending, and various milestone&#13;and future product royalty payments.&amp;#160;&amp;#160;If the delivered technology does not have stand-alone value, the amount of revenue&#13;allocable to the delivered technology is deferred.&amp;#160;&amp;#160;Non-refundable upfront fees with stand-alone value that are not dependent&#13;on future performance under these agreements are recognized as revenue when received, and are deferred if the Company has continuing&#13;performance obligations and has no objective and reliable evidence of the fair value of those obligations.&amp;#160;&amp;#160;The Company&#13;recognizes non-refundable upfront technology access fees under agreements in which it has a continuing performance obligation ratably,&#13;on a straight-line basis, over the period in which the Company is obligated to provide services.&amp;#160;&amp;#160;Cost reimbursements&#13;for research and development spending are recognized when the related costs are incurred and when collectability is reasonably&#13;assured.&amp;#160;&amp;#160;Payments received related to substantive, performance-based &amp;#147;at-risk&amp;#148; milestones are recognized&#13;as revenue upon achievement of the milestone event specified in the underlying contracts, which represent the culmination of the&#13;earnings process.&amp;#160;&amp;#160;Amounts received in advance are recorded as deferred revenue until the technology is transferred,&#13;costs are incurred, or a milestone is reached.&lt;/li&gt;&#13;&#13;&lt;/ul&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;ul style="list-style-type: disc; margin-top: 0in"&gt;&#13;&#13;&lt;li style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;Technology license agreements typically consist of non-refundable&#13;upfront license fees, annual minimum access fees and/or royalty payments. Non-refundable upfront license fees and annual minimum&#13;payments received with separable stand-alone values are recognized when the technology is transferred or accessed, provided that&#13;the technology transferred or accessed is not dependent on the outcome of the continuing research and development efforts. Otherwise,&#13;revenue is recognized over the period of the Company&amp;#146;s continuing involvement.&lt;/li&gt;&#13;&#13;&lt;/ul&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;ul style="list-style-type: disc; margin-top: 0in"&gt;&#13;&#13;&lt;li style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;Government grants, which support the Company&amp;#146;s research&#13;efforts on specific projects, generally provide for reimbursement of approved costs as defined in the terms of grant awards. Grant&#13;revenue is recognized when associated project costs are incurred.&lt;/li&gt;&#13;&#13;&lt;/ul&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;Research and Development Expenses&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Research and development expenses include&#13;internal and external costs. Internal costs include salaries and employment related expenses of scientific personnel and direct&#13;project costs. External research and development expenses consist of sponsored stem cell research and development costs, costs&#13;associated with clinical and non-clinical development of AV-101, the Company&amp;#146;s lead drug development candidate, and costs&#13;related to application and prosecution of patents related to the Company&amp;#146;s stem cell technology platform, &lt;i&gt;Human Clinical&#13;Trials in a Test Tube&lt;/i&gt;&amp;#153;, and AV-101. All such costs are charged to expense as incurred.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Share-Based Compensation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company recognizes compensation&#13;cost for all share-based awards to employees in its financial statements based on their grant date fair value. Share-based compensation&#13;expense is recognized over the period during which the employee is required to perform service in exchange for the award, which&#13;generally represents the scheduled vesting period. The Company has no awards with market or performance conditions. For equity&#13;awards to non-employees, the Company re-measures the fair value of the awards as they vest and the resulting value is recognized&#13;as an expense during the period over which the services are performed.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Corporate Financing and Merger&#13;Costs&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the fiscal year ended March 31,&#13;2011, general and administrative expenses include $2.5 million in costs associated with the Company&amp;#146;s corporate financing&#13;and merger activities focused on becoming a public company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounts for income taxes&#13;using the asset and liability approach for financial reporting purposes. Deferred tax assets and liabilities are recognized for&#13;the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and&#13;liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities&#13;are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are&#13;expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in&#13;income in the period that includes the enactment date. Valuation allowances are established, when necessary, to reduce the deferred&#13;tax assets to an amount expected to be realized.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Concentrations of Credit Risk&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Financial instruments, which potentially&#13;subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents. The Company&amp;#146;s investment&#13;policies limit any such investments to short-term, low-risk investments. The Company deposits cash and cash equivalents with quality&#13;financial institutions and is insured to the maximum of federal limitations. Balances in these accounts may exceed federally insured&#13;limits at times.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Comprehensive Loss&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;There are no components of other comprehensive&#13;loss other than net loss, and accordingly the Company&amp;#146;s comprehensive loss is equivalent to net loss for the periods presented.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Loss per Common Share&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Basic loss per share of common stock&#13;excludes dilution and is computed by dividing the net loss by the weighted-average number of shares of common stock outstanding&#13;for the period. Diluted loss per share of common stock reflects the potential dilution that could occur if securities or other&#13;contracts to issue shares of common stock were exercised or converted into shares of common stock. For all periods presented, potentially&#13;dilutive securities are excluded from the computation in loss periods, as their effect would be antidilutive.&amp;#160;&amp;#160;A total&#13;of 1,569,000 shares of common stock, representing the 784,500 shares held by stockholders of Excaliber immediately prior to the&#13;Merger and effected for the post-Merger two-for-one forward stock split described in Note 1, &lt;i&gt;Description of Business, &lt;/i&gt;have&#13;been retroactively reflected as outstanding for the entire fiscal year ended March 31, 2011 and for the period prior to the Merger&#13;in the fiscal year ended March 31, 2012 for purposes of determining basic and diluted loss per common share in the accompanying&#13;Consolidated Statements of Operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Potentially dilutive securities excluded&#13;in determining diluted net loss per common share are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="text-align: center; border-bottom: Black 1pt solid"&gt;Fiscal Years Ended March 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"&gt;2012&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"&gt;2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 56%; text-align: left"&gt;All series of preferred stock issued and outstanding&lt;/td&gt;&lt;td style="width: 8%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;4,370,550&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,884,655&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Outstanding options under the 2008 and 1999 Stock Incentive Plans and 1998 Scientific Advisory Board Plan&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,805,771&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,949,153&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Outstanding warrants to purchase common stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,126,589&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,265,598&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;13,302,910&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;9,099,406&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;br style="mso-special-character: line-break" /&gt;&#13;&lt;br style="mso-special-character: line-break" /&gt;&#13;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Recently Adopted Accounting Standards&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Effective April 1, 2011, the Company&#13;adopted the Accounting Standards Update, (&amp;#147;ASU&amp;#148;) No.&amp;#160;2009-13 &lt;i&gt;Multiple-Deliverable Revenue Arrangements&lt;/i&gt;&#13;(&amp;#147;ASU No.&amp;#160;2009-13&amp;#148;) on a prospective basis&lt;i&gt;.&lt;/i&gt; ASU No.&amp;#160;2009-13 applies to multiple-deliverable revenue&#13;arrangements that are currently within the scope of ASC Topic 605-25. ASU No.&amp;#160;2009-13 provides principles and application&#13;guidance on whether multiple deliverables exist and how the arrangement should be separated and the consideration allocated. ASU&#13;No.&amp;#160;2009-13 requires an entity to allocate revenue in an arrangement using estimated selling prices of deliverables, if a&#13;vendor does not have vendor-specific objective evidence or third party evidence of selling price. The update eliminates the use&#13;of the residual method and requires an entity to allocate revenue using the relative selling price method and also significantly&#13;expands the disclosure requirements for multiple-deliverable revenue arrangements. The adoption of ASU No.&amp;#160;2009-13 did not&#13;have a material impact on the Company&amp;#146;s results of operations or financial condition in the fiscal year ended March 31, 2012.&#13;However, the adoption of ASU No. 2009-13 may result in different accounting treatment for future collaboration arrangements than&#13;the accounting treatment applied to previous and existing collaboration arrangements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Effective April 1, 2011, the Company&#13;adopted ASU No.&amp;#160;2010-17, &lt;i&gt;Milestone Method of Revenue Recognition.&lt;/i&gt; Under the milestone method, contingent consideration&#13;received from the achievement of a substantive milestone is recognized in its entirety in the period in which the milestone is&#13;achieved. A milestone is defined as an event (i)&amp;#160;that can only be achieved based in whole or in part on either the entity&amp;#146;s&#13;performance or on the occurrence of a specific outcome resulting from the entity&amp;#146;s performance, (ii)&amp;#160;for which there&#13;is substantive uncertainty at the date the arrangement is entered into that the event will be achieved, and (iii)&amp;#160;that would&#13;result in additional payments being due to the entity. A milestone does not include events for which the occurrence is contingent&#13;solely on the passage of time or solely on a collaboration partner&amp;#146;s performance. A milestone is substantive if the consideration&#13;earned from the achievement of the milestone is consistent with the Company&amp;#146;s performance required to achieve the milestone&#13;or the increase in value to the collaboration resulting from the Company&amp;#146;s performance, relates solely to the Company&amp;#146;s&#13;past performance, and is reasonable relative to all of the other deliverables and payments within the arrangement. The adoption&#13;of ASU No.&amp;#160;2010-17 did not have a material impact on the Company&amp;#146;s consolidated results of operations and financial&#13;condition.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;Recent Accounting Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In June&amp;#160;2011, the FASB issued ASU&#13;No.&amp;#160;2011-05, &amp;#147;&lt;i&gt;Presentation of Comprehensive Income,&lt;/i&gt;&amp;#148; which was issued to enhance comparability between&#13;entities that report under U.S. GAAP and International Financial Reporting Standards (&amp;#147;IFRS&amp;#148;), and to provide a more&#13;consistent method of presenting non-owner transactions that affect an entity&amp;#146;s equity. ASU 2011-05 eliminates the option&#13;to report other comprehensive income and its components in the statement of changes in stockholders&amp;#146; equity and requires&#13;an entity to present the total of comprehensive income, the components of net income and the components of other comprehensive&#13;income either in a single continuous statement or in two separate but consecutive statements. This pronouncement is effective for&#13;fiscal years, and interim periods within those years, beginning after December&amp;#160;15, 2011. Early adoption of the new guidance&#13;is permitted and full retrospective application is required. The Company does not expect that the adoption of this ASU will have&#13;any material impact on its results of operations or financial position.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In May&amp;#160;2011, the FASB issued ASU&#13;No.&amp;#160;2011-04, &amp;#147; &lt;i&gt;Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and International&#13;Financial Reporting Standards (&amp;#147;IFRS&amp;#148;).&lt;/i&gt; &amp;#148; This pronouncement was issued to provide a consistent definition&#13;of fair value and ensure that the fair value measurement and disclosure requirements are similar between U.S. GAAP and IFRS. ASU&#13;2011-04 changes certain fair value measurement principles and enhances the disclosure requirements particularly for Level 3 fair&#13;value measurements. This pronouncement is effective for reporting periods beginning on or after December&amp;#160;15, 2011, with early&#13;adoption prohibited. The new guidance will require prospective application. The Company is currently evaluating the impact, if&#13;any, that the adoption of this pronouncement may have on its results of operations or financial position.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="From2011-04-01to2012-03-31">&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April&amp;#160;1, 2008, the Company adopted&#13;the principles of fair value accounting as they relate to its financial assets and financial liabilities. Fair value is defined&#13;as the estimated exit price received to sell an asset or paid to transfer a liability in an orderly transaction between market&#13;participants at the measurement date rather than an entry price which represents the purchase price of an asset or liability. Where&#13;available, fair value is based on observable market prices or parameters or derived from such prices or parameters. Where observable&#13;prices or inputs are not available, valuation models are applied. These valuation techniques involve some level of management estimation&#13;and judgment, the degree of which is dependent on several factors, including the instrument&amp;#146;s complexity. The required fair&#13;value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels is described&#13;as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 3%; font: 10pt/115% Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; font: 10pt/115% Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#149;&lt;/td&gt;&#13;    &lt;td style="width: 95%; font: 10pt/115% Times New Roman, Times, Serif; text-align: justify"&gt;&lt;i&gt;Level&amp;#160;1&lt;/i&gt;&amp;#160;&amp;#151; Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level&amp;#160;1 inputs.&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 3%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%; text-align: justify"&gt;&amp;#149;&lt;/td&gt;&#13;    &lt;td style="width: 95%; line-height: 115%; text-align: justify"&gt;&lt;i&gt;Level&amp;#160;2&lt;/i&gt;&amp;#160;&amp;#151; Inputs other than Level&amp;#160;1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 3%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%; text-align: justify"&gt;&amp;#149;&lt;/td&gt;&#13;    &lt;td style="width: 95%; line-height: 115%; text-align: justify"&gt;&lt;i&gt;Level&amp;#160;3&lt;/i&gt;&amp;#160;&amp;#151; Unobservable inputs (&lt;i&gt;i.e., &lt;/i&gt;inputs that reflect the reporting entity&amp;#146;s own assumptions about the assumptions that market participants would use in estimating the fair value of an asset or liability) are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level&amp;#160;3 inputs.&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;A financial instrument&amp;#146;s categorization&#13;within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Where&#13;quoted prices are available in an active market, securities are classified as Level&amp;#160;1 of the valuation hierarchy. If quoted&#13;market prices are not available for the specific financial instrument, then the Company estimates fair value by using pricing models,&#13;quoted prices of financial instruments with similar characteristics or discounted cash flows. In certain cases where there is limited&#13;activity or less transparency around inputs to valuation, financial assets or liabilities are classified as Level&amp;#160;3 within&#13;the valuation hierarchy.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company does not use derivative&#13;instruments for hedging of market risks or for trading or speculative purposes. In conjunction with the issuance of the Platinum&#13;Notes (see Note&amp;#160;8, &lt;i&gt;Convertible Promissory Notes and Other Notes Payable&lt;/i&gt;), the Company determined that i)&amp;#160;the cash&#13;payment option or put option, which provided the lender with the right to require the Company to repay part of the debt at a 25%&#13;premium, and ii)&amp;#160;the note term extension option, which provided the lender with the right to extend the maturity date one&#13;year, are embedded derivatives that should be bifurcated and accounted for separately as liabilities. Also, in conjunction with&#13;the Platinum Notes, the Company issued warrants to purchase 560,000&amp;#160;shares of its common stock. These warrants included certain&#13;exercise price adjustment features pursuant to which the Company determined that the warrants were liabilities to be recorded at&#13;their estimated fair value. The Company determined the fair value of the i)&amp;#160;put option and note term extension option using&#13;an internal valuation model with Level&amp;#160;3 inputs and ii)&amp;#160;warrants using a lattice model with Level&amp;#160;3 inputs. Inputs&#13;used to determine fair value included the estimated value of the underlying common stock at the valuation measurement date, the&#13;remaining contractual term of the notes, risk-free interest rates, expected volatility of the price of the underlying common stock,&#13;and the probability of a qualified financing. Changes in the fair value of these liabilities were recognized as a non-cash charge&#13;or income in other income (expense) in the consolidated statements of operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;The fair value hierarchy for liabilities measured at fair&#13;value on a recurring basis is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="10" style="border-bottom: black 1pt solid"&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Fair Value Measurements at Reporting&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Date Using&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Quoted Prices&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;in Active&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Significant&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Markets for&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Other&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Significant&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Identical&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Observable&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Unobservable&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Carrying&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Assets&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Inputs&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Inputs&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;Value&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;(Level 1)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;(Level 2)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;(Level 3)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;March 31, 2012:&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 48%; line-height: 115%; text-indent: 27pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Put option and note term extension option liabilities&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 10%; border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 10%; border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 10%; border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 10%; border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 9pt; line-height: 115%; text-indent: 0.25in"&gt;&amp;#160;Warrant liability&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;March 31, 2011:&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%; text-indent: 27pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Put option and note term extension&amp;#160;option liabilities&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;90,800&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;90,800&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 9pt; line-height: 115%; text-indent: 0.25in"&gt;&amp;#160;Warrant liability&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;417,100&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;417,100&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;br /&gt;&#13;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the fiscal years ended March&amp;#160;31,&#13;2012 and 2011, there were no significant changes to the valuation models used for purposes of determining the fair value of the&#13;Level&amp;#160;3 put option and note term extension option liabilities and warrant liability.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The changes in Level&amp;#160;3 liabilities&#13;measured at fair value on a recurring basis are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="10" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Fair Value Measurements Using Significant&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="10" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;Unobservable Inputs (Level 3)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Put Option and&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Note Term&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Extension Option&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Warrant&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;Liabilities&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;Liability&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 61%; line-height: 115%"&gt;Balance at March 31, 2010&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 12%; line-height: 115%; text-align: right"&gt;150,200&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 9%; line-height: 115%; text-align: right"&gt;403,600&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 9%; line-height: 115%; text-align: right"&gt;553,800&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Mark to market (gain) loss included in net loss&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(217,400&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;13,500&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(203,900&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Recognition of liability and note discount upon modification of Platinum Notes&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;158,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;158,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Balance at March 31, 2011&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;90,800&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;417,100&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;507,900&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Mark to market loss included in net loss&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;71,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;7,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;78,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Reclassification of liability to  note discount on Platinum Notes upon Merger&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(161,800&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(161,800&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Reclassification of remaining warrant liability to equity&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(424,100&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(424,100&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Balance at March 31, 2012&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;No assets or other liabilities were&#13;carried at fair value as of March&amp;#160;31, 2012 or 2011.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2011-04-01to2012-03-31">&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;Property and equipment consists of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="text-align: center; border-bottom: Black 1pt solid"&gt;March 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"&gt;2012&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"&gt;2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 56%; text-align: left"&gt;&amp;#160;Laboratory equipment&lt;/td&gt;&lt;td style="width: 8%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;515,800&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;494,900&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;Computers and network equipment&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;60,700&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;Office furniture and equipment&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;75,600&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;75,100&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;604,300&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;630,700&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;Accumulated depreciation and amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(529,800&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(543,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;Property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;74,500&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;87,700&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In February 2004, the Company granted&#13;a security interest covering its laboratory and computer equipment in conjunction with notes payable under a line of credit agreement.&amp;#160;&amp;#160;The&#13;security interest was released in April 2011 in connection with the consolidation of certain notes payable (see Note&amp;#160;8, &lt;i&gt;Convertible&#13;Promissory Notes and Other Notes Payable&lt;/i&gt;).&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <vsta:Av101AcquisitionTextBlock contextRef="From2011-04-01to2012-03-31">&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In November 2003, pursuant to an Agreement&#13;and Plan of Merger (the &amp;#147;Agreement&amp;#148;), the Company acquired Artemis, a private company also in the development stage,&#13;for the purpose of acquiring exclusive licenses to patents related to the use and function of AV-101, a drug candidate then in&#13;preclinical development&amp;#160;which may have the potential to treat&amp;#160; neuropathic pain and other neurological diseases depression,&#13;epilepsy, Huntington&amp;#146;s disease and Parkinson&amp;#146;s disease. Pursuant to the Agreement, each share of common stock of Artemis&#13;was converted into the right to receive 0.9045&amp;#160;shares of the Company&amp;#146;s Series&amp;#160;B-1 preferred stock, resulting in&#13;the Company&amp;#146;s issuing 1,356,750&amp;#160;shares of its Series&amp;#160;B-1 preferred stock. The shares of Series&amp;#160;B-1 preferred&#13;stock were valued at $5.545 per share, and accordingly the purchase price of all outstanding shares of Artemis was $7,523,200.&#13;The total purchase price was allocated to AV-101 acquired in-process research and development and was expensed subsequent to the&#13;acquisition, since AV-101 required further research and development before the Company could commence clinical trials and did not&#13;have any proven alternative future uses.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The NIH awarded the Company $4.3 million&#13;to support preclinical development of AV-101 during fiscal years 2006 through 2008, culminating in the submission in November 2008&#13;of its Investigational New Drug (&amp;#34;IND&amp;#34;) application to conduct Phase 1 human clinical testing of AV-101 for neuropathic&#13;pain. In April 2009, the NIH awarded the Company a $4.2 million grant to support the Phase 1 clinical development of AV-101, and&#13;subsequently increased the grant to $4.6 million in July 2010. The Company completed the Phase 1a clinical trial of AV-101 during&#13;the third calendar quarter of 2011 and initiated Phase 1b clinical testing in the first calendar quarter of 2012.&lt;/p&gt;</vsta:Av101AcquisitionTextBlock>
    <vsta:AccruedExpensesTextBlock contextRef="From2011-04-01to2012-03-31">&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Accrued expenses consist of:&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="line-height: 115%; text-align: center; border-bottom: Black 1pt solid"&gt;March 31,&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;2011&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 70%; line-height: 115%"&gt;&amp;#160;Accrued professional services&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 12%; line-height: 115%; text-align: right"&gt;107,400&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 12%; line-height: 115%; text-align: right"&gt;88,200&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Accrued research and development expenses&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(including $1,050,000 payable to UHN by&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;issuance of 700,000 shares of stock in 2011)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;237,500&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1,089,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Accrued vacation pay and other compensation&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;229,900&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;234,900&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Accrued placement agent fees&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;50,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;All other&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;32,500&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;9,800&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;657,300&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;1,421,900&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</vsta:AccruedExpensesTextBlock>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2011-04-01to2012-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table summarizes the loan&#13;activity for the Company&amp;#146;s convertible promissory notes and other notes payable:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Conversion to/&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Balance&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Exchange for&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Balance&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Acc -rued Inter- est&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;3/31/2011&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;Additions&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;Payments&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;Amort-&#13;    ization&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;Reclass-&#13;    ifications&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;Equity&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;3/31/2012&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;3/31/2012&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%; font-style: italic"&gt;Convertible Promissory Notes:&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 20%; line-height: 115%"&gt;2006/2007 Notes&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 7%; border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;1,837,400&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 7%; border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 7%; border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 7%; border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 7%; border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 7%; border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(1,837,400&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 7%; border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1pt solid; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 7%; border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Platinum Notes&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;4,000,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(4,000,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Note discounts&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(674,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(908,900&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;908,900&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;674,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 9pt; line-height: 115%; text-indent: 9pt"&gt;Platinum Notes, net&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;3,326,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(908,900&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;908,900&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(3,326,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;2008/2010 Notes&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;2,971,800&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(2,971,800&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;12% convertible&lt;/p&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;promissory notes&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;500,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;500,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;5,300&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Note discount&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(495,100&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(4,200&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(499,300&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;12% convertible notes, net&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;4,900&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(4,200&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;700&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;5,300&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 0.25in; line-height: 115%"&gt;Total convertible promissory notes, net&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;8,135,200&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(904,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;904,700&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(8,135,200&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;700&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;5,300&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td colspan="4" style="line-height: 115%; font-style: italic"&gt;Non-interest bearing promissory notes&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-style: italic"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;August 2010 Short-Term Notes&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1,120,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(280,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(840,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 9pt; line-height: 115%; text-indent: 9pt"&gt;Note discount&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(14,300&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;14,300&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 0.25in; line-height: 115%"&gt;Non-interest bearing notes, net&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;1,105,700&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;14,300&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(280,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(840,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%; font-style: italic"&gt;Other Notes Payable&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 9pt; line-height: 115%; text-indent: 9pt"&gt;&amp;#160;&lt;i&gt;Related parties:&lt;/i&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 0.5in; line-height: 115%"&gt;7%&amp;#160;Notes payable to Officer and&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td colspan="4"&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-indent: 27pt"&gt;Directors for&lt;/p&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-indent: 27pt"&gt;legal and consulting&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 27pt; line-height: 115%; font-size: 11pt; text-indent: 27pt"&gt;&lt;font style="font-size: 10pt"&gt;services &lt;/font&gt;&lt;font style="font-size: 7pt"&gt;(1)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;34,400&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;5,100&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(26,400&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(13,100&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td colspan="2" style="padding-left: 0.5in; line-height: 115%"&gt;7 % Note payable to Cato Holding Co.&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;90,800&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(72,500&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;149,900&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;168,200&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;6,900&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 9pt; line-height: 115%; text-indent: 9pt"&gt;Note discount&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(35,900&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;11,600&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(24,300&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td colspan="4" style="padding-left: 0.75in; line-height: 115%"&gt;Total current notes payable to&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 63pt; line-height: 115%"&gt;related parties&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;34,400&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;60,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(98,900&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;11,600&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;149,900&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(13,100&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;143,900&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;6,900&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td colspan="4" style="padding-left: 0.5in; line-height: 115%"&gt;Notes payable to Cato BioVentures&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 0.5in; line-height: 115%; text-indent: -0.5in"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; under line of credit, non-current&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;170,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(170,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td colspan="4"&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: 0.25in"&gt;7 % Note payable to&lt;/p&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: 0.25in"&gt;Cato Holding Co.&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 27pt; line-height: 115%; text-indent: 27pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;non-current&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;125,100&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;125,100&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td colspan="4" style="padding-left: 0.5in; line-height: 115%"&gt;Accrued officer&amp;#146;s compensation&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 0.5in; line-height: 115%"&gt;Non-interest bearing notes payable to&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 0.5in; line-height: 115%; text-indent: -0.5in"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Officer for deferred salary&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;57,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;57,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 9pt; line-height: 115%; font-style: italic; text-indent: 9pt"&gt;Unrelated parties, current portion:&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 0.5in; line-height: 115%"&gt;7.0%&amp;#160;Notes payable&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;7,200&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(118,400&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;175,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;63,800&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;400&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td colspan="4" style="padding-left: 0.5in; line-height: 115%"&gt;7.5%&amp;#160;Notes payable to vendors for&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td colspan="4"&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-indent: -45pt"&gt;ac&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&#13;        accounts payable&lt;/p&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-indent: -45pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;converted&#13;        to notes&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; payable:&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 0.75in; line-height: 115%"&gt;Burr, Pilger, Mayer&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;5,600&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;500&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;6,100&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 27pt; line-height: 115%; text-indent: 27pt"&gt;Desjardins&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;67,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;67,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 0.75in; line-height: 115%"&gt;McCarthy Tetrault&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;182,800&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;182,800&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 0.75in; line-height: 115%"&gt;Morrison Foerster&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;111,800&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;111,800&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 45pt; line-height: 115%; text-indent: -9pt"&gt;&amp;#160;&amp;#160;&amp;#160;5.5%&amp;#160;&amp;#160;and 10% Notes payable to insurance&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: 27pt"&gt;premium&lt;/p&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: 27pt"&gt;financing&lt;/p&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: 27pt"&gt;company&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;5,400&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;88,500&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(89,300&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;4,600&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td colspan="4"&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: 0.25in"&gt;10%&amp;#160;Notes payable&lt;/p&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: 0.25in"&gt;to vendors for&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td colspan="4" style="padding-left: 0.5in; line-height: 115%"&gt;accounts payable converted to notes&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 9pt; line-height: 115%; text-indent: 27pt"&gt;payable&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;140,500&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;11,400&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(66,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;60,100&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;146,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;16,800&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td colspan="4" style="padding-left: 0.75in; line-height: 115%"&gt;Total current notes payable to&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-indent: 27pt"&gt;unrelated&lt;/p&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-indent: 27pt"&gt;parties&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;151,500&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;107,100&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(273,700&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;597,200&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;582,100&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;17,200&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td colspan="4" style="padding-left: 0.25in; line-height: 115%; font-style: italic"&gt;Unrelated parties, long term portion:&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-style: italic"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td colspan="4" style="padding-left: 0.5in; line-height: 115%"&gt;7.5%&amp;#160;Notes payable to vendors for&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td colspan="4"&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in"&gt;accounts payable&lt;/p&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in"&gt;converted to notes&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 9pt; line-height: 115%; text-indent: 27pt"&gt;payable:&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 0.75in; line-height: 115%"&gt;Burr, Pilger, Mayer&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;92,700&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;7,100&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(12,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(500&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;87,300&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1,100&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 27pt; line-height: 115%; text-indent: 27pt"&gt;Desjardins&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;262,300&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(38,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(67,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;157,300&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;2,800&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 0.75in; line-height: 115%"&gt;McCarthy Tetrault&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;554,400&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(95,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(182,800&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;276,600&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;5,700&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 0.75in; line-height: 115%"&gt;Morrison Foerster&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;2,133,400&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;526,700&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(240,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(111,800&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;2,308,300&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;37,900&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: 0.25in"&gt;Note discount&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(236,600&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(58,700&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;66,400&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(228,900&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-left: 0.75in; line-height: 115%"&gt;7.5% Notes, net&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1,989,500&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1,291,800&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(385,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;66,400&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(362,100&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;2,600,600&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;47,500&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td colspan="4"&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: 0.25in"&gt;10%&amp;#160;Notes payable&lt;/p&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: 0.25in"&gt;to vendors for&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td colspan="4"&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 9pt; text-indent: 27pt"&gt;accounts payable&lt;/p&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 9pt; text-indent: 27pt"&gt;converted to notes&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 9pt; line-height: 115%; text-indent: 27pt"&gt;payable&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;79,500&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(60,100&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;19,400&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td colspan="4"&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-indent: 27pt"&gt;Total long term&lt;/p&gt;&#13;        &lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-indent: 27pt"&gt;notes payable to&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 0.75in; line-height: 115%; text-indent: -9pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;unrelated parties&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;2,069,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;1,291,800&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(385,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;66,400&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;(422,200&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;2,620,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;47,500&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"&gt;(1)&#13;Includes two notes with principal balances of $26,400 and $8,000 and corresponding accrued interest of $9,600 and $6,400,&#13;respectively, as of March 31, 2011.&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;2006/2007 Notes&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During 2006 and 2007, the Company issued&#13;an aggregate of $1,837,400 in convertible promissory notes (the &amp;#147;2006/2007 Notes&amp;#148;), including $1,025,000 to individual&#13;investors, and $812,400 to Cato BioVentures (&amp;#147;CBV&amp;#148;), a related party, which agreed to convert $812,400 of the Company&amp;#146;s&#13;accounts payable and accrued interest into the notes as partial payment for contract research services rendered by Cato Research&#13;Ltd. (&amp;#147;CRL&amp;#148;), an affiliate of CBV (see Note 14, &lt;i&gt;Related Party Transactions)&lt;/i&gt;. The 2006/2007 Notes were to bear&#13;interest at an annual rate of 10%, were unsecured, and had an original maturity date of August&amp;#160;31, 2007, which was subsequently&#13;extended to April&amp;#160;30, 2011. The 2006/2007 Notes and accrued interest were to automatically convert into shares of equity securities&#13;issued upon the closing of an equity or equity based financing or series of equity based financings resulting in gross proceeds&#13;to the Company totaling at least $5.0&amp;#160;million and whereby the Company became a publicly traded company (a &amp;#147;Qualified&#13;Financing&amp;#148;) or upon the sale of the Company or its assets. The 2006/2007 Notes and accrued interest would convert into shares&#13;of the Company&amp;#146;s common stock at a conversion price per share equal to the price per share of the stock sold in the Qualified&#13;Financing or, in the case of a sale of the Company or substantially all of its assets, at $6.00 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Along with the issuance of the 2006/2007&#13;Notes, each noteholder was also issued a contingently exercisable warrant to purchase that number of shares of common stock determined&#13;by dividing the principal amount of such noteholder&amp;#146;s 2006/2007 Notes by the price per share sold in the Qualified Financing.&#13;The warrants were exercisable upon a Qualified Financing at an exercise price equal to the lower of: (i)&amp;#160;$6.00; or (ii)&amp;#160;the&#13;price per share in a Qualified Financing. The warrants expire on December&amp;#160;31, 2013 or 10&amp;#160;days preceding the closing date&#13;of the sale of the Company or its assets. The Company determined that the warrants should be accounted for as equity and had a&#13;nominal value at the date of issuance.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As a condition of the Company&amp;#146;s&#13;issuance of the Platinum Notes (as described below), the holders of the 2006/2007 Notes agreed to (i)&amp;#160;extend the maturity&#13;date of the Notes to June&amp;#160;30, 2008; (ii)&amp;#160;use the definition of &amp;#147;Qualified Financing&amp;#148; included in the Platinum&#13;Notes for automatic conversion; (iii)&amp;#160;extend the expiration of the Warrants to June&amp;#160;30, 2012 to be co-terminus with the&#13;warrants issued with the Platinum Notes; (iv)&amp;#160;eliminate a provision causing the Warrants to expire upon completion of the&#13;Company&amp;#146;s initial public offering; (v)&amp;#160;have a warrant exercise price equal to the lesser of $6.00 or the share price&#13;in a Qualified Financing; and (vi)&amp;#160;incorporate the &amp;#147;call&amp;#148; feature into the Warrants.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May&amp;#160;16, 2008, in conjunction&#13;with the issuance by the Company of the 2008/2010 Notes (described below), the 2006/2007 Noteholders agreed to further extend the&#13;maturity of the 2006/2007 Notes to December&amp;#160;31, 2009 and the expiration date of the Warrants to December&amp;#160;31, 2013. On&#13;December&amp;#160;9, 2009, the Company and the Noteholders amended the 2006/2007 Notes to extend the maturity date to December&amp;#160;31,&#13;2010. In December 2010, the Company and the Noteholders again amended the 2006/2007 Notes to extend the maturity date to April&amp;#160;30,&#13;2011.&amp;#160;&amp;#160;The modifications to the 2006/2007 Notes and warrants did not have any accounting consequence as the Notes and&#13;warrants were contingently convertible and exercisable, and the effect of the modification on the fair value of the note conversion&#13;feature and warrants was not significant. The effective annual interest rate on the Notes was 8.52% as a result of the May&amp;#160;16,&#13;2008 modification, 7.71% as a result of the December&amp;#160;15, 2009 modification and 7.32% as a result of the December 2010 modification.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 11, 2011, and concurrent with&#13;the Merger, the 2006/2007 Notes in the amount of $2,559,584, including principal and accrued interest, were converted into 1,462,559&#13;Units (as described in Note 9, &lt;i&gt;Capital Stock&lt;/i&gt;), at a price of $1.75 per Unit, consisting of 1,462,559 shares of the Company&amp;#146;s&#13;common stock and three-year warrants to purchase 365,640 shares of common stock at an exercise price of $2.50 per share.&amp;#160;&amp;#160;The&#13;warrants expire on May 11, 2014.&amp;#160;&amp;#160;The associated contingently exercisable warrants, originally issued with the 2006/2007&#13;Notes, became exercisable for 1,049,897 shares of common stock at an exercise price of $1.75 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;Platinum Notes&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On June&amp;#160;19, 2007, the Company completed&#13;a $2.5&amp;#160;million convertible promissory note offering that was funded by a single investor, Platinum Long Term Growth Fund&amp;#160;VII&#13;(&amp;#147;Platinum&amp;#148;). On July&amp;#160;2, 2007, the Company completed an additional $1.25&amp;#160;million convertible promissory note&#13;offering with the same investor (collectively, the &amp;#147;2007 Platinum Notes&amp;#148;). The 2007 Platinum Notes were to bear interest&#13;at an annual rate of 10%, were unsecured and had an original maturity date of June&amp;#160;30, 2008. On May&amp;#160;16, 2008, in conjunction&#13;with the issuance of the 2008/2010 Notes (described below), the maturity date of the 2007 Platinum Notes was extended to December&amp;#160;31,&#13;2009. On December&amp;#160;30, 2009, Platinum agreed to extend the maturity date of the 2007 Platinum Notes to December&amp;#160;31, 2010.&#13;In December 2010, Platinum agreed to extend the maturity date of the 2007 Platinum Notes to June 30, 2011, and in May 2011 Platinum&#13;agreed to extend the maturity date to June 30, 2012.&amp;#160;&amp;#160;Under the terms of the 2007 Platinum Notes, Platinum had the right,&#13;in its sole discretion, to extend the note maturity by one year, to June 30, 2013&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May&amp;#160;16, 2008, the Company issued&#13;an additional $250,000 convertible promissory note to Platinum (the &amp;#147;2008 Platinum Note&amp;#148;, and together with the 2007&#13;Platinum Notes, the &amp;#147;Original Platinum Notes&amp;#148;). The terms of the 2008 Platinum Note were substantially the same as&#13;those of the 2007 Platinum Notes, with a maturity date of December&amp;#160;31, 2009, which was later extended to December&amp;#160;31,&#13;2010. In December 2010, the 2008 Platinum Note maturity date was extended to June 30, 2011, and in May 2011, the maturity date&#13;was extended to June 30, 2012.&amp;#160;&amp;#160;The 2006/2007 Notes, the 2007 Platinum Notes, and the 2008/2010 Notes (as defined below)&#13;ranked senior in preference or priority to all outstanding and future indebtedness of the Company. The agreement pursuant to which&#13;the Original Platinum Notes were issued contained certain restrictive covenants which, among other things, prohibited the Company&#13;from incurring certain amounts of indebtedness, paying dividends or redeeming its preferred or common stock without Platinum&amp;#146;s&#13;prior written consent.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Principal and interest of the 2007 Platinum&#13;Notes was to be automatically converted, subject to certain conditions, upon the closing of a Qualified Financing. The number of&#13;shares issuable to Platinum upon conversion of the 2007 Platinum Notes was to be determined in accordance with one of the following&#13;two formulas, as selected by Platinum in its sole discretion: (i)&amp;#160;the outstanding principal plus accrued but unpaid interest&#13;of each 2007 Platinum Note as of the closing of the Qualified Financing multiplied by 1.25 and divided by the per share price of&#13;shares sold in the Qualified Financing; or (ii)&amp;#160;the outstanding principal plus accrued but unpaid interest of each 2007 Platinum&#13;Note as of the closing of the Qualified Financing divided by the per share price of a share assuming the Company&amp;#146;s pre-Qualified&#13;Financing value was $30&amp;#160;million, on a fully-diluted basis. In lieu of converting the then current outstanding balance due&#13;under the 2007 Platinum Notes, Platinum could, at its option, elect before converting to receive a cash payment as partial satisfaction&#13;of the outstanding balance of the 2007 Platinum Notes. The cash payment was either $750,000 or $1,125,000, depending on the amount&#13;that would have been raised in a Qualified Financing and would result in a corresponding principal reduction of either $600,000&#13;or $900,000, respectively. The 2007 Platinum Notes were voluntarily convertible, at the option of Platinum, at any time prior to&#13;a Qualified Financing or their maturity date, into shares of common stock generally at the lesser of (i)&amp;#160;the price per share&#13;of the Company&amp;#146;s most recent equity financing; (ii)&amp;#160;the price per share of any subsequent equity financing; or (iii)&amp;#160;the&#13;price per share assuming a $30&amp;#160;million valuation of the Company on a fully diluted basis.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In connection with the issuance of the&#13;2007 Platinum Notes, Platinum was issued warrants to purchase up to 525,000&amp;#160;shares of common stock at an exercise price of&#13;$6.00 per share, subject to adjustment downwards in the event that the Company issued additional shares of common stock at a per&#13;share price lower than $6.00 per share at any time prior to the Company becoming a public company. The warrant exercise price was&#13;subsequently amended to $1.50&amp;#160;per share. The warrants had an original expiration date of June&amp;#160;30, 2012, which was subsequently&#13;extended to December&amp;#160;31, 2013. The warrants were also subject to a &amp;#147;call&amp;#148; feature whereby the Company had the&#13;right to call the warrants at a price of $0.10&amp;#160;per share if shares of the Company&amp;#146;s common stock traded publicly at&#13;a per share price greater than $15.00 for at least 15 consecutive trading days, subject to certain other conditions as described&#13;in the warrants. The Company used the lattice method to determine the fair value of the warrants.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In connection with the issuance and&#13;sale of the 2007 Platinum Notes, the Company engaged a placement agent. Pursuant to the terms of the agreement with the placement&#13;agent, the Company paid a cash fee of 8% of the gross proceeds received in the financings.&amp;#160;&amp;#160;Additionally, the Company&#13;issued to the placement agent a warrant to purchase 120,000&amp;#160;shares of the Company&amp;#146;s common stock at an exercise price&#13;of $6.00 and an expiration date of June&amp;#160;30, 2012. On March&amp;#160;12, 2010, the exercise price of these warrants was amended&#13;to $2.25, and the incremental fair value of the amended warrant was charged to interest expense in the fiscal year ended March&amp;#160;31,&#13;2010. The Company valued the warrants at a fair value of $0.97 per share on the date of issuance using the Black-Scholes option&#13;pricing model and the following assumptions: fair value of common stock&amp;#160;&amp;#151; $2.10 per share; risk-free interest rate&amp;#160;&amp;#151;&#13;4.97%; volatility&amp;#160;&amp;#151; 97%; contractual term&amp;#160;&amp;#151; 5.00&amp;#160;years.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company determined that i)&amp;#160;the&#13;cash payment option, or put option, which provides the lender with the right to require the Company to repay part of the debt at&#13;a 25% premium upon the closing of a Qualified Financing, and ii)&amp;#160;the term extension option, which provides the lender with&#13;the right to extend the maturity date one year, were embedded derivatives that should be bifurcated and accounted for separately.&#13;Accordingly, the Company recorded the fair value of the derivatives at their inception, as liabilities which were required to be&#13;marked to market at each balance sheet date with the changes in fair value recorded as other income and expense. At March&amp;#160;31,&#13;2011, the fair value of the derivatives was $90,800.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company allocated the proceeds from&#13;the 2007 Platinum Notes and warrants based on their relative fair values. The relative fair value attributable to the warrants&#13;was $221,000, which was recorded as a discount to the 2007 Platinum Notes and a corresponding credit to additional paid-in capital.&#13;The Company also recorded an additional note discount for the fair value of the derivative liabilities of $85,200 and $42,700 at&#13;June&amp;#160;18, 2007 and July&amp;#160;2, 2007, respectively, or a total of $127,900, plus $300,000 in cash placement fees and $116,800&#13;as the fair value of warrants issued for placement fees. The note discount totaling $765,700 was amortized to interest expense&#13;using the effective interest method over the original one year term of the 2007 Platinum Notes. The original effective interest&#13;rate on the note was 32.27% based on the stated interest rate, the amount of amortized discount, and its term.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As indicated previously, on May&amp;#160;16,&#13;2008, the Company issued an additional $250,000 convertible promissory note to Platinum.&amp;#160;&amp;#160;In lieu of the automatic conversion&#13;of the entire outstanding balance due under the 2008 Platinum Note pursuant to a Qualified Financing, Platinum had the option to&#13;elect, before automatic conversion, to receive a cash payment as partial satisfaction of the outstanding balance of the note. The&#13;cash payment was either $50,000 or $75,000, depending on the amount that would have been raised in a Qualified Financing and would&#13;result in a corresponding reduction of the note balance of either $40,000 or $60,000, respectively. The Company also issued to&#13;Platinum a warrant to purchase up to 35,000&amp;#160;shares of common stock at an exercise price of $6.00 per share, subject to adjustment&#13;downwards in the event that the Company issued additional shares of common stock at a per share price lower than $6.00 per share&#13;at any time prior to the Company becoming a public company. This warrant expires December&amp;#160;31, 2013.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In connection with the issuance and&#13;sale of the 2008 Platinum Note the Company engaged a placement agent. Pursuant to the terms of the agreement with the placement&#13;agent, the Company was obligated to pay a cash fee of 8% of the gross proceeds received from the financing in excess of $250,000&#13;(&amp;#147;threshold amount&amp;#148;).&amp;#160;&amp;#160;Additionally, the Company agreed to issue to the placement agent warrants to purchase&#13;16,000&amp;#160;shares of the Company&amp;#146;s common stock with an exercise price of $6.00 and an expiration date of June&amp;#160;28,&#13;2012. On March&amp;#160;12, 2010, the exercise price of warrants to purchase 2,400 of the 16,000&amp;#160;shares of common stock was amended&#13;to $2.25, and the incremental fair value of the amended warrant was charged to interest expense in the fiscal year ended March&amp;#160;31,&#13;2010. The Company also agreed to issue the placement agent warrants to purchase 0.032&amp;#160;shares of the Company&amp;#146;s common&#13;stock for each dollar of gross proceeds in excess of the threshold amount. The Company valued these warrants at a fair value of&#13;$0.08 per share on the date of issuance using the Black-Scholes option pricing model and the following assumptions: fair value&#13;of common stock&amp;#160;&amp;#151; $0.60 per share; risk-free interest rate&amp;#160;&amp;#151; 4.12%; volatility&amp;#160;&amp;#151; 77%; contractual&#13;term&amp;#160;&amp;#151; 4.00&amp;#160;years.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company allocated the note proceeds&#13;from the 2008 Platinum Note and associated warrant based on their relative fair values. The relative fair value attributable to&#13;the warrant was $7,100, which the Company recorded as a discount to the 2008 Platinum Note and a corresponding credit to additional&#13;paid-in capital. The Company recorded an additional note discount of $13,300 for the fair value of the put option and term extension&#13;option liabilities and $1,300 for the fair value of warrants issued for placement fees. The note discount totaling $21,700 was&#13;amortized to interest expense using the effective interest method over the term of the 2008 Platinum Note. The original effective&#13;interest rate on the 2008 Platinum Note was 14.98% based on the stated interest rate, the amount of amortized discount, and its&#13;term.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Extension of Maturity Date&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May&amp;#160;16, 2008, in conjunction&#13;with the 2008/2010 Note financing on that date, the maturity date of the 2007 Platinum Notes was extended to December&amp;#160;31,&#13;2009 from June&amp;#160;30, 2008, and the expiration date of the associated warrants was extended to December&amp;#160;31, 2013. On December&amp;#160;30,&#13;2009, Platinum agreed to extend the maturity date of the Original Platinum Notes to December&amp;#160;31, 2010. The Company also reduced&#13;the exercise price of the associated warrants from $6.00 to $1.50 per share. In December 2010, the maturity date of the Original&#13;Platinum Notes was extended to June&amp;#160;30, 2011 from December&amp;#160;31, 2010.&amp;#160;&amp;#160;In May 2011, the maturity date of the&#13;Original Platinum Notes was extended to June 30, 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company evaluated the extension&#13;of the maturity dates of the Original Platinum Notes and modifications to the associated warrants and determined that the modifications&#13;were to be accounted for as a troubled debt restructuring on a prospective basis. The Company recorded discounts to the Platinum&#13;Notes of $65,600 and $90,000, respectively, which amounts were equal to the incremental fair value of the modified warrants under&#13;the May&amp;#160;16, 2008 and December&amp;#160;30, 2009 modifications, with a corresponding credit to additional paid-in capital under&#13;the May&amp;#160;16, 2008 modification, and to warrant liability under the December&amp;#160;30, 2009 modification. The incremental fair&#13;value of the cash payment and note term extension options under the May&amp;#160;16, 2008, December&amp;#160;30, 2009, and December 2010&#13;modifications were $199,300, $122,100, and $158,000, respectively, and were recorded as a note discount, with a corresponding credit&#13;to the related liability for these derivatives. The incremental fair value of the conversion option of the Original Platinum Notes&#13;was not significant under the May&amp;#160;16, 2008 modification and was $828,500 and $1,062,800 under the December&amp;#160;30, 2009 and&#13;December&amp;#160;31, 2010 modifications, respectively, which was recorded as a note discount with a corresponding credit to additional&#13;paid-in capital. The note discount was amortized as non-cash interest expense over the remaining term of the Platinum Notes using&#13;the effective interest method. The effective annual interest rate of the extended Original Platinum Notes was 14.65% under the&#13;May&amp;#160;16, 2008 modification,&amp;#160;27.50% under the December&amp;#160;30, 2009 modification and 26.96% under the December 2010 modification.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;May 2011 Amendment&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 5, 2011, the Original Platinum&#13;Notes were amended, restated and consolidated into a single note (the &amp;#147;New Platinum Note&amp;#148;) with a principal balance&#13;of $4.0 million (&amp;#147;May 2011 Amendment&amp;#148;).&amp;#160;&amp;#160;The following paragraphs describe the May 2011 Amendment.&amp;#160;&amp;#160;In&#13;December 2011, the Company and Platinum entered into a Note and Warrant Exchange Agreement pursuant to which the New Platinum Note&#13;was cancelled and all warrants issued to Platinum were exercised in exchange for a new series of the Company&amp;#146;s preferred&#13;stock.&amp;#160;&amp;#160;See &lt;i&gt;Note and Warrant Exchange Agreement&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/i&gt;below.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As a result of the May 2011 Amendment,&#13;the maturity date of the New Platinum Note became June 30, 2012, a one-year extension from the June 30, 2011 maturity date of the&#13;Original Platinum Notes.&amp;#160;&amp;#160;The New Platinum Note continued to bear interest at an annual rate of 10%. Platinum retained&#13;the right, in its sole discretion, to extend the maturity date of the New Platinum Note by one year to June 30, 2013.&amp;#160;&amp;#160;The&#13;New Platinum Note would have been automatically converted, subject to certain conditions, upon the last to occur of (i) the closing&#13;of an equity or equity-based financing or series of equity or equity-based financings after May 1, 2011 resulting in gross proceeds&#13;to the Company totaling at least $5.0 million, including the 2011 Private Placement (see Note 9, &lt;i&gt;Capital Stock) &lt;/i&gt;and cancellation&#13;of debt not otherwise convertible; and (ii) the Company becoming a publicly traded company (&amp;#34;Amended Qualified Financing&amp;#34;).&amp;#160;&amp;#160;The&#13;number of shares issuable to Platinum upon the automatic conversion of the Platinum Note would have been determined in accordance&#13;with one of the following three formulas, as selected by Platinum in its sole discretion: (i) the outstanding principal plus accrued&#13;but unpaid interest&amp;#160;&amp;#160;(&amp;#34;Outstanding Balance&amp;#34;) as of the closing of the Amended Qualified Financing multiplied&#13;by 1.25 and divided by $1.75 per share; (ii) the Outstanding Balance as of the closing of the Amended Qualified Financing multiplied&#13;by 1.25 and divided by the per share price of shares sold in the Amended Qualified Financing; or (iii) the Outstanding Balance&#13;as of the closing of the Amended Qualified Financing divided by the Company's per share price assuming a pre-Amended Qualified&#13;Financing valuation of the Company of $30 million on a fully-diluted basis, subject to certain exclusions.&amp;#160;&amp;#160;Under the&#13;New Platinum Note, the cash payment option previously included in the Original Platinum Notes was eliminated. In the event the&#13;Company completed an Amended Qualified Financing prior to December 31, 2011, interest accrued on the New Platinum Note from May&#13;5, 2011 through the date of the closing of the Amended Qualified Financing would have been forgiven.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Platinum Note would have been voluntarily&#13;convertible, at the option of Platinum, at any time prior to an Amended Qualified Financing or its maturity date into shares of&#13;common stock determined by multiplying the Outstanding Balance being converted by 1.25 and dividing by the lesser of (i) $1.75&#13;per share; (ii) the per share price in any subsequent equity financing; or (iii) the per share price assuming a $30 million valuation&#13;of the Company on a fully diluted basis (subject to certain exclusions).&amp;#160;&amp;#160;Platinum could have elected to convert the&#13;New Platinum Note at any time, but was not obligated to convert the New Platinum Note until the shares issuable upon conversion&#13;of the note were freely tradable pursuant to an effective registration statement or could have been sold in any ninety day period&#13;without registration under the Securities Act of 1933, as amended (&amp;#147;Securities Act&amp;#148;), in compliance with Rule 144.&#13;Additionally, Platinum could not have converted the New Platinum Note if the shares issuable upon conversion would result in it&#13;beneficially owning in excess of 9.99% of the then outstanding shares of the Company's common stock. However, Platinum could have&#13;waived this condition upon giving 61 days&amp;#146; notice to the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In connection with the issuance of the&#13;New Platinum Note, the Company issued to Platinum a three-year warrant to purchase 825,574 shares of the Company&amp;#146;s common&#13;stock at an exercise price of $2.50 per share.&amp;#160;&amp;#160;The warrant would have expired on May 5, 2014, and become exercisable&#13;upon Platinum&amp;#146;s conversion of the New Platinum Note and would have been exercisable for one-fourth (1/4) of the number of&#13;shares issued in the conversion. The Company valued the warrant at a fair value of $0.69 per share on the date of issuance using&#13;the Black-Scholes option pricing model and the following assumptions:&amp;#160;&amp;#160;fair value of common stock - $1.58; risk-free&#13;rate &amp;#150; 0.96%; volatility &amp;#150; 85%; contractual term &amp;#150; 3.00 years.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company evaluated the extension&#13;of the maturity date of the Original Platinum Notes along with the issuance of the new three-year warrant and determined that the&#13;modifications are to be accounted for as a troubled debt restructuring on a prospective basis.&amp;#160;&amp;#160;The Company recorded&#13;a discount of $908,900 to the New Platinum Note which is equal to the incremental fair value of the note conversion feature and&#13;the cash payment option liability, and the fair value of the new warrant.&amp;#160;&amp;#160;The note discount was to be amortized as non-cash&#13;interest expense over the remaining term of the New Platinum Note using the effective interest method.&amp;#160;&amp;#160;The effective&#13;annual interest rate of the New Platinum Note was determined to be 17.3%, based on the amortization of the note discount, the stated&#13;interest rate, and the note term.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;Warrant Liability&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The warrants issued with the Original&#13;Platinum Notes included certain exercise price adjustment features and accordingly were not deemed to be indexed to the Company&amp;#146;s&#13;common stock. On April&amp;#160;1, 2009, the Company recorded the estimated fair value of the warrant liability of $151,300 as a non-current&#13;liability in the consolidated balance sheet. Changes in the estimated fair value of the warrant liability were recorded in other&#13;income (expense) in the consolidated statement of operations. The Company continued to record adjustments to the fair value of&#13;the warrants until the closing of the Merger on May 11, 2011, when the amended warrants no longer contained the exercise price&#13;adjustment features, at which time the warrants were deemed to be indexed to the Company&amp;#146;s common stock and therefore no&#13;longer treated as a liability.&amp;#160;&amp;#160;The warrant liability was recorded at its fair value of $424,100 at May 11, 2011, which&#13;resulted in a non-cash expense of $7,000 that was charged to other income (expense) in the three-month period ended June 30, 2011.&amp;#160;&amp;#160;As&#13;of May 11, 2011, $424,100, the then-current aggregate fair value of these warrants, was reclassified from warrant liability to&#13;additional paid-in capital, a component of stockholders&amp;#146; deficit.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;Note and Warrant Exchange Agreement&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On December 29, 2011, the Company and&#13;Platinum entered into a Note and Warrant Exchange Agreement pursuant to which the New Platinum Note and outstanding warrants issued&#13;to Platinum to purchase an aggregate of 1,599,858 shares of the Company&amp;#146;s common stock were cancelled in exchange for 391,075&#13;shares of the Company&amp;#146;s newly-created Series A Preferred Stock (&amp;#147;Series A Preferred&amp;#148;).&amp;#160;&amp;#160;Each share&#13;of Series A Preferred is convertible into ten shares of the Company&amp;#146;s common stock (see Note 9, &lt;i&gt;Capital Stock&lt;/i&gt;).&amp;#160;&amp;#160;The&#13;Company issued 231,090 shares of Series A Preferred to Platinum in connection with the note cancellation based on the sum of the&#13;$4,000,000 principal balance of the Platinum Note plus accrued but unpaid interest through May 11, 2011 adjusted for a 125% conversion&#13;premium, net of the $1,719,800 aggregate exercise price of the outstanding 1,599,858 warrants held by Platinum, and a contractual&#13;conversion basis of $1.75 per common share, all adjusted for the 1:10 Series A Preferred to common exchange ratio.&amp;#160;&amp;#160;An&#13;additional 159,985 shares of Series A Preferred were issued to Platinum in connection with the warrant exercise and exchange to&#13;acquire the common shares issued upon the warrant exercise.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company determined that the cancellation&#13;of the Platinum Note and exercise of the warrants pursuant to the Note and Warrant Exchange Agreement should be accounted for as&#13;a debt extinguishment.&amp;#160;&amp;#160;The Company estimated the fair value of the shares of Series A Preferred stock tendered to Platinum&#13;for the cancellation of the Platinum Note under the terms of the agreement at $15.51 per share ($1.55 on a per common share equivalent&#13;basis).&amp;#160;&amp;#160;The Company recorded a loss of $1,193,500 attributable to the early debt extinguishment, reported in Other expenses,&#13;net in the accompanying Consolidated Statements of Operations.&amp;#160;&amp;#160;The loss includes $287,278, calculated using the Black-Scholes&#13;Option Pricing Model, representing the incremental fair value of the warrants exercised by Platinum as modified to reduce their&#13;exercise price.&amp;#160;&amp;#160;(See &lt;i&gt;Discounted Warrant Exercise Program&lt;/i&gt; in Note 9, &lt;i&gt;Capital Stock&lt;/i&gt;, for a description of&#13;the modification of warrant exercise prices and the resulting valuation that occurred during the quarter ended December 31, 2011.)&amp;#160;&amp;#160;The&#13;common shares issued in connection with the warrant exercise that were exchanged for shares of Series A Preferred Stock are treated&#13;as Treasury Stock in the accompanying Consolidated Balance Sheet at March 31, 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;2008/2010 Notes&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Between May 2008 and March&amp;#160;31,&#13;2010, the Company raised $2,701,800 in convertible promissory notes (the &amp;#147;2008/2010 Notes&amp;#148;) including a third party&#13;vendor conversion of $81,300 of the Company&amp;#146;s accounts payable and accrued expenses into the 2008/2010 Notes.&amp;#160;&amp;#160;Between&#13;April 1, 2010 and March 31, 2011, the Company raised an additional $270,000 by issuing convertible promissory notes of like tenor,&#13;resulting in an aggregate issuance of $2,971,800 of 2008/2010 Notes. The 2008/2010 Notes accrued interest at an annual rate of&#13;10%, were unsecured, and had an original maturity date of December&amp;#160;31, 2009 prior to an extension of the maturity date to&#13;December&amp;#160;31, 2010, and, later, to April&amp;#160;30, 2011. The outstanding principal balance of the 2008/2010 Notes and accrued&#13;interest would have automatically converted into shares of common stock upon the occurrence of an equity or equity based financing&#13;or series of equity based financings resulting in gross proceeds to the Company totaling at least $3&amp;#160;million (&amp;#147;$3 Million&#13;Qualified Financing&amp;#148;) or a sale of the Company or substantially all of its assets. The automatic conversion price per share&#13;would have been equal to the price of the common stock sold in the $3 Million Qualified Financing, or $6.00 per share upon a sale&#13;of the Company or its assets, whichever occurs first. The noteholder could voluntarily elect to convert the note and accrued interest&#13;at $6.00 per share any time prior to a $3 Million Qualified Financing or the note maturity date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Each holder of 2008/2010 Notes was also&amp;#160;&amp;#160;issued&#13;warrants to purchase that number of shares of common stock equal to the number of shares determined by dividing the principal amount&#13;of such holder&amp;#146;s 2008/2010 Notes by the price per share sold in a $3 Million Qualified Financing and then multiplying the&#13;quotient by 50%.&amp;#160;&amp;#160;The warrants expire on December&amp;#160;31, 2013 or 10&amp;#160;days preceding the closing date of the sale&#13;of the Company or its assets. The warrants are exercisable at an exercise price equal to the price per share paid in the $3 Million&#13;Qualified Financing multiplied by 1.5. The Company determined that the warrants should be accounted for as equity and had nominal&#13;value at the date of issuance.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On December&amp;#160;15, 2009, the Company&#13;amended the terms of the 2008/2010 Notes to increase the maximum allowable indebtedness under the 2008/2010 Notes to $5,000,000&#13;from $2,000,000; to extend the maturity date of the 2008/2010 Notes to December&amp;#160;31, 2010 from December&amp;#160;31, 2009; and&#13;to use the current definition of $3 Million Qualified Financing. The Company also amended the related warrants to increase the&#13;number of shares issuable upon exercise of the warrants as reflected in the formula in the preceding paragraph. The exercise price&#13;of the warrants was also modified to reflect the formula indicted in the preceding paragraph.&amp;#160;&amp;#160;The modifications to the&#13;2008/2010 Notes and warrants did not have any accounting consequence, as the notes were contingently convertible and the warrants&#13;contingently exercisable so that the effect of the modifications on the fair value of the note conversion feature and warrants&#13;was not significant.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In December 2010, the Company amended&#13;the terms of the 2008/2010 Notes to extend the maturity date to April&amp;#160;30, 2011 from December&amp;#160;31, 2010.&amp;#160;&amp;#160;The&#13;December 2010 modification, consistent with the above, did not have any accounting consequence as the notes were contingently convertible&#13;and the warrants contingently exercisable so that the effect of the modifications on the fair value of the note conversion feature&#13;and warrants was not significant.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 11, 2011, and concurrent with&#13;the Merger, the 2008/2010 Notes in the amount of $3,615,200, including principal and accrued interest, were converted into 2,065,731&#13;Units, at a price of $1.75 per Unit, consisting of 2,065,731 shares of common stock of the Company and three-year warrants to purchase&#13;516,415 shares of common stock at an exercise price of $2.50 per share.&amp;#160;&amp;#160;The warrants expire on May 11, 2014. The associated&#13;contingently exercisable warrants, originally issued with the 2008/2010 Notes, became exercisable for 848,998 shares of common&#13;stock at an exercise price of $2.62 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;August 2010 Short-Term Notes&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In August of 2010, the Company issued&#13;short-term, non-interest bearing, unsecured promissory notes (&amp;#147;August 2010 Short-Term Notes&amp;#148;) having an aggregate principal&#13;amount of $1,064,000 for a purchase price of $800,000.&amp;#160;&amp;#160;The August 2010 Short-Term Notes were due and payable at the&#13;earlier of (i) ten business days following the Closing Date of an initial public offering or (ii) December 1, 2010.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Each holder of August 2010 Short-Term&#13;Notes was also issued warrants to purchase the number of shares of common stock equal to 0.33 times the dollars invested.&amp;#160;&amp;#160;The&#13;warrants expire three years from the date of issuance and have an exercise price of $3.00 per share.&amp;#160;&amp;#160;The Company valued&#13;the resulting 264,000 warrants at a fair value of $0.50 per share on the date of issuance using the Black-Scholes option pricing&#13;model with the following assumptions:&amp;#160;&amp;#160;fair value of common stock - $1.48 per share; risk-free interest rate &amp;#150;&#13;0.86%; volatility - 78.29%; contractual term &amp;#150; 3 years.&amp;#160;&amp;#160;The Company recorded the fair value of the warrants as&#13;a discount to the notes with a corresponding credit to additional paid-in capital.&amp;#160;&amp;#160;The note discount was to be amortized&#13;as non-cash interest expense over the term of the August 2010 Short-Term Notes using the effective interest method.&amp;#160;&amp;#160;The&#13;effective annual interest rate of the August 2010 Short-Term Notes was 151.04% based on the amortization of the note discount,&#13;the stated interest rate, and the note term.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In November 2010, the Company amended&#13;the August 2010 Short-Term Notes to extend the maturity date to December&amp;#160;31, 2010 from December 1, 2010, increased the number&#13;of warrants to purchase the number of shares of common stock to equal 0.50 times the dollars invested from 0.33 times the dollars&#13;invested and reduced the exercise price to $2.00 per share from $3.00 per share.&amp;#160;&amp;#160;This increased the number of warrants&#13;related to this financing to 400,000 from 264,000.&amp;#160;&amp;#160;The Company evaluated the extension of the maturity dates of the&#13;August 2010 Short-Term Notes and modifications to the associated warrants and determined that the modification should be accounted&#13;for as a troubled debt restructuring on a prospective basis.&amp;#160;&amp;#160;The Company recorded a discount to the August 2010 Short-Term&#13;Notes of $121,100, which amount was equal to the incremental fair value of the modified warrants under the November 2010 modification,&#13;with a corresponding credit to additional paid-in capital.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In December 2010, the Company further&#13;amended the August 2010 Short-Term Notes to extend the maturity date to April&amp;#160;30, 2011 from December&amp;#160;31, 2010 and increased&#13;the aggregate principal amount to $1,120,000 from $1,064,000.&amp;#160;&amp;#160;The Company evaluated the extension of the maturity dates&#13;of the August 2010 Short-Term Notes and modifications to the associated principal amount and&amp;#160;determined that the modification&#13;should be accounted for as a troubled debt restructuring on a prospective basis.&amp;#160;&amp;#160;The Company recorded a discount to&#13;the August 2010 Short-Term Notes of $56,000, which amount is equal to the increased principal amount, with a corresponding credit&#13;to debt. The effective interest rate on the August 2010 Short-Term Notes subsequent to these modifications was 63.64% from the&#13;original effective interest rate of 151.04%.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In May 2011, in connection with the&lt;i&gt;&amp;#160;&lt;/i&gt;2011&#13;Private Placement described in Note 9, &lt;i&gt;Capital Stock,&lt;/i&gt; a total of $840,000 of the aggregate $1,120,000 outstanding principal&#13;amount of the August 2010 Short-Term Notes, plus a note cancellation premium of $94,500, were converted into 534,000 Units, at&#13;a price of $1.75 per Unit, consisting of 534,000 shares of the Company&amp;#146;s common stock and three-year warrants to purchase&#13;133,500 shares of the Company&amp;#146;s common stock at an exercise price of $2.50 per share; $105,000 of such amount was converted&#13;into a long-term note issued to Cato Holding Company; and $175,000 of such amount was not converted.&amp;#160;&amp;#160;In April 2011,&#13;the Company and the holder of the $175,000 note amended the note, whereby the Company paid $50,000 of the note balance within three&#13;days of the closing of the 2011 Private Placement, and was to make four monthly payments of $5,000 between May 2011 and August&#13;2011, an additional nine monthly payments of $11,125 per month for the period from September 1, 2011 through May 1, 2012, plus&#13;a final payment on May 2, 2012 equal to any remaining balance.&amp;#160;&amp;#160;The amended note bears interest at 7% per annum. The&#13;note cancellation premium was recorded as interest expense.&amp;#160;&amp;#160;In September 2011, the Company and the holder agreed to&#13;further modify the payment schedule to require payments of $5,000 per month through November 1, 2011, six monthly payments of $11,125&#13;for the period from December 1, 2011 through May 1, 2012, an additional payment of $11,125 on May 2, 2012, plus a final payment&#13;on June 30, 2012 equal to any remaining balance. The Company did not make the February 2012 and March 2012 payments as scheduled.&#13;In March 2012, the Company and the note holder again agreed to modify the payment schedule to require seven monthly payments of&#13;$9,171 beginning June 1, 2012 with the final payment on December 1, 2012 to include interest accrued after March 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;7% Notes Payable for Consulting&#13;Services&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the period from July 2000 to&#13;April 2003, the Company engaged certain members of the Board of Directors to provide consulting services outside of their responsibilities&#13;as Board members. In exchange for these services the Company issued promissory notes and warrants. The notes originally accrued&#13;interest at an annual rate of 7%. Effective January 2006, the Company and the individuals agreed that no further interest would&#13;accrue on the notes and unpaid accrued interest. The notes payable and accrued interest totaled $50,400 at March&amp;#160;31, 2011.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 11, 2011, and concurrent with&#13;the Merger, the note payable to a director for principal and accrued interest totaling $14,400, plus a $5,100 note cancellation&#13;premium, was converted into 11,142 shares of common stock and a three-year warrant to purchase 2,785 shares of common stock at&#13;an exercise price of $2.50 per share.&amp;#160;&amp;#160;The related note cancellation premium was recorded as interest expense. Also,&#13;on May 11, 2011, the 7% note payable to an officer and director including principal and accrued interest totaling $36,000 was paid.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Notes payable to Cato Holding&#13;Company, doing business as Cato BioVentures, under line of credit and August 2010 Short Term Notes; Partial cancellation of August&#13;2010 Short-Term Notes and Issuance of Long-Term Promissory Note to Cato Holding Company&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In February 2004, the Company entered&#13;into a loan agreement that established a revolving line of credit facility for up to $200,000 with Cato Holding Company, doing&#13;business as Cato BioVentures (&amp;#147;CBV&amp;#148;), a related party, which was increased in 2006 to $400,000. Between June 2004 and&#13;October 2004, the Company drew down an aggregate amount of $200,000. Loans made pursuant to the loan agreement accrued interest&#13;at the rate of prime plus 1% and were due to mature on February&amp;#160;3, 2007. In September 2005, the Company paid all interest&#13;accrued to that date and prepaid the interest payable through the maturity date, an aggregate of approximately $35,300, by issuing&#13;5,883&amp;#160;shares of the Company&amp;#146;s Series&amp;#160;C preferred stock. The Company expensed the prepaid interest over the scheduled&#13;remaining term of the notes. Pursuant to the loan agreement, the Company granted CBV a continuing security interest in the Company&amp;#146;s&#13;personal property and equipment, excluding intellectual property. In August 2006 and February 2007, the loan agreement was modified&#13;to extend the maturity date of the outstanding balance to December&amp;#160;31, 2009 and to increase the amount available to the Company&#13;under the credit facility from $200,000 to $400,000. The annual interest rate on the loans made pursuant to the loan agreement&#13;was 4.25% at March&amp;#160;31, 2011.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On December&amp;#160;31, 2009, the Company&#13;amended its loan agreement with CBV to extend the maturity date of the loans made pursuant to the agreement from December&amp;#160;31,&#13;2009 to the earlier of December&amp;#160;31, 2010 or ninety days after the initial public offering of the Company&amp;#146;s common stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On December 28, 2010, the Company again&#13;amended its loan agreement with CBV to extend the maturity date of the loans made pursuant to the loan agreement from December&amp;#160;31,&#13;2010 to December&amp;#160;31, 2012, or ninety days following the closing of an offering of $5,000,000 or more in common stock, or the&#13;closing of a reverse merger into a public shell company whose common stock traded on the OTC Bulletin Board.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 29, 2011, all amounts owed&#13;by the Company to Cato Holding Company (&amp;#34;CHC&amp;#34;) or its affiliates, which include CBV, including the $105,000 principal&#13;balance of August 2010 Short Term Notes and the $170,000 principal balance payable under the line of credit, were consolidated&#13;into a single note, in the principal amount of $352,273.&amp;#160;&amp;#160;Additionally, CHC released the 2004 CBV security interests&#13;in the Company&amp;#146;s personal property.&amp;#160;&amp;#160;The consolidated CHC note bears interest at 7% per annum, compounded monthly.&amp;#160;&amp;#160;Under&#13;the terms of the note, the Company is to make six monthly payments of $10,000 each beginning June 1, 2011; and thereafter will&#13;make payments of $12,500 monthly until the note is repaid in full. The Company may prepay the outstanding balance under this note&#13;in full or in part at any time during the term of this note without penalty.&amp;#160;&amp;#160;At March 31, 2012, the Company had not&#13;paid the monthly payments due subsequent to December 2011.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Notes Payable Issued for the Cancellation&#13;of Accounts Payable&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On October&amp;#160;12, 2009, the Company&#13;issued a promissory note payable to the Regents of the University of California (&amp;#147;UC&amp;#148;) with a principal balance of&#13;$90,000 in exchange for the cancellation of certain amounts payable under a research collaboration agreement (the &amp;#147;UC Note&#13;1&amp;#148;). UC Note 1 was payable in monthly principal installments of $15,000 through May&amp;#160;30, 2010. Interest on UC Note 1&#13;at 10% per annum was payable on May&amp;#160;30, 2010. If the Company had completed an initial public offering of its stock prior to&#13;May 30, 2010, the remaining balance of UC Note 1 would have been payable within 10 business days after the initial public offering&#13;was consummated.&amp;#160;&amp;#160;The Company made the first two monthly installments totaling an aggregate of $30,000.&amp;#160;&amp;#160;On&#13;February 25, 2010, the Company issued a promissory note payable to UC having a principal balance of $170,000 in exchange for the&#13;cancellation of the remaining $60,000 principal balance of UC Note 1 and certain amounts payable under a research collaboration&#13;agreement (&amp;#147;UC Note 2&amp;#148;). UC Note 2 was payable in monthly principal installments of $15,000 through May&amp;#160;31, 2010,&#13;with the remaining $125,000 plus all accrued and unpaid interest due on or before June&amp;#160;30, 2010. If the Company had completed&#13;an initial public offering of its stock prior to June 30, 2010, the remaining balance of the Note would have been payable within&#13;10 business days after the initial public offering was consummated.&amp;#160;&amp;#160;On June 28, 2010, the Company amended UC Note 2&#13;to extend the payment terms as follows: monthly installments of $15,000 payable through May&amp;#160;31, 2010, $10,000 due on June&amp;#160;30,&#13;2010 and $115,000 plus all accrued and unpaid interest due and payable on or before August&amp;#160;30, 2010.&amp;#160;&amp;#160;On August&#13;25, 2010 and again on October&amp;#160;30, 2010, the Company amended UC Note 2 to extend the date of the final installment payment&#13;to be made under UC Note 2 to December&amp;#160;31, 2010 while adding a strategic premium to preserve license rights under the research&#13;collaboration agreement in exchange for an increase in the then-outstanding principal amount of UC Note 2 by $15,000 to $125,000.&#13;On December 22, 2010, the Company amended UC Note 2 a fourth time and decreased the monthly payment amount to $5,000 with payments&#13;continuing until the outstanding balance of principal and interest is paid in full. The provision requiring the payment of the&#13;outstanding balance within 10 business days following the closing of an initial public offering remains unchanged.&amp;#160;&amp;#160;At&#13;March 31, 2012, the Company has not made the monthly payments required for February or March 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 1, 2010, the Company issued&#13;a 10% promissory note with a principal balance of $75,000 to National Jewish Health in exchange for the cancellation of certain&#13;amounts payable for accrued royalties.&amp;#160;&amp;#160;The principal balance plus all accrued and unpaid interest was initially due&#13;on or before December&amp;#160;31, 2010 (&amp;#147;March 2010 Note&amp;#148;). If the Company had completed an initial public offering of&#13;its stock prior to any installment dates, $25,000 of the remaining balance of the March 2010 Note would have been due on June&amp;#160;30,&#13;2010, and any remaining principal balance and all accrued and unpaid interest would have been payable within 90 business days after&#13;the initial public offering was consummated.&amp;#160;&amp;#160;On December 28, 2010, the Company amended the March 2010 Note and extended&#13;its maturity date to the first to occur of April&amp;#160;30, 2011 or 30 days following the closing of a financing with gross proceeds&#13;of $5,000,000 or more.&amp;#160; The Company has been in extended discussions with the holder of the March 2010 Note and expects the&#13;Note will be cancelled in favor of certain amounts payable to the Company equal to or greater than the outstanding balance of the&#13;Note.&amp;#160;&amp;#160;At March 31, 2012, the Company has made no payments on the March 2010 Note.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On August 13, 2010, the Company issued&#13;a 10% promissory note with a principal balance of $40,962 to MicroConstants, Inc. in exchange for the cancellation of certain amounts&#13;payable for services rendered.&amp;#160;&amp;#160;Under the terms of this note, the Company is to make payments of $1,000 per month with&#13;any unpaid principal or accrued interest due and payable upon the first to occur of (i) August 1, 2013, (ii) the issuance and sale&#13;of equity securities whereby the Company raises at least $5,000,000 or (iii) the sale or acquisition of all or substantially all&#13;of the Company&amp;#146;s stock or assets.&amp;#160;&amp;#160;At March 31, 2012, the Company has not made the monthly payments required for&#13;February and March 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 15, 2010, the Company issued&#13;an unsecured 7.5% promissory note with a principal balance of $1,280,125 in exchange for the cancellation of certain amounts payable&#13;for legal services rendered by Morrison &amp;#38; Foerster LLP (&amp;#147;Morrison &amp;#38; Foerster&amp;#148;), the Company&amp;#146;s legal and&#13;intellectual property counsel (&amp;#147;Morrison &amp;#38; Foerster Note&amp;#148;).&amp;#160;&amp;#160;According to its terms, the Company was&#13;obligated to make monthly payments of $10,000 until December&amp;#160;15, 2011. However, the monthly payments were to increase to $50,000&#13;upon the completion of an initial public offering, and, in addition, a $250,000 payment would be payable upon the completion of&#13;an equity financing of at least $3&amp;#160;million. The Note accrued annual interest at 7.5% and, as scheduled, the outstanding balance&#13;of the Morrison &amp;#38; Foerster Note and accrued interest was payable on December&amp;#160;31, 2011 or upon the sale of the Company&#13;or its assets, or upon an event of default (as defined in the Morrison &amp;#38; Foerster Note), whichever occurs first. Additionally,&#13;all amounts payable for services rendered by Morrison &amp;#38; Foerster on behalf of the Company from March 1, 2010 through the closing&#13;of an initial public offering were to be automatically added to the outstanding principal balance of the Morrison &amp;#38; Foerster&#13;Note upon delivery of an invoice for such services.&amp;#160;&amp;#160;Additional billings of $839,700 and $347,800 were added to the outstanding&#13;principal of the Note for the periods ending March&amp;#160;31, 2011 and 2012, respectively, related to services rendered.&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 5, 2011, the Company and Morrison&#13;&amp;#38; Foerster entered into Amendment No. 1 to the Morrison &amp;#38; Foerster Note (&amp;#147;Amendment No. 1&amp;#148;).&amp;#160;&amp;#160;Under&#13;the terms of Amendment No. 1, the principal balance of the Morrison &amp;#38; Foerster note was increased to $2,200,000, with a payment&#13;of $100,000 due within three business days of the effective date of Amendment No. 1, which amount was paid. Under Amendment No.&#13;1, the note bears interest at 7.5% and principal will be due, along with all accrued but unpaid interest on the earliest of (i)&#13;March 31, 2016, (ii) the consummation of a Change of Control, as defined in the Morrison &amp;#38; Foerster note, and (iii) any failure&#13;to pay principal or interest when due.&amp;#160;&amp;#160;The Company was obligated to make payments of $10,000 per month until June 1,&#13;2011 and thereafter to pay $15,000 per month through March 31, 2012, $25,000 per month through March 31, 2013, and $50,000 per&#13;month through maturity.&amp;#160; In addition, the Company is obligated to make payments equal to five percent (5%) of the net proceeds&#13;of any equity financing closed during the term of the note until all outstanding principal and interest is paid in full.&amp;#160;&amp;#160;If&#13;the Company prepays the entire amount due by December 31, 2012, the amount of such payment shall be reduced by ten percent (10%),&#13;up to a maximum of $100,000. At March 31, 2012, the Company has not made the monthly payments required for February and March 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In connection with the issuance of the&#13;Morrison &amp;#38; Foerster Note, the Company issued to Morrison &amp;#38; Foerster a warrant to purchase up to 425,000&amp;#160;shares of&#13;its common stock at an exercise price of $3.00 per share. The Warrant expires on December&amp;#160;31, 2014.&amp;#160;&amp;#160;The Company&#13;valued the Warrant at a fair value of $0.69 per share on the date of issuance using the Black-Scholes option pricing model and&#13;the following assumptions: fair value of common stock&amp;#160;&amp;#151; $1.48 per share; risk-free interest rate&amp;#160;&amp;#151; 2.35%;&#13;volatility&amp;#160;&amp;#151; 74.82%; contractual term&amp;#160;&amp;#151; 4.83 years.&amp;#160;&amp;#160;The Company recorded the fair value of the&#13;Warrant as a discount to the Morrison &amp;#38; Foerster Note and a corresponding credit to additional paid-in capital.&amp;#160;&amp;#160;The&#13;effective annual interest rate of the 7.5% promissory note at issuance was 14.86%.&amp;#160;&amp;#160;In connection with Amendment No.&#13;1, the Company issued 200,000 shares of restricted common stock to Morrison &amp;#38; Foerster which had a value, at the time of issuance,&#13;of $1.75 per share. In addition, the Company reduced the exercise price of the common stock warrants previously issued to Morrison&#13;&amp;#38; Foerster from $3.00 to $2.00 per share. The $58,700 increase in the fair value of the warrants was recorded as a note discount&#13;and a corresponding increase in additional paid-in capital.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On February 25, 2011, the Company issued&#13;to Burr, Pilger, and Mayer, LLC (&amp;#147;BPM&amp;#148;) an unsecured promissory note in the principal amount of $98,674 (the &amp;#147;BPM&#13;Note&amp;#148;) for amounts payable in connection with services provided to the Company by BPM.&amp;#160;&amp;#160;The BPM Note bears interest&#13;at the rate of 7.5% per annum and has payment terms of $1,000 per month, beginning March 1, 2011 and continuing until all principal&#13;and interest are paid in full.&amp;#160; In addition, a payment of $25,000 will be due upon the sale of the Company or upon the Company&#13;completing a financing transaction of at least $5.0 million, with the payment increasing to $50,000 (or the amount then owed under&#13;the note, if less) upon the Company completing a financing of over $10.0 million.&amp;#160;&amp;#160;At March 31, 2012, the Company has&#13;not made the monthly payment required for March 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 29, 2011, the Company issued&#13;to Desjardins Securities, Inc. (&amp;#147;Desjardins&amp;#148;) an unsecured promissory note in the principal amount of CDN $236,000&#13;for amounts payable for legal fees incurred by Desjardins in connection with investment banking services provided to the Company&#13;by Desjardins. The Desjardins note bears interest at 7.5% and will be due, along with all accrued but unpaid interest on the earliest&#13;of (i) June 30, 2014, (ii) the consummation of a Change of Control, as defined in the Desjardins note, and (iii) any failure to&#13;pay principal or interest when due.&amp;#160;&amp;#160;The Company is to make payments of CDN $4,000 per month beginning May 31, 2011,&#13;increasing to CDN $6,000 per month on January 31, 2012. In addition, if, prior to June 30, 2012, the Company closes an equity financing&#13;or series of equity financings with aggregate proceeds of $5.0 million or more, then the Company is obligated to make a payment&#13;of $39,600 to Desjardins within 10 business days of the closing of such transaction(s). Beginning on January 1, 2012, the Company&#13;is also obligated to make payments equal to one-half percent (0.5%) of the net proceeds of all private or public equity financings&#13;closed during the term of the note. In connection with issuance of the note, the Company issued 39,600 shares of restricted common&#13;stock to Desjardins which, at the time of issuance, had a value of $1.75 per share.&amp;#160;&amp;#160;At March 31, 2012, the Company has&#13;not made the monthly payments required for February and March 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 5, 2011, the Company issued to&#13;McCarthy Tetrault LLP (&amp;#147;McCarthy&amp;#148;) an unsecured promissory note in the principal amount of CDN $502,797 for the amounts&#13;payable in connection with legal services provided to the Company.&amp;#160;&amp;#160;The McCarthy note bears interest at 7.5% and will&#13;be due, along with all accrued but unpaid interest on the earliest of (i) June 30, 2014, (ii) the consummation of a Change of Control,&#13;as defined in the McCarthy note, and (iii) any failure to pay principal or interest when due.&amp;#160;&amp;#160;The Company is obligated&#13;to make payments of CDN $10,000 per month beginning May 31, 2011, increasing to CDN $15,000 per month on January 31, 2012. In addition,&#13;if, prior to June 30, 2012, the Company closes an equity financing or series of equity financings with aggregate proceeds of $5.0&#13;million or more, then the Company is to make a payment of $100,000 to McCarthy within 10 business days of the closing of such transaction(s).&#13;Beginning on January 1, 2012, the Company is also obligated to make payments equal to one percent (1%) of the net proceeds of all&#13;private or public equity financings closed during the term of the note. In connection with issuance of this note, the Company issued&#13;100,000 shares of restricted common stock to McCarthy which had a value, at the time of issuance, of $1.75 per share.&amp;#160;&amp;#160;At&#13;March 31, 2012, the Company has not made the monthly payments required for February and March 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;February 2012 12% Convertible&#13;Promissory Notes&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On February 28, 2012, the Company completed&#13;a private placement of convertible promissory notes to certain accredited investors in the aggregate principal amount of $500,000&#13;(the &amp;#34;Notes&amp;#34;).&amp;#160;&amp;#160;Each Note accrues interest at the rate of 12% per annum and will mature on the earlier of (i)&#13;twenty-four months from the date of issuance, or (ii) consummation of an equity, equity-based, or series of equity-based financings&#13;resulting in gross proceeds to the Company of at least $4.0 million (the Qualified Financing Threshold&amp;#148;). The holder of each&#13;Note may voluntarily convert the outstanding principal amount of the Notes and all accrued and unpaid interest (the &amp;#147;Outstanding&#13;Balance&amp;#148;) at any time prior to maturity into that number of shares of the Company&amp;#146;s common stock equal to the Outstanding&#13;Balance, divided by $3.00 (the &amp;#34;Conversion Shares&amp;#34;). In addition, in the event the Company consummates a financing equal&#13;to or exceeding the Qualified Financing Threshold, and the price per unit of the securities sold, or price per share of common&#13;stock issuable in connection with such financing, is at least $2.00 (a &amp;#147;Qualified Financing&amp;#148;), the Outstanding Balance&#13;will automatically convert into such securities, including warrants, that are issued in the Qualified Financing, the amount of&#13;which shall be determined according to the following formula: (Outstanding Balance at the closing date of the Qualified Financing)&#13;x (1.25) / (the per security price of the securities sold in the Qualified Financing).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The purchaser of each Note was issued&#13;a warrant to purchase, for $2.75 per share, the number of shares of the Company&amp;#146;s common stock equal to 150% of the total&#13;principal amount of the Notes purchased by such purchaser, divided by $2.75, resulting in the potential issuance of an aggregate&#13;of 272,724 shares of the Company&amp;#146;s common stock upon exercise of the warrants.&amp;#160;&amp;#160;The warrants terminate, if not&#13;exercised, five years from the date of issuance.&amp;#160;&amp;#160;The Company valued the warrants at a fair value of $1.99 per share&#13;on the date of issuance using the Black-Scholes option pricing model and the following assumptions:&amp;#160;&amp;#160;fair value of common&#13;stock - $2.85; risk-free interest rate &amp;#150; 0.84%; volatility &amp;#150; 89.9%; contractual term &amp;#150; 5.00 years; dividend rate&#13;&amp;#150; 0%.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company allocated the proceeds from&#13;the Notes and associated warrants based on their relative fair values. The relative fair value attributable to the warrants was&#13;$260,076, which the Company recorded as a discount to the Notes and a corresponding credit to additional paid-in capital. The Company&#13;recorded an additional note discount of $235,084 for the fair value of the non-contingent beneficial conversion feature of the&#13;Notes.&amp;#160;&amp;#160;The note discounts totaling $495,160 will be amortized to interest expense using the effective interest method&#13;over the term of the Notes. The effective interest rate on the Notes at the date of issuance was 268.9% based on the stated interest&#13;rate, the amount of discount, and the term of the Notes.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <vsta:CapitalStockTextBlock contextRef="From2011-04-01to2012-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;At March 31, 2011, VistaGen was authorized&#13;to issue a total of 95 million shares of capital stock in two classes, designated, respectively, as common stock and preferred&#13;stock.&amp;#160;&amp;#160;Of the total shares authorized, 75 million shares were designated as no par value common stock and the remaining&#13;20 million shares were designated as no par value preferred stock.&amp;#160;&amp;#160;&amp;#160;At March 31, 2011 and prior to the Merger,&#13;Excaliber was authorized to issue up to 200 million shares of common stock, $0.001 par value, and no shares of preferred stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;2011 Private Placement&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 11, 2011, and immediately preceding&#13;the closing of the Merger, VistaGen sold 2,216,106 Units in a private placement for aggregate gross proceeds of $3,878,200, including&#13;$2,369,200 in cash, a $500,000 short-term note receivable due on September 6, 2011, cancellation of $840,000 of short-term notes&#13;maturing on April 30, 2011, a note cancellation premium of $94,500, and cancellation of $74,500 of accounts payable (the &amp;#147;2011&#13;Private Placement&amp;#148;).&amp;#160;&amp;#160;The Units were sold for $1.75 per Unit and consisted of one share of common stock and a three-year&#13;warrant to purchase one-fourth (1/4) of one share of common stock at an exercise price of $2.50 per share.&amp;#160;&amp;#160;Warrants&#13;to purchase a total of 554,013 shares of common stock were issued to the purchasers of the Units.&amp;#160;&amp;#160;Concurrently, VistaGen&#13;issued to its placement agent three-year warrants to purchase 114,284 shares of its common stock at $2.50 per share, and agreed&#13;to pay $200,000 in placement agent fees, $150,000 of which amount was paid on May 11, 2011.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In October 2011, VistaGen restructured&#13;the terms of the $500,000 short term promissory note received in conjunction with the 2011 Private Placement.&amp;#160;&amp;#160;The note&#13;currently bears interest at 5% per annum.&amp;#160;&amp;#160;The maturity date has been extended to September 1, 2012 and the revised terms&#13;require payments to VistaGen as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160; (a) one payment&#13;of $50,000 on or before October 31, 2011;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 40.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;(b) nine payments of $50,000 on or before the first day of each month commencing December 1, 2011 and ending August 1, 2012;&#13;and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 40.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;(c) one final payment equal to the remaining balance of principal and interest due on or before September 1, 2012.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The outstanding principal balance of&#13;the note receivable at March 31, 2012 is $250,000.&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Conversion of Convertible Promissory&#13;Notes&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 11, 2011, concurrent with the&#13;Merger, holders of certain promissory notes issued by VistaGen from 2006 through 2010 converted their notes totaling aggregate&#13;principal and interest of $6,174,793 into 3,528,290 Units, at a price of $1.75 per Unit.&amp;#160;&amp;#160;These Units were the same Units&#13;issued in connection with the 2011 Private Placement.&amp;#160;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Conversion of Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 11, 2011, concurrent with the&#13;Merger, all holders of VistaGen's then-outstanding preferred stock converted all of their preferred shares into 2,884,655 shares&#13;of common stock so that, at the completion of the Merger, the Company had no shares of preferred stock outstanding.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Changes in Amounts of Capital&#13;Stock Authorized&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Effective with the Merger, the Company&#13;was authorized to issue up to 400,000,000 shares of common stock, $0.001 par value and no shares of preferred stock.&amp;#160;&amp;#160;On&#13;October 28, 2011, the Company held a special meeting of its stockholders at which the stockholders approved a proposal to amend&#13;the Company&amp;#146;s Articles of Incorporation to (1) reduce the number of shares of common stock the Company is authorized to issue&#13;from 400,000,000 shares&amp;#160;to 200,000,000 shares; (2) authorize the Company to issue up to 10,000,000 shares of preferred stock;&#13;and (3) authorize the Company&amp;#146;s Board of Directors to prescribe the classes, series and the number of each class or series&#13;of preferred stock and the voting powers, designations, preferences, limitations, restrictions and relative rights of each class&#13;or series of preferred stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Series A Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In December 2011, the Company&amp;#146;s&#13;Board of Directors authorized the creation of a series of up to 500,000 shares of Series A Preferred Stock, par value $0.001 (&amp;#147;Series&#13;A Preferred&amp;#148;).&amp;#160;&amp;#160;Each share of Series A Preferred is convertible at the option of the holder into ten shares of&#13;the Company's common stock.&amp;#160;&amp;#160;The Series A Preferred ranks prior to the common stock for purposes of liquidation preference.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Series A Preferred has no separate&#13;dividend rights, however, whenever the Board of Directors declares a dividend on the common stock, each holder of record of a share&#13;of Series A Preferred shall be entitled to receive&amp;#160;an amount equal to such dividend declared on one share of common stock&#13;multiplied by the number of shares of common stock into which such share&amp;#160;of Series A Preferred could be converted on the Record&#13;Date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Except with respect to transactions&#13;upon which the Series A Preferred shall be entitled to vote separately as a class, the Series A Preferred has no voting rights.&#13;The common stock into which the Series A Preferred is convertible shall, upon issuance, have all of the same voting rights as other&#13;issued and outstanding shares of the Company&amp;#146;s common stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In the event of the liquidation, dissolution&#13;or winding up of the affairs of the Company, after payment or provision for payment of the debts and other liabilities of the Company,&#13;the holders of Series A Preferred then outstanding shall be entitled to receive an amount per share of Series A Preferred calculated&#13;by taking the total amount available for distribution to holders of all the Company's outstanding common stock before deduction&#13;of any preference payments for the Series A Preferred, divided by the total of (x), all of the then outstanding shares of the Company's&#13;common stock, plus (y) all of the shares of the Company's common stock into which all of the outstanding shares of the Series A&#13;Preferred can be converted before any payment shall be made or any assets distributed to the holders of the common stock or any&#13;other junior stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;At March 31, 2012, there were 437,055&#13;shares of Series A Preferred outstanding, all issued to Platinum under the terms of the Note and Warrant Exchange Agreement described&#13;in Note 8, &lt;i&gt;Convertible Promissory Notes and Other Notes Payable,&lt;/i&gt; and the Common Stock Exchange Agreement, described below.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Common Stock Exchange Agreement&#13;with Platinum&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On December 22, 2011, the Company entered&#13;into a Common Stock Exchange Agreement (the &amp;#34;Exchange Agreement&amp;#34;) with Platinum, pursuant to which Platinum converted&#13;484,000 shares of the Company&amp;#146;s common stock into 45,980 shares of the newly created Series A Preferred (the &amp;#34;Exchange&amp;#34;).&amp;#160;&amp;#160;Each&#13;share of Series A Preferred issued to Platinum is convertible into ten shares of the Company&amp;#146;s common stock.&amp;#160;&amp;#160;In&#13;consideration for the Exchange, the Series A Preferred received by Platinum in connection with the Exchange is convertible into&#13;the equivalent of 0.95 shares of common stock surrendered in connection with the Exchange.&amp;#160;&amp;#160;The Company has determined&#13;the fair value of the common stock subject to the Exchange to be $1.55 per share and has reflected the 484,000 common shares as&#13;treasury stock on that basis in the accompanying Consolidated Balance Sheet at March 31, 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Fall 2011 Follow-On Offering&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Beginning in October 2011, the Company&#13;initiated a follow-on private placement of Units.&amp;#160;&amp;#160;These Units were essentially the same as the Units issued in connection&#13;with the 2011 Private Placement, namely, each Unit was priced at $1.75 and consisted of one share of the Company&amp;#146;s common&#13;stock and a three-year warrant to purchase one-fourth (1/4) of one share of the Company&amp;#146;s common stock at an exercise price&#13;of $2.50 per share.&amp;#160;&amp;#160;The Company sold a total of 63,570 Units and received aggregate cash proceeds of $111,300.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Discounted Warrant Exercise Program&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the quarter ended December 31,&#13;2011, certain warrant holders exercised warrants to purchase an aggregate of 3,121,259 shares of the Company&amp;#146;s common stock&#13;at reduced exercise prices, including warrants to purchase 1,599,858 shares of common stock exercised by Platinum under the terms&#13;of the Note and Warrant Exchange Agreement, as described in Note 8, &lt;i&gt;Convertible&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Promissory Notes and Other Notes&#13;Payable&lt;/i&gt;.&amp;#160;&amp;#160;The warrants exercised by Platinum were exercised at reduced prices ranging from $0.75 per share to $1.25&#13;per share, resulting in proceeds of $1,719,800 which was applied to reduce the outstanding balance of the Platinum Note and accrued&#13;interest under the terms of the Note and Exchange Agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Other investors and service providers&#13;exercised warrants to purchase an aggregate of 1,028,860 shares of the Company&amp;#146;s common stock at reduced exercise prices&#13;ranging from $0.75 per share to $1.31 per share.&amp;#160;&amp;#160;In conjunction with these exercises, the Company:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-indent: -45pt"&gt;&amp;#183;&amp;#160;&amp;#160;&amp;#9;issued&#13;965,734 shares of its common stock and received cash proceeds of $1,106,100;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-indent: -45pt"&gt;&amp;#183;&amp;#160;&amp;#160;&amp;#9;issued&#13;29,426 shares of its common stock to warrant holders who elected to exercise their warrants in lieu of payment by the Company in&#13;satisfaction of outstanding indebtedness to such holders totaling an aggregate of $30,100; and&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-indent: -45pt"&gt;&amp;#183;&amp;#160;&amp;#160;&amp;#9;issued&#13;33,700 shares of its common stock to warrant holders who elected to exercise their warrants in lieu of payment by the Company in&#13;satisfaction of payment for services in the aggregate amount of $41,400 to be performed in the future by such holders.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Additionally, in December 2011, the&#13;Company entered into an Agreement Regarding Payment of Invoices and Warrant Exercises with Cato Holding Company (&amp;#147;CHC&amp;#148;),&#13;CRL, and certain individual warrant holders affiliated with CHC and CRL (collectively, the &amp;#147;CHC Affiliates&amp;#148;) under&#13;the terms of which CHC and the CHC Affiliates exercised warrants to purchase an aggregate of 492,541 shares of the Company&amp;#146;s&#13;common stock at reduced exercise prices ranging from $0.88 per share to $1.25 per share.&amp;#160;&amp;#160;As a result of these warrant&#13;exercises, the Company received cash payments of $60,200 in connection with the exercise of warrants to purchase 68,417 shares&#13;and, in lieu of cash payments for the remainder of the warrants to purchase 424,124 shares, CHC and CRL agreed to the satisfaction&#13;of outstanding indebtedness to CRL in the amount of $245,300 and pre-payment for future services in the amount of $226,400.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company determined that the increase&#13;in the fair value of the warrants exercised as a result of the Discounted Warrant Exercise Program was $618,400, of which $287,300&#13;is a component of the loss on debt extinguishment related to the conversion of the Platinum Note, as described in Note 8, &lt;i&gt;Convertible&#13;Promissory Notes and Other Notes Payable,&lt;/i&gt; $101,200 is attributable to the modifications of the CHC&amp;#160;&amp;#160;and CHC Affiliates&#13;warrants and reflected in research and development expense, and $229,800 is reflected in general and administrative expense for&#13;the fiscal year ended March 31, 2012 in the accompanying Consolidated Statements of Operations.&amp;#160;&amp;#160;The warrants subject&#13;to the exercise price modifications were valued at the inception of the Discounted Warrant Exercise Program using the Black-Scholes&#13;Option Pricing Model and using the following assumptions:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold; text-align: justify"&gt;Assumption:&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: justify"&gt;Pre-modification&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: justify"&gt;Post-modification&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 74%; line-height: 115%; text-align: justify"&gt;Market price per share&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 10%; line-height: 115%; text-align: right"&gt;2.60&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 10%; line-height: 115%; text-align: right"&gt;2.60&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%; text-align: justify"&gt;Exercise price per share&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.50 - $2.625&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;0.75 - $1.31&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%; text-align: justify"&gt;Risk-free interest rate&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;0.18% - 0.45&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;0.02&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%; text-align: justify"&gt;Expected term (years)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;0.90 - 3.25&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;0.25&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%; text-align: justify"&gt;Volatility&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;65.7% - 82.8&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;41.1&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%; text-align: justify"&gt;Dividend rate&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;0.0&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;0.0&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold; text-align: justify"&gt;Weighted Average Fair Value per share&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold; text-align: right"&gt;1.30&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold; text-align: right"&gt;1.50&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The market price per share is based&#13;on the quoted market price of the Company&amp;#146;s common stock on the Over-the-Counter Bulletin Board on the date of the modification&#13;or the closest subsequent date on which there was quoted trading reported.&amp;#160;&amp;#160;Because of its short history as a public&#13;company, the Company has estimated volatility based on the historical volatilities of a peer group of public companies over the&#13;expected term of the option.&amp;#160;&amp;#160;The risk-free rate of interest is based on the quoted constant maturity rate for U.S Treasury&#13;Bills on the date of the modification for the term corresponding with the expected term of the warrant.&amp;#160;&amp;#160;The expected&#13;dividend rate is zero as the Company has not paid and does not expect to pay dividends in the near future.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Other Warrant Modifications&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In December 2011, the Company entered&#13;into a consulting agreement with a strategic consultant for general and capital markets advisory services.&amp;#160;&amp;#160;As consideration&#13;for the services to be provided under this agreement, the Company modified the term and exercise price of certain previously-issued&#13;warrants to purchase an aggregate of 384,184 shares of its common stock.&amp;#160;&amp;#160;The Company determined that the increase in&#13;the fair value of the modified warrants was $397,500, which is reflected in general and administrative expense for the fiscal year&#13;ended March 31, 2012 in the accompanying Consolidated Statements of Operations.&amp;#160;&amp;#160;The warrants modified were valued using&#13;the Black-Scholes Option Pricing Model and using the following assumptions:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold; text-align: justify"&gt;Assumption:&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: justify"&gt;Pre-modification&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: justify"&gt;Post-modification&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 74%; line-height: 115%; text-align: justify"&gt;Market price per share&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 10%; line-height: 115%; text-align: right"&gt;2.99&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 10%; line-height: 115%; text-align: right"&gt;2.99&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%; text-align: justify"&gt;Exercise price per share&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;2.25 - $3.00&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.125 - $1.50&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%; text-align: justify"&gt;Risk-free interest rate&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;0.02% - 0.29&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;0.29&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%; text-align: justify"&gt;Expected term (years)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;0.53 &amp;#150; 2.39&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;2.39&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%; text-align: justify"&gt;Volatility&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;69.4% &amp;#150; 81.0&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;81.0&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%; text-align: justify"&gt;Dividend rate&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;0.0&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;0.0&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold; text-align: justify"&gt;Weighted Average Fair Value per share&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold; text-align: right"&gt;1.00&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold; text-align: right"&gt;2.03&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In December 2011, the Company also entered&#13;into a consulting agreement with an individual for strategic consulting services to be performed as requested by the Company&amp;#146;s&#13;Chief Executive Officer.&amp;#160;&amp;#160;As consideration for the services to be provided under this agreement, the Company modified&#13;the term and exercise price of certain previously-issued warrants to purchase an aggregate of 23,138 shares of its common stock&#13;and will pay the consultant $1,000 per month for the period June 2012 through December 2012.&amp;#160;&amp;#160;The Company determined&#13;that the increase in the fair value of the modified warrants was $13,100, which is reflected in general and administrative expense&#13;for the fiscal year ended March 31, 2012 in the accompanying Consolidated Statements of Operations.&amp;#160;&amp;#160;The warrants modified&#13;were valued using the Black-Scholes Option Pricing Model and using the following assumptions:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold; text-align: justify"&gt;Assumption:&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: justify"&gt;Pre-modification&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: justify"&gt;Post-modification&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 74%; line-height: 115%; text-align: justify"&gt;Market price per share&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 10%; line-height: 115%; text-align: right"&gt;3.05&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 10%; line-height: 115%; text-align: right"&gt;3.05&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%; text-align: justify"&gt;Exercise price per share&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.75 - $2.50&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;0.88 - $1.25&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Risk-free interest rate&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;0.25% - 0.29&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;0.29&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%; text-align: justify"&gt;Expected term (years)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;2.00 &amp;#150; 2.36&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;2.36&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%; text-align: justify"&gt;Volatility&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;74.8 &amp;#150; 78.3&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;78.3&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%; text-align: justify"&gt;Dividend rate&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;0.0&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;0.0&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold; text-align: justify"&gt;Weighted Average Fair Value per share&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold; text-align: right"&gt;1.69&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold; text-align: right"&gt;2.25&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Common Stock and Warrant Grants&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 29, 2011, VistaGen&amp;#160;&amp;#160;issued&#13;157,143 shares of its common stock at a per share price of $1.75 as a prepayment for CRO services to be performed by Cato Research&#13;Ltd., a related party, during 2011.&amp;#160;&amp;#160;The prepayment of $275,000 was recognized in research and development expense in&#13;the Consolidated Statement of Operations as the services were performed by Cato Research, Ltd. during the fiscal year ended March&#13;31, 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In December 2010, VistaGen agreed to&#13;issue 700,000 shares of its common stock, valued at $1.50 per share, related to its execution of the second amendment to its Sponsored&#13;Research Collaboration Agreement (&amp;#147;SRCA&amp;#148;) with UHN as described in Note 12, &lt;i&gt;Licensing and Collaborative Agreements&lt;/i&gt;,&#13;and recorded $1,050,000 of research and development expense in the Consolidated Statements of Operations for the fiscal year ended&#13;March 31, 2011.&amp;#160;&amp;#160;Such shares were issued in May 2011. In April 2011, VistaGen agreed to issue to UHN an additional 100,000&#13;shares of its common stock valued at $1.75 per share in conjunction with its execution of the third amendment to the SRCA, as also&#13;described in Note 12, and recorded $175,000 of research and development expense in the Consolidated Statements of Operations for&#13;the fiscal year ended March 31, 2012.&amp;#160;&amp;#160;Such shares were issued in May 2011.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 10, 2011, VistaGen issued 75,000&#13;shares of common stock, valued at $1.75 per share, to a strategic consultant for services rendered and recorded $131,250 in general&#13;and administrative expense in the Consolidated Statements of Operations for the fiscal year ended March 31, 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In January 2012, the Company issued&#13;an aggregate of 50,000 shares of its common stock, valued at $3.15 per share, and three-year warrants to purchase an aggregate&#13;of 50,000 shares of its common stock at an exercise price of $3.00 per share to two service providers as compensation for services.&amp;#160;&amp;#160;The&#13;Company recorded $157,500 in general and administrative expense in the Consolidated Statements of Operations for the fiscal year&#13;ended March 31, 2012 related to the stock grants.&amp;#160;&amp;#160;The Company valued the warrants at a fair value of $1.73 per share&#13;on the date of issuance using the Black-Scholes option pricing model and the following assumptions:&amp;#160;&amp;#160;fair value of common&#13;stock - $3.15; risk-free interest rate &amp;#150; 0.40%; volatility &amp;#150; 84.6%; contractual term &amp;#150; 3.00 years; dividend rate&#13;&amp;#150; 0%, and recorded $86,700 in general and administrative expense in the Consolidated Statements of Operations for the fiscal&#13;year ended March 31, 2012 related to the warrant grants.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In February 2012, the Company granted&#13;four-year warrants to non-employee members of its Board of Directors and Scientific Advisory Board and to certain strategic consultants&#13;to purchase an aggregate of 280,000 shares of its common stock at an exercise price of $3.00 per share.&amp;#160;&amp;#160;The Company&#13;valued the warrants at a fair value of $1.71 per share on the date of issuance using the Black-Scholes option pricing model and&#13;the following assumptions:&amp;#160;&amp;#160;fair value of common stock - $2.75; risk-free interest rate &amp;#150; 0.63%; volatility &amp;#150;&#13;90.0%; contractual term &amp;#150; 4.00 years; dividend rate &amp;#150; 0%, and recorded $179,200 in research and development expense&#13;and $298,600 in general and administrative expense in the Consolidated Statements of Operations for the fiscal year ended March&#13;31, 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In March 2012, the Company granted three-year&#13;warrants to purchase an aggregate of 100,000 shares of its common stock at an exercise price of $3.00 per share to investors who&#13;had exercised warrants generating more than $100,000 in cash proceeds to the Company during the Discounted Warrant Exercise Program.&amp;#160;&amp;#160;The&#13;Company valued the warrants at a fair value of $1.38 per share on the date of issuance using the Black-Scholes option pricing model&#13;and the following assumptions:&amp;#160;&amp;#160;fair value of common stock - $2.79; risk-free interest rate &amp;#150; 0.54%; volatility&#13;&amp;#150; 79.5%; contractual term &amp;#150; 3.00 years; dividend rate &amp;#150; 0%, and recorded $138,100 in interest expense in the&#13;Consolidated Statements of Operations for the fiscal year ended March 31, 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During March 2012, the Company issued&#13;50,000 shares of its common stock, valued at $2.79 per share, to a strategic consultant for services rendered and recorded $139,500&#13;in general and administrative expense in expense in the Consolidated Statements of Operations for the fiscal year ended March 31,&#13;2012.&amp;#160;&amp;#160;The Company also issued 55,555 shares of its common stock, valued at $2.79 per share, to University Health Network,&#13;a related party, in connection with the execution of License Agreement No. 2, and recorded $155,000 in research and development&#13;expense in the Consolidated Statements of Operations for the fiscal year ended March 31, 2012.&amp;#160;&amp;#160;The Company also issued&#13;8,000 shares of its common stock, valued at $2.80 per share, in connection with the extension of the term of a promissory note,&#13;and recorded $22,400 in interest expense in the Consolidated Statements of Operations for the fiscal year ended March 31, 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Warrants Outstanding&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table summarizes outstanding&#13;warrants to purchase shares of the Company&amp;#146;s common stock as of March 31, 2012 and 2011.&amp;#160;&amp;#160;The weighted average&#13;exercise price of outstanding warrants at March 31, 2012 and 2011 was $2.16 and $2.06 per share, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;Shares Subject to Purchase&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center"&gt;Exercise&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold; text-align: center"&gt;Expiration&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;March 31,&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;Price&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;Date&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center"&gt;2011&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 15%; line-height: 115%; text-align: right"&gt;0.88&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 47%; line-height: 115%; text-align: center"&gt;5/17/2012 to 5/11/2014&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; line-height: 115%; text-align: right"&gt;314,328&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; line-height: 115%; text-align: right"&gt;298,900&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.00&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: center"&gt;11/4/2014&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1,500&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.125&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: center"&gt;12/28/2012&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;97,679&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.25&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: center"&gt;5/11/2014 to 12/31/2014&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;120,280&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.50&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: center"&gt;12/31/2012&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;375,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;795,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;1.75&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: center"&gt;12/31/2013&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;643,184&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;2.00&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: center"&gt;8/3/2013 to 12/31/2014&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;609,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;403,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;2.10&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: center"&gt;3/21/2013&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;2,916&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;2.25&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: center"&gt;6/28/2012&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;122,400&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;2.50&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: center"&gt;5/11/2014&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;617,394&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;2.625&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: center"&gt;12/31/2013&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;588,200&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;2.75&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: center"&gt;2/28/2017&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;272,724&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;3.00&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: center"&gt;1/4/2015 to 2/13/2016&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;430,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;575,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;6.00&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: center"&gt;6/28/2012 to 12/31/2013&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;57,300&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;68,382&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;4,126,589&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;2,265,598&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;VistaGen and Excaliber Common&#13;Stock Summary&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table provides a summary&#13;of the number of issued and outstanding shares of the Company&amp;#146;s common stock from March 31, 2011 through March 31, 2012,&#13;reflecting the impact of the Merger, the exercise of modified warrants and other transactions described in the notes to these Consolidated&#13;Financial Statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;Excaliber Enterprises, Ltd.&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center"&gt;VistaGen Therapeutics, Inc.&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 71%; line-height: 115%"&gt;&amp;#160;Common stock outstanding at March 31, 2011&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; line-height: 115%; text-align: right"&gt;5,848,707&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; line-height: 115%; text-align: right"&gt;3,672,110&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Shares repurchased from Excaliber shareholders&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(5,064,207&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Shares issued in 2011 Private Placement&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;2,216,106&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Shares issued upon conversion of convertible&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&amp;#160;&amp;#160;promissory notes&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;3,528,290&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Shares issued upon conversion of all series of VistaGen&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&amp;#160;&amp;#160;preferred stock&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;2,884,655&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Shares issued to UHN under the SRCA&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;800,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Shares issued for services&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;571,743&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Common stock outstanding at Merger&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;784,500&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;13,672,904&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td colspan="4" style="line-height: 115%"&gt;One-half share of Excaliber common stock issued for each share&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;of VistaGen common stock in the Merger&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;6,836,452&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(13,672,904&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Common stock outstanding post-Merger&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;7,620,952&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Two-for-one post-Merger forward stock split&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;7,620,952&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Shares issued upon exercise of modified warrants, including&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&amp;#160;&amp;#160;1,599,858 shares subject to Note and Warrant Exchange&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&amp;#160;&amp;#160;Agreement with Platinum&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;3,121,259&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Shares issued in Fall 2011 Follow-on Offering&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;63,570&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Shares issued upon exercise of stock options&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;113,979&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Shares issued for services following the Merger&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;155,555&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Shares issued in connection with note term extension&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;8,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Common stock issued at March 31, 2012&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;18,704,267&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Less treasury stock:&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td colspan="4" style="line-height: 115%"&gt;&amp;#160;Shares exchanged for Series A Preferred under the terms of the:&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Common Stock Exchange Agreement with Platinum&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;(484,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Note and Warrant Exchange Agreement with Platinum&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(1,599,858&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Treasury stock held at March 31, 2012&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;(2,083,858&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;Common stock outstanding at March 31, 2012&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;16,620,409&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;Reserved Shares&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;At March 31, 2012, the Company has reserved shares of its&#13;common stock for future issuance as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Series A Preferred Stock:&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 86%; line-height: 115%"&gt;&amp;#160;&amp;#160;&amp;#160;Shares currently outstanding&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; line-height: 115%; text-align: right"&gt;4,370,550&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&amp;#160;&amp;#160;Shares authorized but not issued&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;629,450&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;5,000,000&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Stock incentive plans:&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Subject to outstanding options under the 2008 and 1999 Stock Incentive Plans&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;4,805,771&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Available for future grants&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;433,700&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;5,239,471&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Outstanding warrants to purchase common stock&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;4,126,589&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%; font-size: 11pt"&gt;&lt;font style="font-size: 10pt"&gt;February 2012 12% convertible promissory notes and accrued interest&amp;#160;&amp;#160;&lt;/font&gt;&lt;font style="font-size: 7pt"&gt;(1)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right"&gt;337,893&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Total&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"&gt;14,703,953&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td colspan="5" style="line-height: 115%; font-size: 11pt"&gt;&lt;font style="font-size: 7pt"&gt;(1)&lt;/font&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;assumes mandatory conversion in connection with a qualified financing at $2.00 per share, plus 7% warrants to placement agent&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</vsta:CapitalStockTextBlock>
    <vsta:ForgivenessOfNotesAtTheMergerAmount contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">185100</vsta:ForgivenessOfNotesAtTheMergerAmount>
    <vsta:ForgivenessOfNotesAtTheMergerAmount contextRef="From2011-04-01to2012-03-31_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:ForgivenessOfNotesAtTheMergerAmount contextRef="From2011-04-01to2012-03-31_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <vsta:ForgivenessOfNotesAtTheMergerAmount contextRef="From2011-04-01to2012-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" decimals="0">185100</vsta:ForgivenessOfNotesAtTheMergerAmount>
    <vsta:ForgivenessOfNotesAtTheMergerShares contextRef="From2011-04-01to2012-03-31_CommonStockMember" unitRef="Shares" xsi:nil="true" />
    <vsta:EffectOfMergerShares contextRef="From1998-05-26to1999-03-31_CommonStockMember" unitRef="Shares" decimals="INF">1569000</vsta:EffectOfMergerShares>
    <vsta:EffectOfMergerAmount contextRef="From1998-05-26to1999-03-31_CommonStockMember" unitRef="USD" decimals="0">1600</vsta:EffectOfMergerAmount>
    <vsta:EffectOfMergerAmount contextRef="From1998-05-26to1999-03-31_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-1600</vsta:EffectOfMergerAmount>
    <vsta:PlacementFeesOn12ConvertibleNotes contextRef="From2011-04-01to2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:PlacementFeesOn12ConvertibleNotes contextRef="From2011-04-01to2012-03-31_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:PlacementFeesOn12ConvertibleNotes contextRef="From2011-04-01to2012-03-31_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <vsta:PlacementFeesOn12ConvertibleNotes contextRef="From2011-04-01to2012-03-31_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:PlacementFeesOn12ConvertibleNotes contextRef="From2011-04-01to2012-03-31_NotesReceivableFromSaleOfStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:PlacementFeesOn12ConvertibleNotes contextRef="From2011-04-01to2012-03-31_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" xsi:nil="true" />
    <vsta:SharesIssuedForPreferredStock contextRef="AsOf1998-05-25_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <vsta:SharesIssuedForPreferredStock contextRef="AsOf2000-03-31_PreferredStockMember" unitRef="Shares" decimals="INF">429350</vsta:SharesIssuedForPreferredStock>
    <vsta:SharesIssuedForPreferredStock contextRef="AsOf2001-03-31_PreferredStockMember" unitRef="Shares" decimals="INF">748212</vsta:SharesIssuedForPreferredStock>
    <vsta:SharesIssuedForPreferredStock contextRef="AsOf2002-03-31_PreferredStockMember" unitRef="Shares" decimals="INF">947498</vsta:SharesIssuedForPreferredStock>
    <vsta:SharesIssuedForPreferredStock contextRef="AsOf2003-03-31_PreferredStockMember" unitRef="Shares" decimals="INF">947498</vsta:SharesIssuedForPreferredStock>
    <vsta:SharesIssuedForPreferredStock contextRef="AsOf2004-03-31_PreferredStockMember" unitRef="Shares" decimals="INF">2304248</vsta:SharesIssuedForPreferredStock>
    <vsta:SharesIssuedForPreferredStock contextRef="AsOf2005-03-31_PreferredStockMember" unitRef="Shares" decimals="INF">2694575</vsta:SharesIssuedForPreferredStock>
    <vsta:SharesIssuedForPreferredStock contextRef="AsOf2006-03-31_PreferredStockMember" unitRef="Shares" decimals="INF">2884655</vsta:SharesIssuedForPreferredStock>
    <vsta:SharesIssuedForPreferredStock contextRef="AsOf2007-03-31_PreferredStockMember" unitRef="Shares" decimals="INF">2884655</vsta:SharesIssuedForPreferredStock>
    <vsta:SharesIssuedForPreferredStock contextRef="AsOf2008-03-31_PreferredStockMember" unitRef="Shares" decimals="INF">2884655</vsta:SharesIssuedForPreferredStock>
    <vsta:SharesIssuedForPreferredStock contextRef="AsOf2009-03-31_PreferredStockMember" unitRef="Shares" decimals="INF">2884655</vsta:SharesIssuedForPreferredStock>
    <vsta:SharesIssuedForPreferredStock contextRef="AsOf2010-03-31_PreferredStockMember" unitRef="Shares" decimals="INF">2884655</vsta:SharesIssuedForPreferredStock>
    <vsta:SharesIssuedForPreferredStock contextRef="AsOf2011-03-31_PreferredStockMember" unitRef="Shares" decimals="INF">2884655</vsta:SharesIssuedForPreferredStock>
    <vsta:SharesIssuedForPreferredStock contextRef="AsOf2012-03-31_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2012-03-31" unitRef="USD" xsi:nil="true" />
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">14534800</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2010-03-31" unitRef="USD" decimals="0">14534800</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf1998-05-25_SeriesAPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2000-03-31_SeriesAPreferredStockMember" unitRef="USD" decimals="0">964200</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2001-03-31_SeriesAPreferredStockMember" unitRef="USD" decimals="0">964700</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2002-03-31_SeriesAPreferredStockMember" unitRef="USD" decimals="0">964700</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2003-03-31_SeriesAPreferredStockMember" unitRef="USD" decimals="0">964700</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2004-03-31_SeriesAPreferredStockMember" unitRef="USD" decimals="0">964700</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2005-03-31_SeriesAPreferredStockMember" unitRef="USD" decimals="0">964700</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2006-03-31_SeriesAPreferredStockMember" unitRef="USD" decimals="0">964700</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2007-03-31_SeriesAPreferredStockMember" unitRef="USD" decimals="0">964700</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2008-03-31_SeriesAPreferredStockMember" unitRef="USD" decimals="0">964700</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2009-03-31_SeriesAPreferredStockMember" unitRef="USD" decimals="0">964700</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2010-03-31_SeriesAPreferredStockMember" unitRef="USD" decimals="0">964700</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2011-03-31_SeriesAPreferredStockMember" unitRef="USD" decimals="0">964700</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2012-03-31_SeriesAPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2000-03-31" unitRef="USD" decimals="0">964200</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2001-03-31" unitRef="USD" decimals="0">2608000</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2002-03-31" unitRef="USD" decimals="0">3615800</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2003-03-31" unitRef="USD" decimals="0">3615800</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2004-03-31" unitRef="USD" decimals="0">11139000</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2005-03-31" unitRef="USD" decimals="0">13415000</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2006-03-31" unitRef="USD" decimals="0">14534800</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2007-03-31" unitRef="USD" decimals="0">14534800</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2008-03-31" unitRef="USD" decimals="0">14534800</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2009-03-31" unitRef="USD" decimals="0">14534800</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf1998-05-25_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf1998-05-25_SeriesBPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2000-03-31_SeriesBPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2001-03-31_SeriesBPreferredStockMember" unitRef="USD" decimals="0">1643300</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2002-03-31_SeriesBPreferredStockMember" unitRef="USD" decimals="0">2651100</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2003-03-31_SeriesBPreferredStockMember" unitRef="USD" decimals="0">2651100</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2004-03-31_SeriesBPreferredStockMember" unitRef="USD" decimals="0">2651100</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2005-03-31_SeriesBPreferredStockMember" unitRef="USD" decimals="0">2651100</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2006-03-31_SeriesBPreferredStockMember" unitRef="USD" decimals="0">2651100</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2007-03-31_SeriesBPreferredStockMember" unitRef="USD" decimals="0">2651100</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2008-03-31_SeriesBPreferredStockMember" unitRef="USD" decimals="0">2651100</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2009-03-31_SeriesBPreferredStockMember" unitRef="USD" decimals="0">2651100</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2010-03-31_SeriesBPreferredStockMember" unitRef="USD" decimals="0">2651100</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2011-03-31_SeriesBPreferredStockMember" unitRef="USD" decimals="0">2651100</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2012-03-31_SeriesBPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf1998-05-25_SeriesB1PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2000-03-31_SeriesB1PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2001-03-31_SeriesB1PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2002-03-31_SeriesB1PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2003-03-31_SeriesB1PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2004-03-31_SeriesB1PreferredStockMember" unitRef="USD" decimals="0">7523200</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2005-03-31_SeriesB1PreferredStockMember" unitRef="USD" decimals="0">7523200</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2006-03-31_SeriesB1PreferredStockMember" unitRef="USD" decimals="0">7523200</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2007-03-31_SeriesB1PreferredStockMember" unitRef="USD" decimals="0">7523200</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2008-03-31_SeriesB1PreferredStockMember" unitRef="USD" decimals="0">7523200</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2009-03-31_SeriesB1PreferredStockMember" unitRef="USD" decimals="0">7523200</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2010-03-31_SeriesB1PreferredStockMember" unitRef="USD" decimals="0">7523200</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2011-03-31_SeriesB1PreferredStockMember" unitRef="USD" decimals="0">7523200</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2012-03-31_SeriesB1PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf1998-05-25_SeriesCPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2000-03-31_SeriesCPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2001-03-31_SeriesCPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2002-03-31_SeriesCPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2003-03-31_SeriesCPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2004-03-31_SeriesCPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2005-03-31_SeriesCPreferredStockMember" unitRef="USD" decimals="0">2276000</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2006-03-31_SeriesCPreferredStockMember" unitRef="USD" decimals="0">3395800</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2007-03-31_SeriesCPreferredStockMember" unitRef="USD" decimals="0">3395800</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2008-03-31_SeriesCPreferredStockMember" unitRef="USD" decimals="0">3395800</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2009-03-31_SeriesCPreferredStockMember" unitRef="USD" decimals="0">3395800</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2010-03-31_SeriesCPreferredStockMember" unitRef="USD" decimals="0">3395800</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2011-03-31_SeriesCPreferredStockMember" unitRef="USD" decimals="0">3395800</vsta:StockholdersEquityForPreferredStock>
    <vsta:StockholdersEquityForPreferredStock contextRef="AsOf2012-03-31_SeriesCPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriesaPreferredStockAt2.302PerShareForCashNetOfIssuanceCostsOf24000Amount contextRef="From1998-05-26to2000-03-31_SeriesAPreferredStockMember" unitRef="USD" decimals="0">964200</vsta:IssuanceOfSeriesaPreferredStockAt2.302PerShareForCashNetOfIssuanceCostsOf24000Amount>
    <vsta:IssuanceOfSeriesaPreferredStockAt2.302PerShareForCashNetOfIssuanceCostsOf24000Amount contextRef="From1998-05-26to2000-03-31_SeriesBPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriesaPreferredStockAt2.302PerShareForCashNetOfIssuanceCostsOf24000Amount contextRef="From1998-05-26to2000-03-31_SeriesB1PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriesaPreferredStockAt2.302PerShareForCashNetOfIssuanceCostsOf24000Amount contextRef="From1998-05-26to2000-03-31_SeriesCPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriesaPreferredStockAt2.302PerShareForCashNetOfIssuanceCostsOf24000Amount contextRef="From1998-05-26to2000-03-31" unitRef="USD" decimals="0">964200</vsta:IssuanceOfSeriesaPreferredStockAt2.302PerShareForCashNetOfIssuanceCostsOf24000Amount>
    <vsta:IssuanceOfSeriesaPreferredStockAt2.302PerShareForCashNetOfIssuanceCostsOf24000Shares contextRef="From1998-05-26to2000-03-31_PreferredStockMember" unitRef="Shares" decimals="INF">429350</vsta:IssuanceOfSeriesaPreferredStockAt2.302PerShareForCashNetOfIssuanceCostsOf24000Shares>
    <vsta:IssuanceOfSeriesaPreferredStockAt2.302PerShareForCashNetOfIssuanceCostsOf5500Amount contextRef="From2000-04-01to2001-03-31_SeriesAPreferredStockMember" unitRef="USD" decimals="0">500</vsta:IssuanceOfSeriesaPreferredStockAt2.302PerShareForCashNetOfIssuanceCostsOf5500Amount>
    <vsta:IssuanceOfSeriesaPreferredStockAt2.302PerShareForCashNetOfIssuanceCostsOf5500Amount contextRef="From2000-04-01to2001-03-31" unitRef="USD" decimals="0">500</vsta:IssuanceOfSeriesaPreferredStockAt2.302PerShareForCashNetOfIssuanceCostsOf5500Amount>
    <vsta:IssuanceOfSeriesaPreferredStockAt2.302PerShareForCashNetOfIssuanceCostsOf5500Amount contextRef="From2000-04-01to2001-03-31_SeriesBPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriesaPreferredStockAt2.302PerShareForCashNetOfIssuanceCostsOf5500Amount contextRef="From2000-04-01to2001-03-31_SeriesB1PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriesaPreferredStockAt2.302PerShareForCashNetOfIssuanceCostsOf5500Amount contextRef="From2000-04-01to2001-03-31_SeriesCPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriesaPreferredStockAt2.302PerShareForCashNetOfIssuanceCostsOf5500Shares contextRef="From2000-04-01to2001-03-31_PreferredStockMember" unitRef="Shares" decimals="INF">2580</vsta:IssuanceOfSeriesaPreferredStockAt2.302PerShareForCashNetOfIssuanceCostsOf5500Shares>
    <vsta:IssuanceOfSeriesBPreferredStockat5.545PerShareForCashIncludingConversionOf575000FaceValueOf7ConvertibleNotesPlusAccruedInterestOf3800NetOfUnamortizedDiscountOf70800AndIssuanceCostsOf39800Amount contextRef="From2000-04-01to2001-03-31_SeriesAPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriesBPreferredStockat5.545PerShareForCashIncludingConversionOf575000FaceValueOf7ConvertibleNotesPlusAccruedInterestOf3800NetOfUnamortizedDiscountOf70800AndIssuanceCostsOf39800Amount contextRef="From2000-04-01to2001-03-31" unitRef="USD" decimals="0">1643300</vsta:IssuanceOfSeriesBPreferredStockat5.545PerShareForCashIncludingConversionOf575000FaceValueOf7ConvertibleNotesPlusAccruedInterestOf3800NetOfUnamortizedDiscountOf70800AndIssuanceCostsOf39800Amount>
    <vsta:IssuanceOfSeriesBPreferredStockat5.545PerShareForCashIncludingConversionOf575000FaceValueOf7ConvertibleNotesPlusAccruedInterestOf3800NetOfUnamortizedDiscountOf70800AndIssuanceCostsOf39800Amount contextRef="From2000-04-01to2001-03-31_SeriesBPreferredStockMember" unitRef="USD" decimals="0">1643300</vsta:IssuanceOfSeriesBPreferredStockat5.545PerShareForCashIncludingConversionOf575000FaceValueOf7ConvertibleNotesPlusAccruedInterestOf3800NetOfUnamortizedDiscountOf70800AndIssuanceCostsOf39800Amount>
    <vsta:IssuanceOfSeriesBPreferredStockat5.545PerShareForCashIncludingConversionOf575000FaceValueOf7ConvertibleNotesPlusAccruedInterestOf3800NetOfUnamortizedDiscountOf70800AndIssuanceCostsOf39800Amount contextRef="From2000-04-01to2001-03-31_SeriesB1PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriesBPreferredStockat5.545PerShareForCashIncludingConversionOf575000FaceValueOf7ConvertibleNotesPlusAccruedInterestOf3800NetOfUnamortizedDiscountOf70800AndIssuanceCostsOf39800Amount contextRef="From2000-04-01to2001-03-31_SeriesCPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriesBPreferredStockat5.545PerShareForCashIncludingConversionOf575000FaceValueOf7ConvertibleNotesPlusAccruedInterestOf3800NetOfUnamortizedDiscountOf70800AndIssuanceCostsOf39800Shares contextRef="From2000-04-01to2001-03-31_PreferredStockMember" unitRef="Shares" decimals="INF">316282</vsta:IssuanceOfSeriesBPreferredStockat5.545PerShareForCashIncludingConversionOf575000FaceValueOf7ConvertibleNotesPlusAccruedInterestOf3800NetOfUnamortizedDiscountOf70800AndIssuanceCostsOf39800Shares>
    <vsta:IssuanceOfSeriesbPreferredStockat5.545PerShareForCashNetOfissuanceCostsOf97200Amount contextRef="From2001-04-01to2002-03-31_SeriesAPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriesbPreferredStockat5.545PerShareForCashNetOfissuanceCostsOf97200Amount contextRef="From2001-04-01to2002-03-31" unitRef="USD" decimals="0">1007800</vsta:IssuanceOfSeriesbPreferredStockat5.545PerShareForCashNetOfissuanceCostsOf97200Amount>
    <vsta:IssuanceOfSeriesbPreferredStockat5.545PerShareForCashNetOfissuanceCostsOf97200Amount contextRef="From2001-04-01to2002-03-31_SeriesBPreferredStockMember" unitRef="USD" decimals="0">1007800</vsta:IssuanceOfSeriesbPreferredStockat5.545PerShareForCashNetOfissuanceCostsOf97200Amount>
    <vsta:IssuanceOfSeriesbPreferredStockat5.545PerShareForCashNetOfissuanceCostsOf97200Amount contextRef="From2001-04-01to2002-03-31_SeriesB1PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriesbPreferredStockat5.545PerShareForCashNetOfissuanceCostsOf97200Amount contextRef="From2001-04-01to2002-03-31_SeriesCPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriesbPreferredStockat5.545PerShareForCashNetOfissuanceCostsOf97200Shares contextRef="From2001-04-01to2002-03-31_PreferredStockMember" unitRef="Shares" decimals="INF">199286</vsta:IssuanceOfSeriesbPreferredStockat5.545PerShareForCashNetOfissuanceCostsOf97200Shares>
    <vsta:IssuanceOfSeriesb1PreferredStockat5.545ForAcquiredInprocessresearchAndDevelopmentAmount contextRef="From2003-04-01to2004-03-31_SeriesAPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriesb1PreferredStockat5.545ForAcquiredInprocessresearchAndDevelopmentAmount contextRef="From2003-04-01to2004-03-31" unitRef="USD" decimals="0">7523200</vsta:IssuanceOfSeriesb1PreferredStockat5.545ForAcquiredInprocessresearchAndDevelopmentAmount>
    <vsta:IssuanceOfSeriesb1PreferredStockat5.545ForAcquiredInprocessresearchAndDevelopmentAmount contextRef="From2003-04-01to2004-03-31_SeriesBPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriesb1PreferredStockat5.545ForAcquiredInprocessresearchAndDevelopmentAmount contextRef="From2003-04-01to2004-03-31_SeriesB1PreferredStockMember" unitRef="USD" decimals="0">7523200</vsta:IssuanceOfSeriesb1PreferredStockat5.545ForAcquiredInprocessresearchAndDevelopmentAmount>
    <vsta:IssuanceOfSeriesb1PreferredStockat5.545ForAcquiredInprocessresearchAndDevelopmentAmount contextRef="From2003-04-01to2004-03-31_SeriesCPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriesb1PreferredStockat5.545ForAcquiredInprocessresearchAndDevelopmentShares contextRef="From2003-04-01to2004-03-31_PreferredStockMember" unitRef="Shares" decimals="INF">1356750</vsta:IssuanceOfSeriesb1PreferredStockat5.545ForAcquiredInprocessresearchAndDevelopmentShares>
    <vsta:IssuanceOfSeriesCPreferredStockAt6.00PerShareForCashIncludingConversionOf1655000FaceValueOf10ConvertibleNotesPlusAccruedInterestOf408600NetOfUnamortizedNote contextRef="From2004-04-01to2005-03-31_SeriesAPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriesCPreferredStockAt6.00PerShareForCashIncludingConversionOf1655000FaceValueOf10ConvertibleNotesPlusAccruedInterestOf408600NetOfUnamortizedNote contextRef="From2004-04-01to2005-03-31" unitRef="USD" decimals="0">2301500</vsta:IssuanceOfSeriesCPreferredStockAt6.00PerShareForCashIncludingConversionOf1655000FaceValueOf10ConvertibleNotesPlusAccruedInterestOf408600NetOfUnamortizedNote>
    <vsta:IssuanceOfSeriesCPreferredStockAt6.00PerShareForCashIncludingConversionOf1655000FaceValueOf10ConvertibleNotesPlusAccruedInterestOf408600NetOfUnamortizedNote contextRef="From2004-04-01to2005-03-31_SeriesBPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriesCPreferredStockAt6.00PerShareForCashIncludingConversionOf1655000FaceValueOf10ConvertibleNotesPlusAccruedInterestOf408600NetOfUnamortizedNote contextRef="From2004-04-01to2005-03-31_SeriesB1PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriesCPreferredStockAt6.00PerShareForCashIncludingConversionOf1655000FaceValueOf10ConvertibleNotesPlusAccruedInterestOf408600NetOfUnamortizedNote contextRef="From2004-04-01to2005-03-31_SeriesCPreferredStockMember" unitRef="USD" decimals="0">2301500</vsta:IssuanceOfSeriesCPreferredStockAt6.00PerShareForCashIncludingConversionOf1655000FaceValueOf10ConvertibleNotesPlusAccruedInterestOf408600NetOfUnamortizedNote>
    <vsta:IssuanceOfSeriesCPreferredStockAt6.00PerShareForCashIncludingConversionOf1655000FaceValueOf10ConvertibleNotesPlusAccruedInterestOf408600NetOfUnamortizedShares contextRef="From2004-04-01to2005-03-31_PreferredStockMember" unitRef="Shares" decimals="INF">390327</vsta:IssuanceOfSeriesCPreferredStockAt6.00PerShareForCashIncludingConversionOf1655000FaceValueOf10ConvertibleNotesPlusAccruedInterestOf408600NetOfUnamortizedShares>
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithSeriesCPreferredstockAmount contextRef="From2004-04-01to2005-03-31_SeriesAPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithSeriesCPreferredstockAmount contextRef="From2004-04-01to2005-03-31_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithSeriesCPreferredstockAmount contextRef="From2004-04-01to2005-03-31_SeriesBPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithSeriesCPreferredstockAmount contextRef="From2004-04-01to2005-03-31_SeriesB1PreferredStockMember" unitRef="USD" decimals="0">-25500</vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithSeriesCPreferredstockAmount>
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithSeriesCPreferredstockAmount contextRef="From2004-04-01to2005-03-31_SeriesCPreferredStockMember" unitRef="USD" decimals="0">-25500</vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithSeriesCPreferredstockAmount>
    <vsta:ProceedsAllocatedToWarrantsIssuedInConnectionWithSeriesCPreferredstockShares contextRef="From2004-04-01to2005-03-31_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <vsta:IssuanceOfSeriescPreferredStockat6.00PerShareForCashNetOfissuanceCostsOf20700Amount contextRef="From2005-04-01to2006-03-31_SeriesAPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriescPreferredStockat6.00PerShareForCashNetOfissuanceCostsOf20700Amount contextRef="From2005-04-01to2006-03-31" unitRef="USD" decimals="0">839300</vsta:IssuanceOfSeriescPreferredStockat6.00PerShareForCashNetOfissuanceCostsOf20700Amount>
    <vsta:IssuanceOfSeriescPreferredStockat6.00PerShareForCashNetOfissuanceCostsOf20700Amount contextRef="From2005-04-01to2006-03-31_SeriesBPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriescPreferredStockat6.00PerShareForCashNetOfissuanceCostsOf20700Amount contextRef="From2005-04-01to2006-03-31_SeriesB1PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriescPreferredStockat6.00PerShareForCashNetOfissuanceCostsOf20700Amount contextRef="From2005-04-01to2006-03-31_SeriesCPreferredStockMember" unitRef="USD" decimals="0">839300</vsta:IssuanceOfSeriescPreferredStockat6.00PerShareForCashNetOfissuanceCostsOf20700Amount>
    <vsta:IssuanceOfSeriescPreferredStockat6.00PerShareForCashNetOfissuanceCostsOf20700Shares contextRef="From2005-04-01to2006-03-31_PreferredStockMember" unitRef="Shares" decimals="INF">143331</vsta:IssuanceOfSeriescPreferredStockat6.00PerShareForCashNetOfissuanceCostsOf20700Shares>
    <vsta:IssuanceOfSeriescPreferredStockAt6.00PerShareForServicesAndInPaymentOfInterestOnLineOfCreditAmount contextRef="From2005-04-01to2006-03-31_SeriesAPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriescPreferredStockAt6.00PerShareForServicesAndInPaymentOfInterestOnLineOfCreditAmount contextRef="From2005-04-01to2006-03-31" unitRef="USD" decimals="0">280500</vsta:IssuanceOfSeriescPreferredStockAt6.00PerShareForServicesAndInPaymentOfInterestOnLineOfCreditAmount>
    <vsta:IssuanceOfSeriescPreferredStockAt6.00PerShareForServicesAndInPaymentOfInterestOnLineOfCreditAmount contextRef="From2005-04-01to2006-03-31_SeriesBPreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriescPreferredStockAt6.00PerShareForServicesAndInPaymentOfInterestOnLineOfCreditAmount contextRef="From2005-04-01to2006-03-31_SeriesB1PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <vsta:IssuanceOfSeriescPreferredStockAt6.00PerShareForServicesAndInPaymentOfInterestOnLineOfCreditAmount contextRef="From2005-04-01to2006-03-31_SeriesCPreferredStockMember" unitRef="USD" decimals="0">280500</vsta:IssuanceOfSeriescPreferredStockAt6.00PerShareForServicesAndInPaymentOfInterestOnLineOfCreditAmount>
    <vsta:IssuanceOfSeriescPreferredStockAt6.00PerShareForServicesAndInPaymentOfInterestOnLineOfCreditShares contextRef="From2005-04-01to2006-03-31_PreferredStockMember" unitRef="Shares" decimals="INF">46749</vsta:IssuanceOfSeriescPreferredStockAt6.00PerShareForServicesAndInPaymentOfInterestOnLineOfCreditShares>
    <vsta:ConversionOfAllSeriesOfPreferredStockIntoVistagenCommonStockInConnectionWithMergerAmount contextRef="From2011-04-01to2012-03-31" unitRef="USD" decimals="0">-14534800</vsta:ConversionOfAllSeriesOfPreferredStockIntoVistagenCommonStockInConnectionWithMergerAmount>
    <vsta:ConversionOfAllSeriesOfPreferredStockIntoVistagenCommonStockInConnectionWithMergerAmount contextRef="From2011-04-01to2012-03-31_SeriesAPreferredStockMember" unitRef="USD" decimals="0">-964700</vsta:ConversionOfAllSeriesOfPreferredStockIntoVistagenCommonStockInConnectionWithMergerAmount>
    <vsta:ConversionOfAllSeriesOfPreferredStockIntoVistagenCommonStockInConnectionWithMergerAmount contextRef="From2011-04-01to2012-03-31_SeriesBPreferredStockMember" unitRef="USD" decimals="0">-2651100</vsta:ConversionOfAllSeriesOfPreferredStockIntoVistagenCommonStockInConnectionWithMergerAmount>
    <vsta:ConversionOfAllSeriesOfPreferredStockIntoVistagenCommonStockInConnectionWithMergerAmount contextRef="From2011-04-01to2012-03-31_SeriesB1PreferredStockMember" unitRef="USD" decimals="0">-7523200</vsta:ConversionOfAllSeriesOfPreferredStockIntoVistagenCommonStockInConnectionWithMergerAmount>
    <vsta:ConversionOfAllSeriesOfPreferredStockIntoVistagenCommonStockInConnectionWithMergerAmount contextRef="From2011-04-01to2012-03-31_SeriesCPreferredStockMember" unitRef="USD" decimals="0">-3395800</vsta:ConversionOfAllSeriesOfPreferredStockIntoVistagenCommonStockInConnectionWithMergerAmount>
    <vsta:ConversionOfAllSeriesOfPreferredStockIntoVistagenCommonStockInConnectionWithMergerShares contextRef="From2011-04-01to2012-03-31_PreferredStockMember" unitRef="Shares" decimals="INF">-2884655</vsta:ConversionOfAllSeriesOfPreferredStockIntoVistagenCommonStockInConnectionWithMergerShares>
</xbrli:xbrl>
</XBRL>
